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O Trypanosoma brucei é um protozoário unicelular que vive na corrente 
sanguínea e espaços intersticiais de um hospedeiro mamífero e que é transmitido pela 
mosca tsétsé, o seu vetor de transmissão. Em humanos, o T. brucei causa a doença do 
sono. O T brucei tem um ciclo de vida complexo no qual o parasita passa por vários 
estadios de desenvolvimento. Dentro do mamífero, o parasita vive sob a forma de 
tripomastigotas sanguíneos (bloodstream forms; BSFs), e após ser transmitido para a 
mosca tsé-tsé, diferencia-se em tripomastigotas procíclicos (procyclic forms; PFs). O 
parasita T. brucei é um organismo que divergiu cedo na evolução e que possui muitas 
características pouco usuais para um eucariota. A sua transcrição é maioritariamente 
constitutiva e executada pela RNA polimerase II (Pol II)., enquanto que a RNA 
polimerase I (Pol I) transcreve não só os RNAs ribossomais, mas também genes 
codificantes de proteínas. Entre os genes transcritos por Pol I encontram-se os genes 
que codificam as glicoproteínas variantes de superfície (variant surface glycoproteins; 
VSGs) e as prociclinas. As VSGs e as prociclinas são proteínas muito abundantes que 
revestem a superfície dos BSFs e dos PFs, respetivamente, e cuja expressão é 
estritamente regulada ao longo do desenvolvimento do parasita. 
Nos BFSs, os genes das VSGs são transcritos em locais de expressão 
subteloméricos (bloodstream expression sites; BESs). Existem cerca de 15 BESs no 
genoma, contudo apenas um está transcricionalmente ativo em determinado 
momento. Os restantes BESs necessitam de ser mantidos silenciados por forma a 
manter a expressão monoalélica de um único BES. Para evitar o reconhecimento pelo 
sistema imunitário do hospedeiro, periodicamente os parasitas mudam o gene VSG 
expresso, através de um mecanismo denominado de variação antigénica. Nos BSFs o 
loci das prociclinas também está parcialmente reprimido por forma a evitar a 
substituição das VSGs por prociclinas à superfície. Existem evidências de que em T. 
brucei alguns fatores epigenéticos regulam a ativação ou o silenciamento transcricional 
de Pol I nos BESs e loci das prociclinas. Para além disso, existem algumas variantes de 
histonas e modificações pós-traducionais de histonas que estão associadas com os 




No núcleo de células eucarióticas o DNA encontra-se enrolado em volta de um 
octâmero de histonas formando o nucleosoma, a unidade básica da cromatina. A 
histona H1 (H1) liga-se ao DNA que entra e sai do nucleosoma, estabilizando a sua 
estrutura e contribuindo para o estabelecimento de estruturas de cromatina de ordem 
mais elevada. Em T. brucei a H1 é codificada por pelo menos 5 genes que, de acordo 
com a sua sequência proteica esperada, podem agrupar-se em 3 classes. No meu 
trabalho de doutoramento, tive por objetivo investigar as funções da H1 na estrutura 
da cromatina, na expressão génica e na transcrição de T. brucei. Para além disso, 
também foi estudada a importância da H1 nas infeções in vivo de T. brucei no 
hospedeiro mamífero. 
Foram realizados estudos funcionais em que se depletaram todas as classes de 
H1 por RNA de interferência (RNAi). Na presença de tetraciclina, RNAs de dupla-cadeia 
são produzidos que induzem a depleção dos RNAs mensageiros (mRNAs) de H1. 
Usando imunoprecipitação de chromatina (chromatin immunoprecipitation; ChIP) 
associada a histona H3 e formaldehyde-assisted isolation of regulatory elements 
(FAIRE), detetou-se uma descondensação global de cromatina ao longo do genoma nos 
parasitas depletados de H1. No entanto, esta descondensação foi mais proeminente 
nos promotores de BES silenciados e nos loci de prociclinas, apesar de mais 
ligeiramente nestes últimos. Curiosamente, a sequenciação de RNA (RNA-Seq) revelou 
que a abertura global da cromatina devida à depleção de H1 não estava associada a 
alterações generalizadas de expressão génica mas pelo contrário à desrepressão de um 
subgrupo específico de genes. De cerca de 9000 genes, apenas 26 passarm a ser 
significativamente sobreexpressos, maioritariamente genes de BESs silenciados 
(inclusive VSGs silenciados) e genes de loci de prociclinas. Eu adaptei e apliquei a 
marcação metabólica de RNA com 4-tiouridina (4sU) em T. brucei para purificar e 
quantificar os transcritos nascentes produzidos nos loci transcritos por Pol I e Pol II. A 
marcação com 4sU traz vantagens em relação à técnica classicamente utilizada de 
nuclear run–on, por permitir a medição da transcrição de novo em células não 
perturbadas. A quantificação de RNA nascente marcado com 4sU demonstrou que a 
H1 é necessária para reprimir a transcrição de Pol I nos BESs silenciados e nos loci de 




No seu conjunto, os nossos resultados suportam um modelo em que a H1 induz 
a compactação global de cromatina, mas desempenha funções mais específicas no que 
respeita à expressão génica, nomeadamente a regulação transcricional de genes 
silenciados de Pol I. Este modelo é consistente com a noção de que a transcrição 
policistrónica por Pol II, que ocorre na maior parte do genoma de tripanossomas, é 
constitutiva e a maioria dos genes são controlados ao nível pós-transcricional. Pelo 
contrário, existem evidências de que os genes transcritos por Pol I são regulados ao 
nível transcricional, consistente com a função da H1 no silenciamento da 
iniciação/elongamento da transcrição por Pol I. 
Outro fenótipo observado em parasitas depletados de H1 foi um aumento da 
resistência a danos no DNA induzidos por metanossulfonato de metilo (MMS). Esta 
observação poderá indicar que a H1 desempenha funções mais gerais ao suprimir a 
recombinação homóloga e, talvez, a instabilidade genómica. 
Interessantemente, os parasitas de T. brucei depletados em H1 revelaram uma 
aparente perda de fitness durante infeções in vivo. Em murganhos infetados com 
parasitas depletados em H1, a progressão da parasitémia (percentagem de parasitas 
no sangue) foi mais lenta e os murganhos sucumbiram mais tarde. Curiosamente, este 
fenótipo foi completamente abolido em murganhos severamente imuno-
comprometidos que não possuem linfócitos T, B e NK, demonstrando que a fitness de 
parasitas depletados em H1 é perturbada porque, de alguma forma, estes parasitas 
tornam-se mais suscetíveis ao sistema imunitário do hospedeiro. 
Coletivamente os nossos resultados mostram que a H1 de T. brucei, um 
parasita que divergiu cedo na evolução, tem capacidades abrangentes porque é 
necessária para compactar a cromatina globalmente ao longo do genoma, mas em 
termos de transcrição desempenha funções específicas porque inibe a transcrição de 
um grupo restrito de genes, nomeadamente de loci silenciados transcritos por Pol I. A 
regulação de um grupo específio de genes mediada por H1 foi também observada 
noutros eucariotas superiores e inferiores, o que sugere que apesar de ser a família 






Trypanosoma brucei is a unicellular protozoan parasite that lives in the 
bloodstream and interstitial spaces of a mammalian host and that is transmitted by the 
tsetse, an insect vector. In humans, it causes sleeping sickness. T. brucei has a complex 
life cycle that progresses through different developmental stages. Inside the mammal, 
the parasite lives as bloodstream forms (BSFs), which differentiates differentiates into 
procyclic forms (PFs) upon transmission to the insect vector. T. brucei is an 
evolutionarily early-branching organism that possesses many unusual features for an 
eukaryote. Most of its transcription is constitutive and driven by RNA polymerase II 
(Pol II) and RNA polymerase I (Pol I) transcribes not only ribosomal RNA genes, but also 
protein-coding genes, including genes encoding variant surface glycoproteins (VSGs) 
and procyclins. These are highly abundant proteins that cover the surface of the BSFs 
and the PFs, respectively, and whose expression is tightly developmentally regulated. 
In BSFs, VSGs are transcribed in subtelomeric bloodstream expression sites 
(BESs). There are ~15 BESs in the genome, however only one is fully transcriptionally 
active at a time. The remaining BESs need to be kept silent to maintain monoallelic 
expression of BES. To evade the host immune system, parasites switch the expressed 
VSG from time to time by a mechanism called antigenic variation. In addition, in BSFs 
procyclin loci are also partially repressed to prevent illegitimate VSG replacement for 
procyclins. Some epigenetic factors have been found to regulate Pol I transcriptional 
activation/silencing at BESs and procyclin loci. Besides, a number of histone variants 
and histone modifications seem to be associated with Pol II transcription initiation and 
termination. 
Inside the eukaryotic nucleus, DNA is wrapped around an octamer of histones 
that forms the nucleosome, the basic unit of chromatin. Linker histone or histone H1 
(H1) binds to the DNA entering and exiting the nucleosome, stabilizing its structure and 
contributing to the establishment of higher-order chromatin structures. In T. brucei, H1 
is encoded by at least five genes and, based on the predicted protein sequence, they 




chromatin structure, genome-wide gene expression and transcription in T. brucei. In 
addition, the importance of H1 for T. brucei mammalian infections in vivo was also 
addressed. 
Functional studies were performed by simultaneously depleting all classes of 
H1 by RNA interference (RNAi). Using chromatin immunoprecipitation (ChIP) of histone 
H3 and formaldehyde-assisted isolation of regulatory elements (FAIRE), in H1-depleted 
parasites we detected a global chromatin opening across the genome, even though 
this happened at silent BESs promoters more prominently and procyclin loci, to a 
lesser extent. Curiously, RNA sequencing (RNA-Seq) revealed that global chromatin 
opening due to H1 depletion is not associated with widespread alterations in gene 
expression but rather with derepression of a specific subset of genes. Out of ~9,000 
genes, only 26 were significantly upregulated, mostly from silent BESs (including silent 
VSGs) and procyclin loci genes. I adapted and used 4-thiouridine (4sU) metabolic 
labeling of RNA in T. brucei to purify and quantify nascent transcripts emanating from 
Pol I and Pol II-transcribed loci. 4sU-labeling has the advantage over classical nuclear 
run-on of measuring transcription de novo in unperturbed cells. Quantification of 4sU-
labeled nascent RNA showed that H1 is necessary to repress Pol I transcription at silent 
BESs and procyclin loci but apparently not at Pol II genes. 
Altogether our data strongly supports a model in which H1 induces global 
chromatin compaction, but in what concerns gene expression, H1 plays more specific 
functions, namely on transcriptional regulation of silent Pol I transcribed genes. This is 
consistent with the long-stand notion that polycistronic transcription by Pol II is 
constitutive and most genes are controlled essentially at the post-transcriptional level. 
On the other hand, Pol I genes are known to be regulated at the transcriptional level, 
consistent with a role of H1 in silencing Pol I transcription initiation/elongation. 
An additional phenotype observed in H1-depleted parasites was its increased 
resistance to methyl methanoesulfonate (MMS)-induced DNA damage. This might 
indicate that H1 also plays a more general role such as suppressing homologous 




Interestingly, H1-depleted T. brucei parasites revealed an apparent loss-of-
fitness during in vivo infections. In mice infected with H1-depleted parasites, 
progression of parasitaemia (percentage of parasites in the blood) was delayed and 
mice succumbed later in infection. Curiously, this phenotype was completely abolished 
in highly immune-compromised mice that lack T, B and NK lymphocytes, 
demonstrating that fitness of H1-depleted parasites inside the host is impaired 
because, somehow, these parasites are more susceptible to host immune system. 
Altogether our results show that H1 of the early divergent T. brucei has ‘broad 
skills’ because it compacts chromatin throughout the genome, but it plays ‘specific 
functions’ at the transcription level because it represses transcription of a limited 
cohort of genes, namely silent Pol I loci. H1-mediated regulation of a specific set of 
genes was also observed in other higher and lower eukaryotes, which suggests that 








1.1 TRYPANOSOMA BRUCEI 
1.1.1 EARLY EVOLUTIONARY ORIGINS  
If origin of Life is one of the biggest mysteries in Biology, deciphering the 
evolution of the first eukaryotic lineages is not a minor enigma. At the early branches 
of the eukaryotic tree of life, many groups of protists have daunted phylogenetic 
positioning, diverging incredibly from the plant, fungi and animal branches. Despite its 
apparent simplicity as organisms, about 1,000 million years of life on Earth (Eme et al., 
2014) set the grounds for a tremendous diversification in lifestyles and the emergence 
of exceptional biological features among them. An emblematic example is the 
supergroup Excavata, phylum Euglenozoa to which the parasite Trypanosoma brucei 
belongs. Given its unique and divergent properties, the root of eukaryotic tree was 
even proposed to lie within Euglenozoa or between it and all other eukaryotes, which 
would place T. brucei as one of the earliest branching organisms. Independently of the 
veracity of this hypothesis, trypanosomes such as T. brucei stand as evolutionary highly 
distant organisms from the well-known eukaryotic groups of animals, fungi and plants 
(Cavalier-Smith, 2010). 
T. brucei is a unicellular flagellate that parasitizes the bloodstream and 
interstitial spaces of various mammalian hosts following transmission by flies of the 
genus Glossina, also known as ‘tsetse’ flies. Within Euglenozoa, trypanosomes belong 
to a very particular clade, the Kinetoplastida, marked by the presence of special 
mitochondrial DNA, the kinetoplast or kinetoplast DNA (kDNA). This is a very large, 
usually disc-shaped mass consisting of an extensive network of interlocked circular 
DNA molecules, located adjacent to the basal body at the base of the flagellum. As its 
name indicates, kDNA arose uniquely in these organisms (Adl et al., 2012) (Fig. 1). 
Trypanosomatida, such as T. brucei, offer a rare opportunity to study the origin 
and evolution of parasitism. This is because trypanosomatids were the only 




adaptations to succeed in a lifetime co-existence with their hosts (Lukes et al., 2014). 
Researcher’s attention has focused particularly on trypanosomatids that represent a 
burden for public health and agricultural economy, namely species that infect humans 
and livestock from the Trypanosoma and Leishmania genus. These trypanosomatid 
species share their life between a variety of mammalian hosts and insect vectors and 
might develop intracellularly in host cells at some stage of its life cycle, such as T. cruzi 
and Leishmania spp., or, as in the case of T. brucei, live exclusively as extracellular 
parasites. 
My PhD work focused on the study of Trypanosoma brucei. T. brucei holds a 
number of unusual, some unique, biological characteristics, which can go from 
transcription and nucleus organization to cell cycle, metabolism and surface proteins. 
While some are shared by most trypanosomatids, others, such as antigenic variation of 
its protective coat of variant surface glycoproteins (VSGs), are exclusive to African 
trypanosomes and arose as extremely efficient adaptations to life inside its hosts. The 
availability of a fully sequenced genome (Berriman et al., 2005) and of a variety of 
molecular tools, including an RNA interference (RNAi) system (Ngo et al., 1998), has 
made of Trypanosoma brucei a favorite model to gain insights not only about the 
biology, evolution and disease mechanisms in trypanosomatids, but also for 
fundamental questions in eukaryotic cell biology. Indeed, many important discoveries 
in eukaryotic molecular biology were made in cultured T. brucei such as RNA editing 
(Benne et al., 1986), trans-splicing (Boothroyd & Cross, 1982) and 
glycosylphosphatidylinositol (GPI) anchors (Ferguson et al., 1988); also, the 
hypermodified DNA base J (Gommers-Ampt et al., 1993), the glycosomes (Opperdoes 
& Borst, 1977) and, quite recently, an unconventional set of kinetochore proteins 
(Akiyoshi 2014) were first identified in T. brucei. Besides, this parasite has been used as 
a privileged model organism for studying the eukaryotic flagella (Baron et al., 2007, 





1.1.2 AFRICAN TRYPANOSOMIASIS 
African trypanosomiasis encompasses a variety of human and animal 
pathologies caused by infection with different Trypanosoma species, after 
transmission through the bite of an infected tsetse fly (Gibson, 2007). It affects mainly 
sub-Saharan Africa, where suitable environmental conditions exist for the presence of 
the tsetse fly vector (Glossina spp.) (WHO, 2013). Among African trypanosomes, only 
Trypanosoma brucei is pathogenic for humans, causing human African trypanosomiasis 
(HAT), more specifically two of its subspecies: T. b. gambiense and T. b. rhodesiense. A 
third T. brucei subspecies, T. b. brucei is non-infective for humans, but parasitizes 
domestic and wild animals, causing a disease called Nagana. Because of its proximity to 
the human infective subspecies, T. b. brucei has been widely used as an experimental 
model of HAT in murine and rat animal models (Giroud et al., 2009, Mogk et al., 2014). 
Clinically, HAT develops in two stages. In the first or early stage, parasites live in 
the lymphatic system and bloodstream. After a variable period, a late or second stage 
starts when the trypanosomes invade the central nervous system. This late stage is 
accompanied by progressive neurological damage leading to neuropsychiatric, motor 
and sensory disturbances that eventually result into coma and death (WHO, 2013, 
Brun et al., 2010). The disease owes its name of ‘sleeping sickness’ due to the sleep 
disorders long known to characterize most late-stage HAT patients. Sleep 
abnormalities include a deregulation of the circadian rhythm of the sleep/wake cycle 
characterized by periods of nocturnal insomnia and daytime sleep, episodes of 
uncontrollable sleep, and fragmentation of the normal sleep structure (Blum et al., 
2006, Buguet et al., 2005). 
HAT is usually considered lethal if left untreated; however sporadic cases of 
natural progression to asymptomatic carriage or even apparent spontaneous 
resolution of the infection have been reported for gambiense HAT, resembling the 
trypanotolerance phenomena described for some African cattle species (Jamonneau et 
al., 2012, Guirnalda et al., 2007). 
Although the pathologies caused by gambiense and rhodesiense subspecies are 




sickness, they have different epidemiology and clinical progression. T. b. gambiense is 
found in Western and Central Africa and occurs mainly in humans, accounting for the 
vast majority of HAT cases, about 98% in the last decade (WHO, 2013). It is 
characterized by a chronic progression with an average duration of almost 3 years 
(Seyffer et al., 2012). By contrast, T. b. rhodesiense is found in Eastern and Southern 
Africa and generally causes an acute diseases that rapidly progresses into second-
stage, leading to death within 6 months (Oguchi et al., 2012). However, it is less 
adapted to human beings, affecting mostly animals (livestock and wildlife), which act 
as dangerous reservoirs of the parasite (WHO, 2013). 
The resurgence of HAT epidemics in the 1980’s and 1990’s alerted the 
international community for the risks of neglecting this disease. Since then, an 
international coordinated effort lead by the World Health Organization reinforced 
control and surveillance programs which lead to a drop in HAT cases since 2009 to less 
than 10,000 new cases per year (WHO, 2013). Nevertheless, it is believed that a 
substantial number of cases remain unreported and more recent estimates predict 
that 70 million people in tropical Africa are at risk for HAT (WHO, 2013).  
As a whole, African trypanosomiasis represents a serious health and socio-
economic problem. Besides the severe life threat posed by HAT, animal African 
trypanosomiasis (AAT), or Nagana causes around 3 million cattle deaths and total 
annual losses of US$ 4.75 billion. AAT is an incredibly heavy burden particularly in rural 
areas where livestock production is the main livelihood, perpetrating 
underdevelopment and poverty in these regions (FAO, 2014). 
In humans, a major obstacle for eradication of HAT is the insufficiency of the 
existent treatments. No prophylactic treatment or vaccine is available and the drugs 
used to treat early and late-stage HAT are in their majority not accessible orally, often 
very toxic, and sometimes ineffective (Kennedy, 2013). While some new promising 
drugs are on the pipeline (e.g. fexinidazole and oxaborole SCYX-7158) 
(http://www.dndi.org) (Kennedy, 2013), investment on the search for more effective 
treatments has been set as a priority. That, together with continued surveillance, 




Organization’s target to eliminate HAT as a public health problem by 2020 (WHO, 
2015). 
 
1.1.3 A CHALLENGING LIFE - FROM MAMMAL TO FLY 
As for the other trypanosomes, Trypanosoma brucei is a heteroxenous parasite 
i.e. requires more than one obligatory host to complete its life cycle: a mammalian 
host and the blood-feeding tsetse fly vector. Infection in the mammal starts with a bite 
of an infected tsetse that inoculates the infective cell cycle-arrested metacyclic stage 
into the mammal bloodstream and draining lymphatics. T. brucei then differentiates to 
a long slender bloodstream form (BSF) that divides asexually by binary fission. In the 
mammal, parasites can live extracellularly in the blood or in the extravascular fluids 
and interstitial spaces of organs and tissues. At high parasite density, a yet unidentified 
parasite-released factor induces differentiation of long slender forms to short stumpy 
BSFs, passing through an intermediate form (Vassella et al., 1997, Reuner et al., 1997). 
Stumpy forms are non-dividing cells and the only life cycle stage transmissible to the 
tsetse, which can occur during a blood meal of the fly. 
Once in the fly midgut, the stumpy forms differentiate into procyclic forms 
(PFs), which re-enter the cell cycle, actively multiplying and colonizing the fly gut. PFs 
undergo a complex differentiation process while migrating to the fly proventriculus. 
During this process each PF gives rise by an asymmetric cell division to one long and 
one short epimastigote; the long epimastigotes are not able to proceed in 
development while the short epimastigotes migrate to the tsetse salivary glands. Here, 
they attach to epithelial cells and start to multiply. Attached epimastigotes are the only 
life cycle stage known to perform meiosis (Peacock et al., 2011). Finally, in the salivary 
glands, epimastigotes differentiate to metacyclic forms, ready to be transmitted back 
to the mammalian host by a tsetse bite (Sharma et al., 2009) (Fig. 1). 
Throughout its life cycle, T. brucei exhibits a series of specific adaptations that 
allow it to cope with the completely different environments it encounters in the 
mammal and the fly. The several life cycle stages reflect the alterations undergone by 




Figure 1. Life cycle of African trypanosomes. In the bloodstream of the mammalian host, 
parasites exist as a polymorphic population of bloodstream forms (BSFs) consisting of dividing 
(black arrows) slender forms and cell cycle arrested intermediate and stumpy forms. In the 
tsetse fly vector, after entering the midgut, stumpy forms differentiate to the procyclic forms 
(PFs), which further develop to the migrating epimastigotes. In the salivary glands, the latter 
transform into the infective metacyclic forms, which are injected during the next blood meal of 
the fly into the mammalian host (adapted from Brun et al., 2010). 
proliferation and transmissibility. The process of differentiating from one life cycle 
stage to the other is complex and implicates deep changes in cell morphology and 
ultrastructure, metabolism, cell cycle and cell surface proteins, accompanied by a 
strong reprogramming in gene expression (Kramer, 2012). 
So far, the best-studied differentiation pathway in T. brucei, and in 
kinetoplastids in general, is the differentiation of BSFs to PFs. Five recent studies 
brought to light the genome-wide changes in gene expression between these two 
developmental stages identifying a significant percentage of genes that are 




the technology used) (Jensen et al., 2009, Kabani et al., 2009, Nilsson et al., 2010, 
Siegel et al., 2010, Veitch et al., 2010, Queiroz et al., 2009). This reflects the 
extraordinary parasite capacity of rapidly remodeling its gene expression pattern upon 
sensing the environmental changes that take place when switching hosts. 
One of the fundamental changes occurring when T. brucei alternates between 
the mammal and the insect is the dramatic change of its surface protein composition. 
Inside the fly, PFs are coated with highly acidic and repetitive proteins, the procyclins 
(GPEET and EP procyclins), (Roditi et al., 1989, Clayton & Mowatt, 1989, Vassella et al., 
2001) which are later exchanged for a coat of brucei alanine-rich protein (BARP) coat in 
epimastigotes (Urwyler et al., 2007). Further differentiation into the metacyclic stage 
replaces BARPs for a dense coat of metacyclic variant surface glycoproteins (MVSGs). 
After transmission to the mammal, a similar type of VSG (Cross, 1975) is maintained as 
the major surface protein in the BSF slender and stumpy forms of T. brucei (Vickerman, 
1985). When stumpy forms differentiate to PFs, the VSG coat is shed and replaced by 
procyclins (Roditi et al., 1989) (Fig. 1). 
As extracellular parasites, one of the major challenges that T. brucei is 
confronted with are the host’s natural defenses. The cell surface of the parasite lies at 
the host-parasite interface, serving as a first line of defense against the attacks 
mounted by the host. In PFs, the procyclin coat is crucial for parasite survival in the 
tsetse midgut (Ruepp et al., 1997, Acosta-Serrano et al., 2001). On the other hand, in 
BSFs the very dense coat of VSGs is crucial for protecting the parasite against the 
mammalian immune system. VSGs are molecules of approximately 55-65 kDa (Cross, 
1975), which are present at the parasite cell surface as homodimers and are attached 
to the membrane by a GPI moiety (Ferguson et al., 1988). A stunning number of VSG 
homodimers are tightly and orderly packed at the parasite surface: ~107 VSG molecules 
per parasite (Jackson et al., 1985), which account for about 90% of its surface proteins 
(Grunfelder et al., 2002). Although the VSG family displays extensive sequence 
variation, the secondary and tertiary structure of these molecules is highly conserved 
(Blum et al., 1993, Carrington & Boothroyd, 1996), maybe to ensure that a dense VSG 




The VSG coat is a remarkable protective barrier against the innate and the 
adaptive immune system of the mammal. VSG protects parasites against recognition 
and lysis by the alternative complement pathway (Ferrante & Allison, 1983) and from 
anti-VSG antibody-mediated phagocytosis (Guirnalda et al., 2007, Pan et al., 2006). At 
low antibody titres, protection against antibody-mediated killing results in part from 
clearance of antibody-VSG complexes from the parasite surface, facilitated by the high 
rates of endocytosis and surface recycling existent in T. brucei (Barry, 1979, Natesan et 
al., 2007) and the hydrodynamic forces generated by its flagellar movement (Engstler 
et al., 2007). Additionally, the dense VSG coat is probably shielding many other cell-
surface molecules from immune recognition such as invariant or less variable protein 
domains such as the VSG C-terminal domain (Schwede et al., 2011). There is also 
evidence that VSG shed from the membrane contributes to immune suppression of 
both B- and T-cell activation (Mansfield & Paulnock, 2005). 
Even though all these phenomena cooperate to defend the parasite against the host 
immune response, T. brucei accomplishes immune evasion primarily through another 
exceptional strategy: antigenic variation of the VSG. As it will be discussed next, 
antigenic variation is as far as we know the leading process that allows the T. brucei 
parasite to thrive against the immune attack and persist in the bloodstream of the 
mammal for prolonged periods. 
 
1.1.4 ANTIGENIC VARIATION - THE POWER OF CHANGING 
Paradoxically, although the VSG coat is essential for immune evasion, it is 
extremely immunogenic. Most VSGs possess an N-terminal ‘variable’ domain, with 
high sequence divergence and which contains the epitopes exposed at the surface 
(Miller et al., 1984, Cross, 1984). The VSG C-terminal domain is generally more 
conserved and encodes the subsurface GPI-anchor signal (Cross, 1984, Carrington et 
al., 1991). The VSG epitopes strongly elicit an antibody response in the mammal 
(Morrison et al., 1982, Black et al., 2010). The parasite has the capacity to evade 




Figure 2. Antigenic variation during T. brucei infection. During infection the overall 
parasitaemia, i.e. ‘total parasite burden’ in the blood varies in a wave-like manner (upper black 
line). Peaks correspond to maximal parasite density and valleys represent massive parasite 
clearance primarily by the action of VSG-specific antibodies produced by the host. A small 
number of VSG variants (‘major’) dominate the infections peaks, but the entire number of 
variants expressed at any time is greater and there may be many VSGs present in low abundance 
(‘minor’). Except for the ‘total parasite burden’, each line corresponds to different VSGs and 
peaks only once. The first peak is frequently dominated by the VSG most expressed in the initial 
population (day 0) (adapted from McCulloch & Field, 2015). 
Typically during a T. brucei infection, VSG epitopes are recognized and activate 
host B-cells to produce VSG-specific antibodies against the ‘major’, predominantly 
expressed VSG in the population. The anti-VSG antibodies produced are largely 
responsible for clearing most of the parasites, leading to a drop in parasitaemia, i.e. in 
parasite density in the blood (Black et al., 2010). A few parasites in the population have 
switched their VSG and represent ‘minor’ VSG variants that have not been recognized 
yet by the immune system; as a result, these parasites will successfully replicate and 
substitute the previous parasite population. As prior VSG variants are recognized by 
the immune system and cleared, newly switched variants emerge, giving rise to the 
characteristic periodic waves of parasitaemia, with several infection peaks which 
reflect the episodes of parasite clearance and relapse, described for the first time in 
humans more than a century ago (Ross & Thomson, 1910) (Fig. 2). 
Antigenic variation relies on two key features: VSG monoallelic expression and 




out of a genomic repertoire of ~2,000 VSG genes encoding different variants of the 
protein (Cross et al., 2014). Therefore, each parasite expresses only one VSG variant at 
the surface at a time. The active VSG gene is expressed from a specialized subtelomeric 
locus called a bloodstream expression site (BES). Of the ~15 BESs present in the 
genome (Hertz-Fowler et al., 2008), only one BES is transcriptionally active, while the 
others are silent. 
VSG switching can occur via different molecular mechanisms. The most 
frequent mechanism is the activation of a silent VSG by homologous recombination 
(HR) into the active BES (Robinson et al., 1999). Recombination is the only way to 
access the VSG repertoire of ~2000 genes that lie mainly in subtelomeric non-BES loci 
The most frequent HR switching mechanism is the so-called duplicative gene 
conversion. This involves duplication and insertion of an inactive telomeric or array 
VSG into the active BES, replacing the previously active VSG gene. A new VSG might 
also be assembled by segmental gene conversion in which segments of VSG genes and 
pseudogenes are copied and recombine to generate novel functional ‘mosaic’ VSGs 
that will replace the previously active VSG. In addition, HR can also mediate a telomere 
exchange in which reciprocal crossover between two telomeres (no DNA sequence is 
lost) and their associated VSGs takes place. 
VSG switching can also be recombination-independent. This less common 
mechanism consists of a transcriptional activation of a different BES and silencing of 
the previous one with no involvement of DNA rearrangements by recombination. This 
is termed in situ switch (McCulloch et al., 2015, Rudenko, 2011). In contrast with BSFs, 
in situ transcriptional activation is considered to be the only route by which MVSGs are 
activated in metacyclic parasites (Barry & McCulloch, 2001). 
Curiously, trypanosome infections typically show hierarchical expression of 
individual VSGs in which some variants appear early in infection while others appear 
progressively later (Gray, 1965, Miller & Turner, 1981, Morrison et al., 2005, Marcello 
& Barry, 2007). This sequential expression seems to depend on the differential 
activation probabilities of each VSG, which are dictated in part by the type of genetic 




telomeric VSGs resident in BESs and minichromosomes followed by inactive VSGs from 
subtelomeric arrays, and subsequently by ‘mosaic’ VSGs (Robinson et al., 1999, 
Morrison et al., 2005, Aitcheson et al., 2005, Marcello & Barry, 2007, Lythgoe et al., 
2007, Hall et al., 2013, McCulloch et al., 2015). 
We know that one infection peak can actually be composed by mixtures of 
subpopulations expressing more than one VSG variant (Miller & Turner, 1981, Hajduk 
& Vickerman, 1981, Robinson et al., 1999, Barry & McCulloch, 2001) (Fig. 2). Recent 
studies observed that although a small number of VSG variants dominate in each peak 
of infection, there was a higher than expected diversity of total VSG variants being 
expressed at any given time (an average of 20-30 VSG variants/peak). As a result, 
probably most of the intact VSG repertoire is exhausted rather early in infection and 
recombinatorial mechanisms such as mosaic formation should be critical to expand the 
VSG repertoire. Perhaps the assembly of mosaic VSGs can even be the predominant 
switch mode in nature, where infections are sustained for long periods (Hall et al., 
2013, Mugnier et al., 2015).  
It is important to note that VSG switching does not depend on the immune 
response to occur because T. brucei still switches VSG in axenic cultures (Doyle et al., 
1980). Nevertheless, switching rates are noticeably higher (10-2-10-5 
switches/trypanosome/generation) in strains recently isolated from nature or fly-
transmitted which are ‘pleomorphic’, i.e. that retain the capacity to differentiate into 
stumpy forms and are tsetse transmissible (Turner & Barry, 1989, Turner, 1997). By 
contrast, in laboratory-adapted ‘monomorphic’ strains, which have lost the ability to 
naturally differentiate into the stumpy stage and complete the life cycle, switching 
frequencies are typically low (10-4-10-7 switches/trypanosome/generation) (Lamont et 
al., 1986, Aitcheson et al., 2005, Boothroyd et al., 2009). This supports the view that 
VSG switching is a stochastic process in which antibodies act chiefly a selective force, 
rather than a trigger. 
Antigenic variation is essential for parasite survival. However, it needs to be 
balanced in order ensure infection chronicity. While VSG switching needs to occur at a 




should be kept under certain limits to avoid VSG repertoire exhaustion or host immune 
system overwhelming (Gjini et al., 2010). The interplay between antigenic variation 
and stumpy differentiation seems critical for this balance. Stumpy forms are the only 
transmissible stage to the tsetse fly and differentiate at high parasite densities 
apparently through a quorum-sensing-like mechanism (Vassella et al., 1997, Reuner et 
al., 1997). Although slender forms establish the first BSF population within the 
mammal, stumpy forms predominate in chronic infections (MacGregor et al., 2011). 
Since stumpy forms do not divide and do not switch VSG they contribute to prevent 
population overgrow and limit the frequency of emergence of new VSG variants, 
optimizing the balance between transmission probability, parasite virulence and 
chronicity of infection (Matthews et al., 2015, MacGregor et al., 2011). 
 
1.2 CHROMATIN 
1.2.1 GENOME ORGANIZATION 
Trypanosoma brucei is a diploid organism with a nuclear genome of 
approximately 35 Mb/haploid DNA content. Despite its small genome, the karyotype in 
T. brucei is remarkable, consisting of more than 120 chromosomes (Berriman et al., 
2005) divided into three different classes according to their size: 11 megabase 
chromosomes (1-6 Mb), 1-5 intermediate chromosomes (200-900 kb) and ~100 
minichromosomes (30-150 kb) (Melville et al., 2000, Wickstead et al., 2004, Cross et 
al., 2014). The core of minichromosomes consists mostly of repetitive palindromes of 
177-bp repeats (Wickstead et al., 2004). Intermediate chromosome structure is not 
entirely known but it shares with minichromosomes a large core of 177-bp repeats 
(Wickstead et al., 2004). Some strains of T. brucei also contain nuclear 
extrachromosomal circular DNAs, termed NlaIII repeat-elements (Alsford et al., 2003) 
of unknown function. 
About 15% of the total DNA in trypanosomes corresponds to the kDNA which 
consists on a intertwined network of thousands of double-stranded circular DNA 
molecules which include large maxicircles (~23 kb) (Sloof et al., 1992) and smaller 




eukaryotes, maxicircles encode ribosomal RNA (rRNA) genes plus genes mostly coding 
for subunits of the mitochondrial membrane complexes involved in oxidative 
phosphorylation. The kinetoplast has a special replication and segregation mechanism, 
prior to nuclear DNA replication and division, respectively (Jensen & Englund, 2012, 
Woodward & Gull, 1990). Importantly, many of its maxicircle transcripts require a 
process of RNA editing in order to mature into functional and translatable messenger 
RNAs (mRNAs). This process is characterized by, sometimes extensive, insertions 
and/or deletions of uridine (U) nucleotides into the pre-mRNAs (Goringer, 2012). 
Gene density in trypanosomes is extremely high, with the 26-megabase 
genome encoding ~9,000 putative genes encompassing all known housekeeping genes 
(Berriman et al., 2005). Trypanosome genome is organized in a very unusual way for 
eukaryotes. The majority of protein-coding genes are densely packed in large 
directional clusters in which genes are organized in a head-to-tail orientation. Most of 
these clusters are transcribed polycistronically by RNA polymerase II (Pol II). Hence, 
each of them is termed a polycistronic transcription unit (PTU) (Imboden et al., 1987, 
Muhich & Boothroyd, 1988) (see 1.3.1 Transcriptional and post-transcriptional 
regulation). Such type of organization resembles that of prokaryotic operons, except 
for the fact that in trypanosomes genes belonging to the same PTU are generally not 
functionally related (Berriman et al., 2005). Although polycistrons exist among other 
eukaryotes such as Caenorhabditis elegans, in trypanosomes they are remarkable for 
encompassing nearly all protein-coding genes in a genome-wide fashion: about 150 
PTUs are predicted to exist in the housekeeping regions of T. brucei genome where 
some can harbor  100 genes (Siegel et al., 2009, Kolev et al., 2010). 
 
1.2.2 THE LARGE VSG REPERTOIRE 
Remarkably, the large family of VSGs is composed of ~2,000 genes and occupies 
a vast extension of the genome. Hundreds of silent VSG copies are organized in 
tandem arrays at proximal subtelomeric positions in megabase chromosomes or as 
single genes in minichromosomes (Williams et al., 1982, Berriman et al., 2005, Cross et 




Figure 3. Distribution of VSG genes in the genome of T. brucei. Megabase chromosomes encode 
all housekeeping genes, which are expressed in polycistronic transcription units (PTUs) by RNA 
polymerase II (Pol II) (see 1.3.1 Transcriptional and post-transcriptional regulation). Hundreds of 
VSG copies are located proximal to subtelomeres in VSG arrays and include VSG genes, 
pseudogenes and incomplete sequences. VSGs are transcribed in bloodstream expression sites 
(BESs) which reside at subtelomeres in megabase and intermediate chromosomes. A BES 
contains several expression site-associated genes (ESAGs) and a single functional VSG at its end. 
ESAGs are interspersed through other genomic locations such as VSG arrays. Minichromosomes 
can also contain VSGs at subtelomeres. Intermediate and minichromosomes contain stretches of 
177-bp repeats, which in minichromosomes form a palindromic core. Typically, VSGs are flanked 
upstream by 70-bp repeats, important for homologous recombination-dependent VSG switching 
(see 1.3.2 Control of bloodstream expression sites). Arrows indicate direction of transcription. 
The diagram is not drawn to scale. For simplicity, genes are single-oriented but they display both 
orientations in the genome and can reside at both subtelomeric ends. 
megabase or intermediate chromosomes (Becker et al., 2004, Hertz-Fowler et al., 
2008) (Fig. 3).  
In the genome of T. brucei VSGs can be grouped into four categories: 
‘functional’ (encodes all recognizable features of known functional VSGs), ‘atypical’ 
(complete genes possibly encoding proteins with inconsistent VSG folding or post-




codons), and ‘incomplete’ containing N-terminal or C-terminal fragments (Berriman et 
al., 2005). Whereas putative functional VSGs represent a minority (13-20% in the strain 
Lister 427), pseudo and incomplete VSGs predominate (Berriman et al., 2005, Marcello 
& Barry, 2007). Among this large family, there appears to exist small VSG subfamilies 
with high sequence identity at the N-terminal or C-terminal which are thought be 
important to provide interacting partners for mosaic VSG formation (Marcello & Barry, 
2007). Part of the VSG archive is not unique (10% in T. b. brucei strain Lister 427), 
existing as two copies or more (Cross et al., 2014). Besides, MVSGs represent a very 
small part of the repertoire. In Lister 427 there are six MVSGs (Cross et al., 2014), with 
sequence identities consistent with those expressed in metacyclic parasites 
differentiated in vitro (Kolev et al., 2012). 
The VSG repertoire is significantly divergent between species and strains and 
even between different life cycle stages or laboratory growth conditions. For 
examples, most VSG gene sequences in strains Lister 427 and TREU 927/4 are very 
distant. The closest match between both has less than 50% coding sequence (CDS) 
identity. An important observation was that the VSG archive also diverges considerably 
within the same strain (Lister 427) propagated as different life cycle forms (BSFs vs PFs) 
or cultured in distinct laboratories, exhibiting loss or duplication of VSG genes (Cross et 
al., 2014). Besides providing us with a comprehension of the diversity of the VSG 
family, such data draws attention for the importance of knowing the ‘VSGnome’ 
repertoire of the strain/isolate being studied. 
Similarly to T. brucei, many other pathogens such as Plasmodium falciparum 
(malaria parasite) (Scherf et al., 2008) and Borrelia spp. (Lyme disease bacteria) 
(Barbour et al., 2000, Zhang et al., 1997) express their variant surface antigens at 
subtelomeres. This highlights the existence of preferential conditions at these genomic 
locations for the function of such genes. Since subtelomeres are prone to ectopic 
recombination it seems likely that these are privileged sites for VSG duplication and 
recombination, and therefore for VSG repertoire diversification; besides, it has become 
apparent that the characteristic reversible silencing events associated with the 
telomere probably sustain monoallelic VSG expression and provide transcriptional 




relationship between telomeric location and VSG silencing will be discussed in a 
subsequent section (see 1.3.2. Control of bloodstream expression sites). 
 
1.2.3 CHROMATIN ORGANIZATION IN EUKARYOTES 
Organization of DNA into chromatin is a hallmark of the eukaryotic nucleus. 
Chromatin is necessary for packaging the DNA molecules inside the physical limits of 
the nucleus and plays important roles in essential processes such as DNA replication, 
DNA damage repair, RNA processing and transcription. The basic unit of chromatin is 
the nucleosome: ~145–147 bp DNA superhelix wrapped around an octamer composed 
of two copies each of the histone proteins H2A, H2B, H3 and H4 (Luger et al., 1997). 
Interacting with the nucleosome core, there is usually a distinct histone, histone H1 
(H1) or ‘linker histone’, which binds externally to the nucleosomal DNA and the ‘linker 
DNA’ i.e. the short DNA segments that interconnect nucleosomes, and that altogether 
with the nucleosome core forms the chromatosome (Simpson, 1978, Bharath et al., 
2003). Histones are small proteins (~13 kDa) rich in positively charged, basic amino 
acids (aa) (e.g. arginine and lysine) that facilitate interaction with the negatively 
charged DNA molecules. 
The long-held notion is that chromatin can be organized in a series of 
increasingly complex and compact conformations which go from ‘primary’ to higher-
order ‘secondary’ and ‘tertiary’ structures. Primary structure of chromatin consists in 
the linear DNA molecules arranged in long nucleosomal arrays often referred as 
‘beads-on-a-string’. A secondary structure is defined as that arising from the folding 
and condensation of individual nucleosomal arrays into chromatin fiber, such as the 
often mentioned ’30-nm fiber’, which is driven by short-range interactions between 
neighboring nucleosomes where histone H1 seems to be a key player (Robinson & 
Rhodes, 2006). Succeeding interactions between fiber leads to large-scale chromatin 
assemblages, designated as tertiary structure, which ultimately culminates in the fully 
condensed chromosomes typically observed during metaphase (Luger et al., 2012). 
Despite the well-established importance of higher-order structures for chromatin 




remains unsolved and, more recently, its existence in vivo has even been questioned 
(Maeshima et al., 2010, Nishino et al., 2012). 
Chromatin can be organized and regulate short-range DNA domains, for 
example the local structure of an active promoter, or larger DNA domains (up to Mb of 
length) generating local structures at the micro-scale. For instance, chromatin can 
organize into nuclear bodies, chromatin domains or territories, which might involve 
several chromatin modifications and binding proteins and anchoring to nuclear 
structures like the nuclear lamina (Pombo & Dillon, 2015). The nucleolus is a hallmark 
example of a nuclear body of eukaryotes: it is the subnuclear compartment where 
transcription of ribosomal DNA (rDNA) by RNA polymerase I (Pol I), rRNA processing 
and ribosome assembly takes place (Lam & Trinkle-Mulcahy, 2015). 
Chromatin domains can be subdivided in heterochromatin and euchromatin. In 
a simplified definition, heterochromatin is more packed (visible as electron-dense 
domains), gene-poor and generally less transcriptionally active. By contrast, 
euchromatin typically consists of open chromatin regions that are gene-rich and 
transcriptionally active. Transposable elements and repetitive DNA regions such as the 
centromere and the telomere are usually organized in constitutive heterochromatin, 
which suppresses transcription and/or DNA recombination at these loci, maintaining 
genome integrity. On the other hand, facultative heterochromatin has the potential to 
interchange with euchromatin, i.e. to reversible convert to more decondensed 
chromatin and transcriptionally active state, for instance in the context of monoallelic 
gene expression (Trojer & Reinberg, 2007). In most cell types repressive 
heterochromatin is organized around the nucleolus or tethered to the nuclear envelop, 
whereas euchromatin is found at more central positions in the nucleus (Misteli, 2005, 
Padeken & Heun, 2014, Pombo & Dillon, 2015). 
Different structural and functional states of chromatin can be defined by DNA 
modifications and variations in nucleosome composition specified by different histone 
variants or histone covalent post-translational modifications (PTMs) (e.g. methylation, 
acetylation, phosphorylation), especially present at their N-terminal tails (Luger & 




theoretical possible combinations of nucleosome components are astonishing and 
have the capacity to ‘code’ for a large number of chromatin states. PTMs are added or 
removed from histones by several histone-modifying enzymes, which ‘write’ or “erase” 
the code. Other chromatin-binding proteins can “read” specific histone PTMs and 
recruit several other factors such chromatin remodelers and chromatin architectural 
proteins which trigger a set of downstream events that include changes in nucleosome 
positioning, DNA accessibility and recruitment of other nuclear machinery e.g. 
transcription factors (Strahl & Allis, 2000, Lee et al., 2010, Yun et al., 2011). 
Together with histone PTMs, histone variants contribute to alter nucleosome 
stability, chromosome structure and gene expression. Histone variants are non-allelic 
variants with a distinct amino acid sequence from their canonical counterparts and 
their deposition onto the DNA is not replication-dependent. Variants might substitute 
missing histones or be specifically recruited to defined genomic locations to serve 
specific functions (Luger et al., 2012).  
The action of all these players results in a pallet of dynamic chromatin states 
which can influence for instance, DNA replication, RNA processing and transcription, 
for instance, working as epigenetic on/off transcriptional switches (Preuss & Pikaard, 
2007, Venkatesh & Workman, 2015). 
 
1.2.4 CHROMATIN ORGANIZATION IN T. BRUCEI 
Alike other lower eukaryotes, T. brucei mitosis is ‘closed’, which means that 
nuclear envelope and nucleolus do not disassemble (Vickerman & Preston, 1970, 
Ogbadoyi et al., 2000). Interestingly, even though all chromosome classes segregate 
via a mitotic spindle (Ersfeld et al., 1998), it was recently found that T. brucei uses 
unconventional kinetochores which appear to have emerged exclusively in 
kinetoplastids early in evolution (Akiyoshi & Gull, 2014). 
The main nuclear architectural features typical of eukaryotes are also observed 
in T. brucei such as a double bilayered nuclear envelope, nuclear pore complexes with 




euchromatin and heterochromatin, the latter predominant at the nuclear periphery 
(Ersfeld, 2011). While the typical nuclear lamina found in metazoans seems to be 
absent from the parasite (Field et al., 2012), one protein with lamin-like functions, 
NUP-1, has been identified in T. brucei (Rout & Field, 2001, DuBois et al., 2012).and 
shown to be important for nucleus structural integrity and telomere positioning at the 
nuclear periphery (DuBois et al., 2012). 
Contrary to what generally occurs, in trypanosomatids chromosomes do not 
visibly condense during metaphase and a 30-nm fiber has never been observed 
(Hecker & Gander, 1985, Burri et al., 1995). Overall trypanosome DNA is less 
compacted within the nucleus when compared with higher eukaryotes (Hecker & 
Gander, 1985) and even between two stages of the parasite life cycle, with chromatin 
being more compact in BSFs than in PFs (Schlimme et al., 1993). This has been 
suggested as an important adaptation to accommodate the rapid changes in gene 
expression required throughout life cycle development of the parasite (Hecker et al., 
1994, Belli, 2000). Curiously, the less compacted state of trypanosome chromatin has 
been attributed the presence of divergent histones and differential expression of 
histone variants between BSFs and PFs, namely that of H1 proteins (Schlimme et al., 
1993, Burri et al., 1994). 
A paradigmatic example of nuclear subcompartmentalization in T. brucei is the 
so-called expression site body (ESB). This is an extranucleolar Pol I body, functionally 
distinct from the nucleolus and that appears to be solely dedicated to the transcription 
of the active BES in BSFs (Navarro & Gull, 2001, Chaves et al., 1998). Telomeres also 
occupy different nuclear positions throughout development of T. brucei. While in the 
bloodstream slenders, at interphase, telomeres preferentially localize at inner regions 
of the nucleus in the transmissible, non-dividing stumpy and in the insect PF stage, 
telomeres cluster close to the nuclear periphery and appear to be associated with 
heterochromatin (Ogbadoyi et al., 2000, Perez-Morga et al., 2001). Thus, telomeres are 
closer to the peripheral heterochromatic regions in those life cycle stages in which 
active BES is almost (Amiguet-Vercher et al., 2004) or completely inactive (stumpy and 
PF, respectively). While telomeric repeats are probably packed into constitutive 




heterochromatin whose transcriptional status is exchangeable during an in situ switch 
and or throughout T. brucei life cycle progression. 
 
1.2.5 EPIGENETIC REGULATORS IN T. BRUCEI 
There is compelling evidence that epigenetic mechanisms underlie essential 
processes in T. brucei such as the cell cycle, cell differentiation and antigenic variation 
(Figueiredo et al., 2009). An ‘epigenetic’ phenomenon can be defined as a heritable 
change in genome function that does not depend on changes in DNA sequence. 
Epigenetic changes are linked with modifications on chromatin composition and 
structure that that generally derive from different histone PTMs, histone variants or 
covalent DNA modifications (Deans & Maggert, 2015). Subsequently, many of the 
epigenetic regulators that have been implicated in T. brucei biology are briefly 
described. 
Histones. T. brucei contains the four canonical core histones (H2A, H2B, H3 and 
H4) and histone H1 (Alsford & Horn, 2004). According with its classification as 
canonical histones, mRNAs of the major histones of T. brucei oscillate throughout the 
cell cycle, peaking at the S-phase (Ersfeld et al., 1996, Archer et al., 2011). Though 
histones are some of the most conserved proteins throughout evolution, 
trypanosomatid histones are among the most divergent histones known, particularly 
within the unstructured N-terminal tails (Thatcher & Gorovsky, 1994). 
Histone PTMs described in T. brucei are rather unusual. Core histones lack 
many PTMs that are well-conserved across eukaryotes and on the other hand, some 
histone PTMs appear exclusive of the parasite. Examples of the latter are a complex 
pattern of acetylations on multiple lysines of H2A C-terminus and abundant levels of 
methylated alanines at H2A, H2B and H4 N-termini (Janzen et al., 2006a, Mandava et 
al., 2007). Nevertheless, some PTMs conserved in other eukaryotes are also found in T. 
brucei such as the tri-methylation of H3 lysine 4 (H3K4) and mono-, di- or tri-
methylation of H3K76 (K79 in other species) (Janzen et al., 2006b); in addition, 




homologues to acetylations conserved in other eukaryotes at lysine residues in nearby 
positions (K5, K12 and K16) (Mandava et al., 2007). 
Histone variants in T brucei encompass four variants of core histones: a 
homologue of H2A.Z and the three parasite-specific histone variants H3.V, H4.V and 
H2B.V (Lowell & Cross, 2004, Lowell et al., 2005). While H2A.Z and H2B.V are essential 
for parasite viability, H3.V and H4.V are not (Lowell & Cross, 2004, Lowell et al., 2005, 
Siegel et al., 2009). T. brucei also contains sequence variants of H1 which display a few 
aa differences (Gruter & Betschart, 2001), but it is unknown whether these are 
functional distinct.  
Histone-modifying enzymes have also been characterized in T. brucei. Histone 
deacetylases include four homologues of class I and class II deacetylases TbDAC1-2 and 
TbDAC3-4, respectively (Ingram & Horn, 2002, Wang et al., 2010) and class III silent 
information regulator 2 (SIR2)-related proteins (TbSIR2rp1-3) (Alsford et al., 2007, 
Garcia-Salcedo et al., 2003). Histone deacetylase activity has been confirmed in 
TbDAC1, TbDAC3 and TbSIR2rp1 (Garcia-Salcedo et al., 2003, Wang et al., 2010). T. 
brucei also possesses histone acetyltransferases from the MYST-family (TbHAT1-3) and 
putative histone acetyltransferases related with Elongator protein 3 (ELP3), TbELP3a 
and TbELP3b (Alsford & Horn, 2011). TbHAT2 and TbHAT3 are known to catalyze H4 
lysine acetylation (Siegel et al., 2008, Kawahara et al., 2008). Two lysine 
methyltransferase orthologs of disruptor of telomeric silencing 1 (DOT1), TbDOT1A 
and TbDOT1B, were characterized in the parasite: TbDOT1A is responsible for the 
mono- and di-methylation of H3K76 while TbDOT1B catalyzes its tri-methylation 
(Janzen et al., 2006b). 
Histone chaperones regulate the supply, deposition or displacement of 
histones from nucleosomes, being key players in the multiple processes where 
nucleosome reorganization is required. Some histone chaperones also may couple 
nucleosome assembly with crucial DNA metabolic processes such as DNA replication 
(Gurard-Levin et al., 2014). T. brucei possesses four types of histone chaperones: anti-
silencing factor 1A (TbASF1A), chromatin assembly factor 1 subunit b (TbCAF-1b), 




(TbNLP) (Alsford & Horn, 2012, Denninger et al., 2010, Denninger & Rudenko, 2014, 
Narayanan et al., 2011). 
Chromatin-remodeling enzymes comprise different subfamilies of multiprotein 
complexes with a core ATPase which catalyze a wide range of changes in the 
conformation, composition and position of nucleosomes, providing a means of 
producing rapid chromatin rearrangements (Narlikar et al., 2013). T. brucei possesses a 
novel member of the imitation switch (ISWI) family of SWI2/SNF2-related chromatin-
remodeling enzymes (TbISWI). TbISWI is a nuclear protein and associates with 
chromatin at several loci across the genome (Hughes et al., 2007, Stanne et al., 2011, 
Stanne et al., 2015). 
Chromatin architectural proteins can be histones or non-histone proteins that 
interact with and modulate chromatin structure acting as DNA benders, bridgers or 
wrappers (Luijsterburg et al., 2008). High-mobility group box (HMGB) proteins are 
ubiquitous chromatin architectural proteins that usually decompact chromatin and can 
facilitate transcription, DNA replication, DNA recombination or repair (Stros, 2010). 
HMGBs can interact with nucleosomes, displace histone H1 and facilitate the 
recruitment of other nuclear regulatory factors (Stros, 2010). A HMGB protein has 
been characterized in T. brucei: the trypanosome DNA binding protein (TDP-1), which 
predominantly associates with open chromatin at Pol I loci (Narayanan & Rudenko, 
2013). 
Telomeric proteins form a complex that protects telomeres and mediates the 
assembly of a specialized heterochromatin at telomeres, which typically spreads onto 
subtelomeric regions (Blasco, 2007). A number of telomere-associated proteins have 
been characterized in T. brucei: the Ku DNA-end binding heterodimer (TbKu70/Ku80), 
(Conway et al., 2002, Janzen et al., 2004), the above-mentioned histone deacetylase 
SIR2rp1 (Alsford et al., 2007, Garcia-Salcedo et al., 2003), an homologue of 
repressor/activator protein 1 (TbRAP1) (Yang et al., 2009), a telomeric repeat-binding 
factor (TbTRF) and TRF-interacting factor 2 (TbTIF2) (Yang et al., 2009, Jehi et al., 
2014b, Jehi et al., 2014a, Li et al., 2005). In addition, similarly to other eukaryotes, the 




1/cell division cycle 6-like protein (TbORC1/CDC6), also associates with telomeric 
repeats (Benmerzouga et al., 2013). 
DNA covalent modifications so far known in T. brucei are rather atypical. 
Contrarily to most eukaryotes, DNA methylation (5-methylcytosine) levels are very low 
in T. brucei (Militello et al., 2008). Besides, about 1% of thymidine residues in the 
nuclear genome are replaced by a bizarre DNA modification unique to 
trypanosomatids and the related Euglena algae: β-D-glucosyl-hydroxymethyluracil, 
also termed base J (Gommers-Ampt et al., 1993, van Leeuwen et al., 1998, Dooijes et 
al., 2000). Curiously, base J appears to be essential for T. cruzi or Leishmania spp. 
(Genest et al., 2005, Ekanayake et al., 2011) but it is dispensable for T. brucei (Cliffe et 
al., 2009). Regardless of recent advances about the role of base J in transcription 
initiation and termination in T. cruzi and Leishmania spp., respectively (Ekanayake & 
Sabatini, 2011, van Luenen et al., 2012, Reynolds et al., 2014), the functions of this 
DNA modification in T. brucei remain largely a mystery. 
 
Reverse genetics has revealed that many of the referred epigenetic factors are 
important regulators of gene expression in trypanosomatids (Figueiredo et al., 2009). 
Not surprisingly, some of these factors have been implicated in several functions 
beyond transcriptional control, such as the cell cycle (e.g. TbDOT1A, TbCAF-1b), DNA 
repair and homologous recombination (e.g. TbSIR2rp1, TbHAT1), 
subtelomere/telomere integrity (e.g. TbKu70/Ku80, TbTIF2, TbTRF) and parasite 
differentiation (e.g. TbDOT1B). These topics are out of the scope of this thesis and 
below I will only focus on the functions of these factors for gene expression in T. 
brucei. 
Most of what is known so far about chromatin organization and epigenetics in T. 
brucei is related to VSG genes (Figueiredo et al., 2009, Navarro et al., 2007). The focus 
on these genes is not only due to the importance of antigenic variation for T. brucei 
but also because BESs are controlled at the level of transcription, contrasting with 
gene expression for most of T. brucei genome, which is probably regulated mostly at 




procyclin gene expression will be highlighted in following sections (see 1.3.2 Control of 
bloodstream expression sites and 1.3.3 Control of procyclin loci). 
 
1.3 GENE EXPRESSION IN T. BRUCEI 
1.3.1 TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL REGULATION 
 
Organization of transcription units 
As mentioned earlier (see 1.2.1 Genome organization), in trypanosomatids 
large clusters of unrelated genes are co-transcribed by Pol II from the same coding 
strand as a single PTU (Berriman et al., 2005, Imboden et al., 1987, Muhich & 
Boothroyd, 1988). Typically, the regions between PTUs are strand-switch regions 
(SSRs) because they separate PTUs with opposite coding strands. Experimental 
evidence supports that Pol II transcription initiates bidirectionally at divergent SSRs 
and terminates at convergent SSRs (Martinez-Calvillo et al., 2003, El-Sayed et al., 2003, 
Kolev et al., 2010). Pol II transcription can also initiate internally within transcripton 
units and at other non-SSRs, for instance where a change of RNA polymerase type 
likely occurs (Kolev et al., 2010, Siegel et al., 2009). Regions between Pol II 
transcription units often contain transfer RNAs (tRNAs) and other RNA polymerase III 
(Pol III)-transcribed small RNAs. Besides, in T. brucei the Pol I-transcribed rDNA units 
and procyclin loci (see below, RNA polymerases) also lie between Pol II transcription 




Figure 4. (previous page) Transcription units and flanking epigenetic signals in T. brucei. Most 
of T. brucei genome is organized in polycistronic transcription units (PTUs) transcribed by Pol II. 
Neighboring PTUs are usually separated by strand-switch regions (SSR). In SSRs, Pol II 
transcription initiates at divergent SSRs and terminates at convergent SSRs. Transcription might 
also initiate at non-SSRs. Arrows indicate direction of transcription. Regions in-between Pol II 
units often contain Pol III-transcribed genes such as tRNAs and the Pol I-transcribed rDNA units 
and procyclin loci. Predicted transcription start sites (TSS) are enriched for acetylated H4K10 
(H4K10ac), tri-methylated H3K4 (H3K4me3), H2A.Z, H2B.V and TbBDF3. Putative Pol II 
transcription termination sites (TTSs) are enriched for H3.V and H4.V. In addition, the origin 
replication complex protein TbORC1/CDC6 binds frequently at the boundaries of PTUs, mostly at 
predicted TSSs. This a representative diagram, not drawn to scale. 
 RNA polymerases 
The three eukaryotic RNA polymerases have been biochemically identified in 
trypanosomatids (Martinez-Calvillo et al., 2010, Bindereif, 2012). Remarkably, T. brucei 
Pol I is the only known multifunctional Pol I among eukaryotes that, besides 
transcribing the rDNA unit (18S, 5.8S and 28S-like genes), also transcribes three other 
protein-coding loci: the VSG bloodstream expression sites (BESs), the procyclin loci and 
the MVSG expression sites (MESs) (Kooter & Borst, 1984, Ginger et al., 2002, Gunzl et 
al., 2003). Besides, ~10 rDNA transcription units are predicted in T. brucei (Alsford et 
al., 2005b), a small number compared with other eukaryotes (e.g. more than a 
hundred in yeast and mammals). It is also unknown whether only half the rDNA genes 
are transcriptionally active as was shown in other eukaryotes (Dammann et al., 1993, 
Grummt & Langst, 2013). T. brucei Pol II transcribes most mRNAs, the spliced leader 
(SL) RNA gene required for mRNA processing by trans-splicing (see below, mRNA 
splicing and polyadenylation) and small nucleolar RNAs (snoRNAs) (Gilinger & 
Bellofatto, 2001, Dunbar et al., 2000), whereas Pol III transcribes tRNAs, 5S rRNA, small 
nuclear RNAs (snRNAs) and the 7SL RNA, similarly to the other eukaryotes (Nakaar et 
al., 1994, Michaeli et al., 1992, Fantoni et al., 1994). 
 
RNA polymerase I transcription of rDNA genes is the most active transcription 
in a eukaryotic cell, generally accounting for over 50% of the total transcription 
activity. The high rates of rDNA transcription seem to arise from the high transcription 
initiation rates of Pol I which can be achieved by ~150 Pol I enzymes simultaneously 




brucei had evolved the unique capacity to highjack the highly efficient Pol I enzyme to 
ensure the production of the high number of VSG molecules it requires (~107 VSG 
surface copies per bloodstream parasite (Jackson et al., 1985)) from only a single active 
gene. 
The T. brucei multifunctional Pol I might result from specific differences in its 
structure and molecular partners (e.g. transcription factors) even though all Pol I 
machinery deviations identified so far, such as the trypanosome-specific Pol I subunit 
variants TbRPB5z, TbRPB6z and TbRPB10z (Nguyen et al., 2006, Devaux et al., 2007), 
are shared by other trypanosomatids (e.g. T. cruzi) that lack VSG or procyclin genes. In 
addition, the promoters of rDNA, BES, procyclin loci and MES are structurally different 
(Vanhamme et al., 1995b, Ginger et al., 2002, Pham et al., 1996, Laufer & Gunzl, 2001, 
Brown et al., 1992), suggesting that they might recruit different regulatory factors. The 
compartmentalization of the transcriptionally active BES in the ESB also supports this 
hypothesis. The putative histone acetyltransferase TbELP3b specifically localizes at the 
nucleolus and is excluded from the ESB. Accordingly, it suppresses rDNA transcription 
but does not affect transcription in BES (Alsford & Horn, 2011). In recent years, a 
multisubunit complex was found to act as a general transcription factor of Pol I, 
conserved across trypanosomatids. The multi-subunit complex, termed class I 
transcription factor A (CITFA), binds to VSG, procyclin and rDNA promoters and it is 
necessary for transcription initiation in all of them (Brandenburg et al., 2007, Nguyen 
et al., 2012, Nguyen et al., 2014). 
 
Epigenetic regulation of transcription 
Unlike many eukaryotes, in which Pol II regulation is considerably well 
understood, in trypanosomes it remains essentially a mystery. No Pol II promoters or 
associated transcription factors have been found except for the SL RNA gene promoter 
(Gunzl et al., 1997, Das et al., 2005, Schimanski et al., 2005). A milestone in 
trypanosome research was the finding that several epigenetic marks associate with 
putative Pol II transcription start sites (TSSs) and transcription termination sites (TTSs) 
(Respuela et al., 2008, Thomas et al., 2009, Siegel et al., 2009, Wright et al., 2010). In T. 




acetylated H4K10, tri-methylated H3K4 and a putative acetyl-binding protein, the 
bromodomain factor 3 (TbBDF3) are enriched at predicted transcription start sites 
(TSSs) whereas H3.V and H4.V preferentially locate at potential TTSs (Siegel et al., 
2009, Wright et al., 2010). (Fig. 4). High-throughput RNA sequencing (RNA-Seq) of a 
library enriched in precursor transcripts was used to map the TSSs in T. brucei (Kolev et 
al., 2010), demonstrating that, indeed, transcription initiates at those regions (SSRs 
and non-SSRs) where an enrichment for H2A.Z, H2B.V, acetylated H4K10, tri-
methylated H3K4 and TbBDF3 was previously detected (Siegel et al., 2009). H2A.Z and 
H2B.V specifically associate with each other (Lowell et al., 2005) and nucleosomes 
containing H2A.Z-H2B.V dimers associate less with H3 and H4, which is indicative of 
destabilized nucleosomes. This suggests that H2A.Z/H2B.V-enriched chromatin is less 
compact and therefore more accessible to the Pol II transcription machinery (Siegel et 
al., 2009). These data suggests that epigenetic marking has been adopted as an 
evolutionarily ancient means of controlling Pol II transcription. Nevertheless, we still 
ignore how these marks functionally interact and regulate Pol II activity. 
 Others have suggested that Pol II transcription initiation might be unusually 
unspecific and that the presence of a more open chromatin is sufficient for its 
engagement and transcription initiation (McAndrew et al., 1998). Chromatin is devoid 
of nucleosomes at the highly expressed SL RNA gene arrays transcribed by Pol II (see 
below, mRNA splicing and polyadenylation) when compared with its associated 
retrotransposon SLACS and with other Pol II protein-coding genes; nucleosomes are 
also highly depleted at the promoter regions of Pol I transcribed rDNA units and BESs, 
when compared with its respective protein-coding genes (Hitchcock et al., 2007, 
Stanne & Rudenko, 2010, Figueiredo & Cross, 2010). Thus, nucleosome occupancy is 
likely playing a role in the control of transcription initiation/elongation by the two 
types of RNA polymerases in trypanosomatids, as has been reported in other 
eukaryotes. 
 In several eukaryotes an association between promoter regions and/or the 
transcriptional activity and replication origins has been observed (Mechali et al., 2013). 
Interestingly, replication is also functionally coupled to transcription in T. brucei 




TbORC1/CDC6 of T. brucei binds at the boundaries of PTUs and upon its depletion 
mRNA levels increase globally throughout the genome (Tiengwe et al., 2012). In 
addition, H3K76 mono- and di-methylated is relatively enriched at some PTU 
boundaries, possibly marking replication origins (Gassen et al., 2012). 
 
 mRNA splicing and polyadenylation 
 Besides its genome-wide polycistronic transcription, trypanosomes also differ 
remarkably from other eukaryotes regarding mRNA maturation. The polycistronic 
precursor transcripts are processed into mature monocistronic mRNAs via trans-
splicing, which adds a m7G-capped 39-nucleotide Spliced Leader RNA to the 5’ 
untranslated region (5’UTR), and by polyadenylation of the 3’ untranslated region 
(3’UTR) (Boothroyd & Cross, 1982, Ullu & Tschudi, 1991). Trans-splicing and 
polyadenylation occur cotranscriptionally and the trans-splicing of the downstream 
mRNA is coupled with polyadenylation of the upstream mRNA (Huang & van der Ploeg, 
1991, LeBowitz et al., 1993, Ullu et al., 1993). Contrary to other eukaryotes where 
mRNA capping machinery directly interacts with Pol II, trans-splicing provides a means 
of uncoupling Pol II from the 5’ m7G capping of mRNAs, which is essential to allow T. 
brucei Pol I to produce functional mRNAs (Rudenko et al., 1991, Zomerdijk et al., 
1991). Trans-splicing of trypanosome mRNAs contrasts with mRNA maturation via cis-
splicing, which typically occurs in eukaryotes and excises non-coding introns from the 
pre-mRNAs. In T.brucei, however, cis-spliced introns seem to be restricted to only two 
genes, the poly(A) polymerase (Mair et al., 2000) and a putative RNA helicase gene 
(Berriman et al., 2005, Jae et al., 2010, Siegel et al., 2010). 
 
 Post-transcriptional regulation 
 Within a PTU, the steady-state mRNA abundances between genes can vary at 
least 50-fold (Siegel et al., 2010) and also differ considerably throughout the life cycle 
of the parasite. Recent genome-wide studies have compared the transcript levels 




gene expression and RNA-Seq) and T. brucei cell-lines (monomorphic and 
pleomorphic). Collectively, these studies have exposed an extensive number of genes 
(6-40% of genes) whose mRNA levels significantly change between the two parasite 
stages (Jensen et al., 2009, Kabani et al., 2009, Nilsson et al., 2010, Siegel et al., 2010, 
Veitch et al., 2010, Queiroz et al., 2009). In the absence of transcriptional control in, 
post-transcriptional control of mRNA levels is expected to be the major source of gene 
expression regulation in trypanosomes, and has been interrogated for a long time 
(Kramer, 2012). However, so far, this veil has been lifted considerably for only a few 
genes. Paradigmatic examples are the switch from low to high mRNA levels from 
procyclin and phosphoglycerate kinase B genes upon differentiation of BSFs to PFs. The 
developmental regulation of these transcripts results from the control of mRNA half-
live mediated by U-rich regulatory elements at the 3’UTR, which destabilize both 
mRNAs in BSFs (Hotz et al., 1997, Blattner & Clayton, 1995). 
 RNA-Seq based genome-wide approaches have been valuable tools in gaining a 
comprehensive view on the dominant post-transcriptional mechanisms shaping T. 
brucei transcriptome. Several studies have gathered evidence for the importance of 
alternative splicing and polyadenylation (Kolev et al., 2010, Nilsson et al., 2010, Siegel 
et al., 2010) and control of mRNA half-live and decay rates (Fadda et al., 2014, Manful 
et al., 2011) in regulation of mRNA levels. More recently, widespread control at the 
level of translation is also supported by two studies where RNA translation was 
examined by ribosome profiling in BSFs and PFs (Jensen et al., 2014, Vasquez et al., 
2014). Finally, trans-acting RNA-binding proteins have been emerging as crucial players 
in remodeling gene expression patterns during T. brucei life cycle (Kolev et al., 2014). A 
major breakthrough in trypanosome research came from the observation that the 
overexpression of a single T. brucei RNA-binding protein (RBP), TbRBP6, is sufficient to 
trigger the entire differentiation pathway of BSFs to metacyclic parasites in axenic 
cultures (Kolev et al., 2012). In addition, several other studies have identified subsets 
of target mRNAs potentially regulated by RPBs throughout the life cycle development 
in T. brucei (Najafabadi et al., 2013, Walrad et al., 2012, Wurst et al., 2012). 
 Even though most of the genes are expected to be controlled mainly post-




where the genes coding for VSGs (the BESs), procyclin and MVSGs (the MESs) are 
expressed, which are controlled are at the level of transcription (Rudenko, 2010, Park 
et al., 2012, Barry & McCulloch, 2001). How gene expression is regulated at these loci 
will be explored below. 
 
1.3.2 CONTROL OF BLOODSTREAM EXPRESSION SITES 
 
 Bloodstream expression sites 
 Bloodstream expression sites are ~45-60 kb polycistronic units that contain 
several expression site-associated genes (ESAGs) and a single functional VSG as the last 
gene located ~0.2-1.5 kb away from the telomere (Hertz-Fowler et al., 2008). The VSG 
unit is typically a 3-4 kb cassette flanked upstream by tracts of 70-bp repeats which 
vary in length and can go up to several kbs (Hertz-Fowler et al., 2008). The VSG also 
contains a conserved region from the end of the C-terminal region to elements in the 
3’UTR. Both 70-bp repeats together and the conserved VSG 3’ regions provide 
boundaries of homology for switching via gene conversion with an inactive VSG 
(Michels et al., 1983), even though recombination can also occur further upstream 
within an ESAG (McCulloch et al., 1997) or other BES sequences (Hertz-Fowler et al., 
2008, Boothroyd et al., 2009). 
 BESs promoters are very short and composed of two elements residing within 
67 bp upstream of the TSS (Vanhamme et al., 1995b, Pham et al., 1996). Half of the 
BESs contain an additional promoter ~13 kb upstream, which drives the expression of 
ESAG10 (Hertz-Fowler et al., 2008). The upstream region of BESs invariably contains 
long arrays of 50-bp repeats (Zomerdijk et al., 1990) (Fig. 5). 
 Each BES encodes a distinct combination of ESAGs, which comprise 
polymorphic variants of ESAG1-12 (Hertz-Fowler et al., 2008). Some ESAGs have been 
characterized and encode proteins important for a successful infection inside the 
mammal. For instance, ESAG6 and ESAG7 encode the subunits of the transferrin 




parasites (Bitter et al., 1998). Studying the ESAGs expressed from the BES is challenged 
by the fact that many ESAGs are members of large families of similar but not identical 
genes dispersed throughout the genome (Berriman et al., 2005). Since different BESs 
contain different polymorphic versions of the same ESAGs it has been debated 
whether different ESAG variants might favor T. brucei infection in specific mammalian 
hosts (Gerrits et al., 2002, Salmon et al., 2005). 
 
 Similarly to VSGs, MVSGs activated in the metacyclic parasites are transcribed 
by Pol I from a subtelomeric expression site. The metacyclic expression site (MES) 
probably evolved from BESs even though important differences distinguish both. MES 
are short, ~1-5 kb monocistronic units which lack ESAGs and encode only a MSVSG 
gene (Graham & Barry, 1995, Alarcon et al., 1994, Ginger et al., 2002). In fact, they 
represent the only Pol I monocistronic units with protein-coding genes known in T. 
brucei. Also, BES and MES promoters are structurally similar but functionally different 
(Ginger et al., 2002). A recent study confirmed former evidence that even though 
several MVSGs are expressed in a metacyclic population, only one MVSG is activated in 
each individual metacyclic parasite, similarly to VSG activation in BSFs (Ramey-Butler et 
al., 2015). However, in contrast with VSGs, MVSGs are switched on only by in situ 
Figure 5. A generic bloodstream expression site (BES). BESs have a typical size of ~45-60 kb, 
localize at the subtelomeres and are transcribed polycistronically by Pol I (Pol I promoter, flag). 
Several expression site-associated genes (ESAGs) or pseudogenes (Ψ) are encoded within a BES. 
The diagram depicts the most common set of ESAGs, but the number and order of ESAGs varies 
between BESs. The last gene in a BES is always a ‘functional’ VSG that resides ~0.2-1.5 kb 
upstream of the telomere. Different DNA repeats are associated with the BES (hatched boxes): 
most VSGs are flanked upstream by a stretch of 70-bp; upstream of the BES promoter there are 
long tracts of 50-bp repeats; telomere repeats locate downstream of the BES and mark the 




transcriptional activation, which appears to be controlled at the level of transcription 
initiation (Graham & Barry, 1995, Pedram & Donelson, 1999, Ginger et al., 2002). 
 
 Transcriptional regulation of bloodstream expression sites 
 How monoallelic expression of the BES is achieved has been a subject of 
thorough investigation. The parasite needs to maintain transcription active at one BES 
while silencing it in the others and the active/silent transcriptional states need to be 
rapidly reversible to ensure successful in situ switching. Besides, upon differentiation 
of BSFs to PFs, all BESs are silenced and procyclin loci need to be fully activated. 
 It has become clear that trypanosomes and other protozoan parasites such as 
P. falciparum and Toxoplasma gondii (toxoplasmosis parasite) use epigenetic 
regulation as a common means for controlling gene expression (Croken et al., 2012). P. 
falciparum, for instance, employs epigenetic regulation to control antigenic variation 
of var genes that are essential for its virulence (Scherf et al., 2008). Similarly, in 
trypanosomes, there is compelling evidence that control of BES expression and VSG 
switching is a complex interplay of chromatin-associated factors (Figueiredo 2009, 
Glover 2013): the chromosomal location proximal to telomeres, the nuclear 
positioning of BESs and its epigenetic environment. 
 Telomere-proximal location is thought to contribute to BES regulation. Such is 
supported by several findings. Telomeric heterochromatin has the ability to 
transcriptionally silence genes positioned nearby, an effect termed telomere position 
effect (TPE) which extends from yeast to higher eukaryotes (Gottschling et al., 1990, 
Tham & Zakian, 2002, Misteli, 2014). TPE silencing occurs in T. brucei and is capable of 
silencing transcription from Pol I promoters inserted proximal to telomeres (Horn & 
Cross, 1995, Horn & Cross, 1997). Also, the telomere-associated proteins TbRAP1 and 
TbORC1/CDC6 are necessary for BES silencing and expression of only one VSG at the 
surface (Yang et al., 2009, Benmerzouga et al., 2013). However, telomere-independent 
repression must be operating in BESs as well. For instance, telomeric silencing extends 




associated silencing is preserved even when the telomere is lost (Glover et al., 2007). 
Besides, other proteins which are important for telomere maintenance such as the 
complex Ku70/Ku80 (Conway et al., 2002, Janzen et al., 2004), and telomeric silencing, 
namely the histone acetyltransferase TbHAT1 (Kawahara et al., 2008) and TbSIR2rp1 
(Alsford et al., 2007) and the histone deacetylase TbDAC1 (Wang et al., 2010), are not 
required for BES silencing. 
 Nuclear positioning importance for BES monoallelic expression is underscored 
by the finding of the ESB. In BSFs the active BES specifically locates and is transcribed 
at the ESB while silent BESs are excluded from it (Navarro & Gull, 2001). Differentiation 
of BSFs to PFs is accompanied by ESB loss and rapid repositioning of the active BES 
promoter close to the nuclear envelope (Landeira & Navarro, 2007, Navarro & Gull, 
2001). It is unknown what functionally distinguishes Pol I transcription at the ESB from 
the nucleolus. The ESB might provide specific factors required for BES Pol I 
transcription and RNA processing. There is evidence that the active BES is marked by a 
specific epigenetic environment that distinguishes it from the equally Pol I-transcribed 
rDNA loci, for instance: high levels of the SUMOylation PTM (Lopez-Farfan et al., 2014) 
and low levels/absence of the putative histone acetyltransferase TbELP3b (Alsford & 
Horn, 2011). 
 Epigenetic regulation is certainly controlling expression at BESs. Consistent 
with the different nuclear territories occupied by active and silent BESs, chromatin at 
active BES is nucleosome-depleted and displays a more accessible when compared 
with silent BESs (Figueiredo & Cross, 2010, Stanne & Rudenko, 2010). Derepression of 
BES promoter-proximal regions occurs upon depletion of histone H3 (Alsford & Horn, 
2012), histone H1 (Povelones et al., 2012), the histone chaperones TbFACT (Denninger 
et al., 2010, Denninger & Rudenko, 2014), TbNLP (Narayanan et al., 2011), TbASF1A 
and TbCAF-1b (Alsford & Horn, 2012) and histone deacetylase TbDAC3 (Wang et al., 
2010). The histone methyltrasferase TbDOT1B (Figueiredo et al., 2008), the chromatin 
remodeler TbISWI (Stanne et al., 2011, Hughes et al., 2007), the telomeric protein 
TbRAP1 (Yang et al., 2009) and the lamin-like TbNUP-1 (DuBois et al., 2012) were 
found to repress the entire BES locus including its terminal VSGs (Table 1). Depletion or 




derepression, still several orders of magnitude (~102-103) lower than the expression of 
the active VSG. This indicates that the repressive epigenetic environment at silent BESs 
is robustly sustained by several non-redundant mechanisms, with distinct ranges of 
activity. 
 Based on the available evidence, a current model proposes that net 
transcription at BES results from a balance between two major forces: i) a repressive 
epigenetic gradient spreading from the telomere which gradually attenuates Pol I 
transcription elongation and/or RNA processing; ii) the recruitment of transcription 
factors and Pol I machinery to BES promoter which drives transcription initiation 
(Gunzl et al., 2014)  
 Transcription attenuation towards the telomere is supported by several 
evidences: despite VSG monoallelic expression, transcription is actually initiated at 
several silent BESs simultaneously, which was observed in cell populations (Ansorge et 
al., 1999, Vanhamme et al., 2000, Pays et al., 1990) and in single-cells of BSFs and PFs 
(Kassem et al., 2014); RNA processing (processing, export to cytoplasm and stability) is 
more efficient for transcripts from active than silent BESs (Vanhamme et al., 2000); 
several chromatin-related factors silence BES promoter regions but not the terminal 
VSGs (Table 1); transcripts from promoter-proximal regions are more abundant than 
from promoter-distal regions of silent BESs; TbRAP1–mediated silencing is weaker at 
BES promoter-proximal regions that at terminal ones (Yang et al., 2009); shut down of 
BES during slender to stumpy differentiation was associated with gradual Pol I stalling 
towards the telomere (Amiguet-Vercher et al., 2004); finally, in a model of induced 
ectopic VSG expression, BES reactivation occurs gradually from the promoter towards 
the telomere (Batram et al., 2014). 
 Transcription initiation control at BES promoters is sustained by more recent 
findings. Even when silent BESs are derepressed, transcripts from promoter-proximal 
regions are still 100 to 1000-fold lower when compared with the active BES (Yang et 
al., 2009, Figueiredo et al., 2008), indicating that additional mechanisms prevent them 
from full activation. Importantly, subunits of the Pol I transcription factor CITFA, 




this correlates with higher levels of Pol I occupancy and promoter-proximal primary 
transcripts (Nguyen et al., 2014). Collectively, this suggests the existence of higher 
rates of transcription initiation at the active BES promoter. On the contrary, at the 
promoters of silent BESs, access to CITFA and Pol I is somehow constrained and by 
consequence transcription initiation is reduced (Nguyen et al., 2014). 
Some epigenetic factors are probably controlling primarily transcription 
initiation at BES promoters. These include the histone chaperone TbFACT and the 
chromatin architectural protein TDP-1. TbFACT (TbSPT16 subunit) is highly enriched at 
the silent BES promoters (Denninger et al., 2010) and it is necessary for chromatin 
condensation and transcriptional repression at its promoter regions (Denninger & 
Rudenko, 2014) (Table 1). Contrary to most known BES regulators, which function on 
BES silencing, TDP-1 regulates the active BES (Narayanan & Rudenko, 2013). TDP-1 is 
specifically enriched at active Pol I loci (active BES and the rDNA loci) particularly at 
promoter regions, in inverse correlation with nucleosome density. Depletion of TDP-1 
drives chromatin condensation and shut down of transcription at these Pol I loci 
(Narayanan & Rudenko, 2013) (Table 1). In light of these observations, TDP-1 was 
proposed to ‘replace’ the nucleosomes at active BES, creating and/or maintaining an 
open chromatin structure that allows maximal rates of Pol I transcription 
initiation/elongation. 
Cell cycle link with transcriptional regulation of BES is evidenced by a number 
of observations, even though we ignore how replication occurs in the BESs or other 
VSG loci. TbORC1/CDC6 and the mini-chromosome maintenance-binding protein 
(TbMCM-BP) which make part of the pre-replication complex, are necessary for fully 
silencing BES-linked VSGs, MVSGs and procyclin genes (Tiengwe et al., 2012, 
Benmerzouga et al., 2013, Kim et al., 2013); cohesin, that maintains cohesion between 
sister chromatids during mitosis, is critical for the inheritance of the transcriptionally 
active BES (Landeira et al., 2009). Also, the histone chaperones TbFACT and TbCAF-1b 
specifically repress BESs at the S- and G2/M-phase of the cell cycle (Denninger et al., 





Functional category Factor 
Necessary for BES 
silent state? 





Other related roles References 
Histones 
H3 YES: PRO n.d. n.d. n.d. (Alsford & Horn, 2012) 
H1 YES: PRO n.d. n.d. Chromatin compaction particularly at silent BES promoters (Povelones et al., 2012) 
Histone modifying-
enzymes 
DOT1B YES: PRO;VSG NO n.d. Rapid VSG in situ switching (Figueiredo et al., 2008) 
DAC3 YES: PRO n.d. n.d. - (Wang et al., 2010) 
Histone chaperones 
FACT YES: PRO YES: VSG n.d. 
Maintaining chromatin compaction at silent BES 
promoters/chromatin opening at active BES; BES silencing is 
G2/M-dependent 
(Denninger & Rudenko, 
2014, Denninger et al., 
2010) 
NLP YES: PRO YES: PRO;VSG YES: PRO; EP1 Binds equally to active and silent BESs; interacts with TbISWI 
(Narayanan et al., 2011, 
Stanne et al., 2015) 
ASF1A YES: PRO n.d. n.d. BES silencing at all cell cycle stages 
(Alsford & Horn, 2012) 
CAF-1b YES: PRO n.d. n.d. BES silencing is S- and G2/M-dependent 
Chromatin 
remodeler 
ISWI YES: PRO > VSG NO YES: PRO Binds equally to active and silent BESs:interacts with TbNLP 
(Hughes et al., 2007, 
Stanne et al., 2011, 
Stanne et al., 2015) 
Telomeric protein RAP1 YES: PRO < VSG NO n.d. Repression of MVSGs 
(Yang et al., 2009, 
Pandya et al., 2013) 
Lamin-like protein NUP-1 YES: PRO < VSG n.d. 
YES: EP, 
GPEET 
Positioning of ESB to nuclear periphery during PF 
differentiation; Repression of VSG switching 
(DuBois et al., 2012) 
Chromatin 
architectural protein 
TDP-1 n.d. YES: VSG n.d. 
Maintaining chromatin open at active Pol I units (BES and 
rDNA) 
(Narayanan & Rudenko, 
2013) 
Pol I transcription 
factor 
CITFA n.d. YES: VSG n.d. 
High CITFA occupancy at active Pol I promoters (BES and 
rDNA) 
(Nguyen et al., 2014) 
Replication -related 
ORC1/CDC6 YES: VSG NO n.d. Repression of VSG switching 
(Benmerzouga et al., 
2013) 
MCM-BP YES: PRO < VSG NO YES: EP1 Repression of mini-chromosome VSG (Kim et al., 2013) 
Cohesin 
complex 
YES: VSG YES: VSG n.d. Inheritance of active BES; Repression of VSG in situ switching (Landeira et al., 2009) 
Table 1. Chromatin-associated factors involved in BES and procyclin expression in T. brucei bloodstream forms. 







Some kind of monitoring of the number of VSG molecules also seems to be connected 
with the cell cycle. When VSG synthesis is suppressed by RNAi-mediated knockdown, 
there is a general protein translation block (Smith et al., 2009) and parasites do not 
proceed to cytokinesis (Sheader et al., 2005). This might suggest that T. brucei evolved 
a VSG ‘counting’ mechanism that monitors the number of VSG transcripts and/or 
proteins, turning it into a decisive checkpoint for parasite replication and survival. 
 VSG switching is also regulated by epigenetic factors involved in BESs 
transcriptional control such as: histone H1 (Povelones et al., 2012), TbNUP-1 (DuBois et 
al., 2012) and TbORC1/CDC6 (Benmerzouga et al., 2013) in which all repress VSG 
switching; TbDOT1B which is required for fast transcriptional in situ switching 
(Figueiredo et al., 2008); histone acetyltransferase TbHAT3, which inhibits BES-linked 
VSG recombination (Glover & Horn, 2014). Telomeres are propitious sites for double-
strand DNA breaks (DSBs) and ectopic HR that trigger VSG switching (Boothroyd et al., 
2009, Li, 2015). Consistent with this, the telomere-binding proteins TbTIF2 and TbTRF 
suppress VSG switching due to, at least for TbTIF2, its ability to restrain the amount of 
DSBs at telomeres (Jehi et al., 2014a, Jehi et al., 2014b). 
 
 Despite the recent advances, there are still many questions unanswered on the 
control of VSG monoallelic expression: What are the mechanisms behind differential 
regulation of active/silent BES promoters? Are epigenetic factors and chromatin 
structure driving the transcriptional status of BES or are these a downstream effect of 
BES transcriptional state? Given that downregulation of active BES is associated with 
derepression of silent BESs (upon depletion of TbFACT and TbNLP, Table 1) or with 
ectopic expression of a second VSG (Batram et al., 2014) is there any cross-talk 





1.3.3 CONTROL OF PROCYCLIN LOCI 
 
 Procyclin loci 
 When BSFs differentiate to PFs, the VSG coat is shed and replaced within hours 
by a high number of copies (106-107) of other surface GPI-anchored glycoproteins, the 
procyclins (Roditi et al., 1989, Clayton & Mowatt, 1989). Procyclin proteins can be 
classified as EP or GPEET, according to the presence of internal dipeptide Glu-Pro (EP) 
repeats or pentapeptide Gly-Pro-Glu-Glu-Thr (GPEET) repeats in their C-terminal 
domain (Vassella et al., 2001). 
 Similarly to VSGs, procyclin genes are expressed from polycistronic units 
transcribed by Pol I (Gunzl et al., 2003). However, in contrast with BESs, procyclin loci 
are short polycistronic units of ~6-9 kbs located at chromosomal internal positions 
flanked by Pol II PTUs (Rudenko et al., 1990, Liniger et al., 2001). There are four 
procyclin loci located in the two alleles of chromosome 6 and 10. Each procyclin locus 
encodes two procyclin genes in tandem, followed by one or more procyclin-associated 
genes (PAGs), which potentially encode membrane or secreted proteins (Roditi et al., 
1998, Haenni et al., 2006). T. brucei Lister 427 strain has four EP isoforms and a GPEET 
isoform (Acosta-Serrano et al., 1999). The procyclin loci on chromosome 10 encode 
EP1-EP2 procyclin genes followed by several PAG genes, except for PAG3. In several 
strains, such as Lister 427, the two allelic loci on chromosome 10 are heterozygous, 
encoding distinct PAGs (Koenig-Martin et al., 1992, Liniger et al., 2001) On 
chromosome 6, procyclin loci are identical and have four genes consisting on GPEET-
EP3-PAG3 and a gene related to ESAG2 (GRESAG2) (Roditi et al., 1998). In T. brucei 
Lister 427 genome this locus is preceded by additional units encoding only EP3-PAG3 





Figure 6. Genomic context of procyclin loci in T. brucei. Four procyclin loci exist on the two 
alleles of chromosome 6 and 10. Arrows indicate Pol I transcription start sites at procyclin 
promoters. Grey boxes indicate coding sequences of procyclin loci genes. Black boxes indicate 
open reading frames of Pol II-transcribed genes. Flanking genes of procyclin loci are based on the 
annotated genome of T. brucei TREU 927 and Lister 427 (TriTrypDB 9.0). Organization of genes at 
procyclin loci located on chromosome 10 is based on previous genome analysis of T. brucei Lister 
427 (Koenig-Martin et al., 1992, Liniger et al., 2001) and AnTat 1.1 (Haenni et al., 2009). EP, gene 
encoding a procyclin with dipeptide repeats; GPEET, gene encoding a procyclin with 
pentapeptide repeats; GRESAG, gene related to ESAG; HP, gene encoding hypothetical protein; 
HpHbR, gene encoding the haptoglobin-hemoglobin receptor; MARP, gene encoding a 
microtubule-associated repetitive protein; PAG, procyclin-associated gene; The figure is drawn 
to scale (adapated from Haenni et al., 2009). 
 
 Transcriptional and post-transcriptional regulation 
 EP and GPEET procyclins are differentially expressed during early to late PF 
transition, which happens in vivo when PFs migrate to the ectoperitrophic space in the 
fly midgut. In early PFs, both EP and, predominantly, GPEET procyclins are synthesized 
whereas in late PFs GPEET expression is repressed (Vassella et al., 2000, Acosta-
Serrano et al., 2001, Vassella et al., 2001). Therefore, in contrast with BESs, 
transcription can occur simultaneously from two or more procyclin expression sites 
(Mowatt & Clayton, 1987, Ruepp et al., 1997). Upon differentiation to PFs, 




expressed within the first hours (Roditi et al., 1989, Pays et al., 1993). This tight control 
of procyclin expression is achieved at both the transcriptional and post-transcriptional 
levels. Transcription at the procyclin loci is controlled at the level of initiation and 
elongation. In BSFs, transcription initiation at procyclin promoters is ~10-fold lower 
than in PFs (Pays et al., 1990). Transcription elongation is also inhibited along the 
procyclin units. In the first hours after inducing differentiation with several stimuli, 
transcription is upregulated strongly at promoter-distal genes such as GRESAG2 (40-
fold) than at the promoter-proximal genes such as the procyclin genes (6-fold) 
(Vanhamme et al., 1995a). 
 Epigenetic regulation is also controlling expression of procyclin genes. In PFs 
the ESB disappears and, contrary to BES, the procyclin loci are transcribed from a 
peripheral region of the nucleolus, to a region of high Pol I transcriptional activity 
proximal to where rDNA units locate (Landeira & Navarro, 2007). If in one hand 
differential nuclear positioning seems to distinguish the activation of BESs and procylin 
loci (Landeira & Navarro, 2007, Navarro & Gull, 2001), in the other, many of the 
epigenetic factors involved in BES transcriptional silencing also act as repressors of the 
procyclin loci, suggesting a shared epigenetic mechanisms for Pol I silencing. These 
factors include TbNUP-1, TbNLP, TbISWI and TbMCM-BP (DuBois et al., 2012, 
Narayanan et al., 2011, Stanne et al., 2011, Kim et al., 2013) (Table 1). Involvement of 
the nuclear lamina (TbNUP-1) in both silencing of BESs and procyclin loci suggests a 
common repression mechanism via heterochromatin regions close to the nuclear 
periphery. Perhaps both active BES and procyclin loci are pulled away from repressive 
chromatin via recruitment to the ESB or the nucleolus in the BSFs and PFs, 
respectively. 
 Post-transcriptional regulation is critical to define procyclin mRNA abundance 
in BSFs and PFs. Elements at the 3’UTRs of both EP and GPEET procyclin mRNAs 
strongly destabilize and induce rapid degradation of the transcripts leading to ~11-fold 
downregulation of mRNA levels in BSFs (Hotz et al., 1998). In particular, the presence 
of 26mer containing two U-rich tracts in the 3’UTRs is critical for the stability of 
procyclin mRNAs, diminishing mRNAs half-lives about 5-fold in BSFs (Hotz et al., 1997). 




translation repression of procyclin mRNAs (Hotz et al., 1997, Schurch et al., 1997). 
Reduced translational efficiency of EP, GPEET and PAG mRNAs in BSFs was also 
recently corroborated by ribosome profiling (Vasquez et al., 2014, Jensen et al., 2014). 
Given the existence of detectable amounts of procyclin mRNAs in BSFs, translational 
repression should be responsible, at least in part, for preventing the inappropriate 
expression of procyclin proteins in the BSF stages. Altogether the several 
transcriptional and post-transcriptional levels of regulation were predicted to account 
for at least 1000-fold downregulation of procyclin expression in BSFs when compared 
with PFs (Hotz et al., 1998). 
 In addition, repression of GPEET expression in late PFs is also determined post-
transcriptionally (Vassella et al., 2000). A cis-regulatory element in the 3’UTR of GPEET 
mRNA, termed the ‘glycerol responsive element’, destabilizes the transcript in late PFs 
in the fly gut and in vitro in response to high glucose or glycerol deprivation (Vassella 
et al., 2000, Vassella et al., 2004, Urwyler et al., 2005). Besides, during transition from 
early to late PFs, GPEET mRNA stability decreases significantly and this correlates with 
an accumulation of alternatively processed GPEET transcripts e.g. lacking a poly(A) tail, 
with extended 3´UTRs or carrying oligo(U) tails (Knusel & Roditi, 2013). 
 
1.4 HISTONE H1 
1.4.1  STRUCTURAL AND FUNCTIONAL DIVERSITY 
 Histone H1 or linker histone, binds to the DNA that links nucleosomes, as well 
as DNA entering and exiting the nucleosome core (Noll & Kornberg, 1977, Allan et al., 
1980). The binding of H1 stabilizes nucleosomes and promotes the folding of 
chromatin into higher-order chromatin structures (Robinson & Rhodes, 2006). Histone 
H1 affects nucleosome spacing and mobility and can stabilize the position of 
nucleosomes by inhibiting spontaneous transitions in the nucleosomal structure and 
chromatin remodeling (Ramachandran et al., 2003). The H1/core nucleosome ratio is 
variable and it can range from 0.5 in embryonic stem cells up to 1.3 in chicken 




Figure 7. Structural diversity of histone H1 proteins. Diagram depicting the major structural 
domains of histone H1 in different eukaryotes. The number of amino acid (aa) residues in each 
H1 protein is indicated. Metazoans typically have several H1 variants, whereas other organisms 
such as S. cerevisiae and T thermophila only contain a single H1 protein. T. brucei encodes 
several H1 isoforms. H1 in metazoans (e.g. human H1.1) has a characteristic tripartite structure 
consisting of a short flexible N-terminal tail, a globular domain (dark grey) with a winged-helix 
fold, and a long, extremely lysine rich C-terminal tail. By contrast in S. cerevisiae H1 contains two 
globular domains. In lower eukaryotes such as T. thermophila and T. brucei (e.g. H1.1), H1 is a 
smaller protein that lacks a globular domain and resembles the C-terminus of H1 from 
metazoans. 
 Metazoan H1 exhibits a tripartite structure with a short flexible N-terminal tail, 
a globular domain containing a winged-helix fold and a long, extended, extremely 
lysine rich C-terminal tail. N- and C-terminal domains are less structured and so far, 
only the crystallographic structure of the globular domain of H1 has been determined 
(Ramakrishnan et al., 1993). Chromatin reconstitution with histone H1 fragments 
consisting of the globular and C-terminal domain have shown that from the three 
structural domains, the C-terminal appears to be the critical one for chromatin folding 
(Allan et al., 1980, Allan et al., 1986). In lower eukaryotes, histone H1 does not have 
this classical structure. In the ciliate protozoa Tetrahymena termophila, H1 lacks the 
globular domain and is similar to the C-terminal domain of metazoan H1 (Hayashi et 
al., 1987), whereas H1 of the yeast Saccharomyces cerevisiae, possesses two globular 
domains (Patterton et al., 1998) (Fig.7). 
Histone H1 is the least conserved of all histones and it is frequently encoded by 
a multigene family of highly heterogeneous members (Happel & Doenecke, 2009, Izzo 




genes, which form several protein variants (11 variants in humans). Variants can be 
subgrouped according to their temporal and spatial expression. For instance, in 
mammals there are replication-dependent and replication-independent H1 variants. 
Besides, there are somatic H1 variants which are present in almost every cell and H1 
subtypes which exist mainly in terminally differentiated cells or gametes (Happel & 
Doenecke, 2009). Different H1 protein subtypes can also differ in their chromatin-
binding affinities, genome distribution and PTMs (Harshman et al., 2013, Happel & 
Doenecke, 2009). In contrast with organisms that have a H1 gene family encoding 
several isoforms, other organisms have very few or only a single H1 gene such as 
Saccharomyces cerevisiae (Ushinsky et al., 1997). 
 Among histones, histone H1 has been then least studied (Harshman et al., 
2013). Much of what we know about the functions of H1 comes from in vitro studies. 
These studies indicated that two principal functions of H1 histones are to stabilize the 
DNA entering and exiting the core particle and to facilitate the folding of nucleosome 
arrays and chromatin condensation (Ramakrishnan, 1997, Wolffe et al., 1997, Bednar 
et al., 1998, Thoma et al., 1979). In vitro transcription analysis of chromatin 
reconstituted in the absence or presence of histone H1 also suggested that H1 acts 
primarily as a transcriptional repressor (Laybourn & Kadonaga, 1991, Shimamura et al., 
1989). More recently, the functions of H1 have been studied in vivo using gene 
knockdown/knockout or overexpression approaches. Both in higher and lower 
eukaryotes, H1 was confirmed to be a global regulator of chromatin architecture in 
vivo (Fan et al., 2005, Masina et al., 2007, Hashimoto et al., 2010, Barra et al., 2000). 
However, some studies also revealed that H1 is not a global transcription repressor, 
but rather regulates the transcription of specific and limited sets of genes by a yet 
unknown mechanism. Such is observed for the mammalian H1 with the typical 
tripartite structure, as well as for the unconventional H1 of yeast (Hellauer et al., 
2001), or the simpler H1 of T. thermophila (Shen & Gorovsky, 1996). Interestingly, in 
the case of mouse embryonic stem cells, when H1 is depleted only a specific set of 
genes is up or downregulated, even though chromatin gets globally less compacted 
(Fan et al., 2005). In addition, a number of studies provide evidence that different H1 




instance, selective knockdown of each H1 variant in a human cell line alters the 
expression of distinct subsets of genes, and has different phenotypic outcomes at the 
cell cycle and cell survival levels (Sancho et al., 2008). 
 H1 is also involved in other biological processes, including inhibition of DNA 
repair, telomere maintenance in yeast and mammalian cells (Downs et al., 2003, 
Murga et al., 2007), silencing of retrotransposons at the rDNA locus in D. melanogaster 
(Vujatovic et al., 2012) and differentiation and virulence in Leishmania major, a 
trypanosomatid closely related with T. brucei (Smirlis et al., 2006). Despite the 
conservation of some functions, it remains unclear why H1 is dispensable for growth in 
unicellular eukaryotes such as S. cerevisiae and T. thermophila (Shen et al., 1995, Shen 
& Gorovsky, 1996, Patterton et al., 1998), but is absolutely essential for mammalian 
embryonic development (Fan et al., 2003, Zhang et al., 2012) and Drosophila 
melanogaster development (Lu et al., 2009). Besides, studies in the fungus Ascobolus 
immersus (Barra et al., 2000) and Saccharomyces cerevisiae (Downs et al., 2003) 
revealed that even though H1 is not essential for growth, it results in shortened life 
span, indicating that loss of H1 has important consequences even in these lower 
eukaryotes. 
 Studies in unperturbed chromatin in vivo have shown that rather than being a 
mere structural protein that statically binds to chromatin, H1 interacting with 
chromatin is very dynamic. These are highly mobile proteins which exchange 
continuously between chromatin regions (Misteli et al., 2000). H1 dynamically 
interacts with other highly mobile chromatin architectural proteins, the HMGB 
proteins, and both can act as regulators of nucleosome accessibility and transcription. 
Similarly to H1, HMGBs can bind to linker DNA and with DNA entering/exiting the 
nucleosome (Thomas & Stott, 2012). In different cellular contexts, H1-HMGB 
interchanging drives opposite chromatin structure transitions, with H1 contributing to 
a more compacted chromatin and its replacement by HMGBs leading to a looser 
chromatin structure. Consequently, HGMBs can compete with H1 in order to activate 
particular transcriptional programs (Ogawa et al., 1995, Travers, 2003, Catez et al., 




act in the formation of heterochromatin, chromatin remodeling and transcriptional 
silencing (El Gazzar et al., 2009). 
 Another interacting partner of H1 recently described is Phosphatase and TENsin 
homologue (PTEN), a multifunctional tumor suppressor. PTEN stabilizes H1 binding to 
chromatin and H1 occupancy at gene promoters. Physical interaction between PTEN 
and H1 is essential for global chromatin condensation that apparently underlies PTEN-
mediated genome-wide transcriptional regulation (Chen et al., 2014). This stands as an 
example in which H1 seems to act as an effector of gene regulatory signals, bridging 
control of chromatin structure and regulation of gene expression patterns. 
 The mechanism behind H1-mediated control of gene expression was recently 
studied in detail in human cells. Within the first minute of progesterone hormone 
stimulation, a coordinated recruitment of chromatin remodeling complexes, histone 
modifications and kinase activation signals leads to histone H1 displacement from 
promoter regions which is a prerequisite for the following transcriptional activation of 
hormone target genes (Vicent et al., 2011). This study remarkably implies histone H1 
as one of the elementary components regulating promoter chromatin architecture 
necessary in the initial steps of promoter activation. 
 Similarly to what is already known for core histones, the functional diversity of 
H1 is in part a result of the different of H1 variants and their PTMs. In human cells, 
H1.4 variant phosphorylated at specific amino acids is enriched at active Pol I and Pol II 
transcribed genes (Zheng et al., 2010). 
 
1.4.2 HISTONE H1 IN T. BRUCEI 
T. brucei H1 proteins differ considerably from metazoan H1. T. brucei H1 are 
predicted to be small proteins (7-8 kDa) that contain a very lysine polypeptide 
sequence, similar to the typical C-terminal domain of metazoan H1 and lack a central 
globular domain (Burri et al., 1995, Schlimme et al., 1993). In the genome of T. brucei 
Lister 427, H1 proteins are predicted to be encoded by a multigene family with at least 




polycistronic unit, located on chromosome 11. Each gene encodes different H1 protein 
isoforms, or sequence variants, which can be sorted into three classes according to a 
few amino acid substitutions in the N-terminal (TriTrypDB 9.0) (Gruter & Betschart, 
2001). Even among the T. brucei species, H1-coding genes vary significantly in number 
and sequence between subspecies and even strains (Gruter & Betschart, 2001). 
 The small molecular weight and high hydrophobicity of trypanosomatid H1 
proteins initially precluded its identification by standard gel analysis. T. brucei H1 was 
first identified by separation on Triton acid-urea PAGE (according to its hydrophobicity) 
and two-dimensional gel electrophoresis (hydrophobicity/charge and molecular 
weight) optimized for high resolution. This analysis revealed the presence of five to six 
H1 protein variants and/or PTMs (Burri et al., 1993, Schlimme et al., 1993). 
Interestingly, the type and abundance of these H1 variants/PTMs varies between BSFs 
and PFs, with one of them being overexpressed in BSFs (Burri et al., 1994, Burri et al., 
1995). The distinct set of H1 proteins in the two life cycle stages was proposed to 
contribute for the fact that chromatin in BSFs is more condensed than in PFs 
(Schlimme et al., 1993). 
 Dissociation of H1 from the DNA fiber under high-salt concentrations in vitro 
showed that H1 is essential for the regular spacing of nucleosomes and salt-dependent 
chromatin condensation both in BSFs and PFs (Burri et al., 1993, Burri et al., 1994). T. 
brucei H1 is displaced from the DNA filament at lower salt concentrations compared 
with H1 of higher eukaryotes, indicating that T. brucei H1 interacts more weakly with 
chromatin (Burri et al., 1993). Although this weak binding was initially proposed to 
explain why chromatin in T. brucei does not form the 30-nm fiber (Schlimme et al., 
1993), it was later shown that T. brucei H1 is capable of reconstituting dense 
chromatin tangles and a 30-nm fiber in mammalian nucleosome filaments in vitro 
(Burri et al., 1995). Therefore, the less compacted chromatin of T. brucei cannot be 
explained alone by H1, but should result from the joined properties of T. brucei H1 and 
other chromatin components, including core histones, which bind weakly to chromatin 
when compared with their counterparts in higher eukaryotes (Bender et al., 1992, 




 Very little is known about the functions of histone H1 in T. brucei in vivo. Until 
recently, the functional properties of T. brucei H1 had only been analyzed in in vitro 
systems using isolated nucleosome filaments and studying the effects of salt-
dependent dissociation and reconstitution of H1 (Burri et al., 1994, Burri et al., 1995, 
Schlimme et al., 1993). These studies have corroborated repeatedly the role of H1 in 
chromatin condensation and the presence of distinct H1 protein isoforms and/or PTMs 
in BSFs and PFs in T. brucei. Besides, they have also shown that T. brucei histone H1 
phosphorylation is inversely correlated with chromatin condensation (Burri et al., 
1995). This is in line with similar observations done in T. thermophila (Lin et al., 1991) 
but also, more recently, in higher  eukaryotes (Lopez et al., 2015) and sustain the 
hypothesis that H1 phosphorylation triggers transient chromatin decondensation 
states facilitating access, for instance, to RNA polymerases (Roth & Allis, 1992, Zheng 
et al., 2010). Phosphorylation of T. brucei H1 is probably restricted to its N-terminus, 
which is the only containing serine and threonine residues, the two most common 
phosphorylation sites. Curiously, the three H1 classes of T. brucei vary in the number of 
serine and threonine residues at the N-terminus (Gruter & Betschart, 2001). 
 In parallel to my PhD work, another group addressed the roles of H1 in T. brucei 
in vivo. RNAi-mediated depletion of the several H1 isoforms lead to a reduction of 
heterochromatin domains inside the nucleus of BSFs, observed by electron 
microscopy, and to a more accessible chromatin observed upon digestion with 
Micrococcal Nuclease (MNase) (Povelones et al., 2012). Interestingly, when H1 was 
depleted, derepression of a silent BES promoter was observed and VSG switching 
frequencies increased, suggesting a role of H1 in antigenic variation (Povelones et al., 
2012). 
 
 At the onset of this thesis, in 2011, no in vivo studies were available to address 
the role of H1 in T. brucei. Considering the unusual gene expression and genome 
organization of this parasite, I decided that for my PhD work it would be interesting to 
understand the relevance of H1 in the biology of this parasite, at the level of genome 






In the present thesis I had four major aims: (i) to determine the importance of T. brucei 
histone H1 in overall chromatin structure; (ii) to study the importance of H1 in 
genome-wide gene expression regulation; (iii) to investigate the role of H1 in 
transcription initiation/elongation in T. brucei; (vi) to examine the general relevance of 
H1 for T. brucei infection in the mammal. 
In addition, we also addressed the role of H1 in response to DNA damage, as a possible 
although indirect read-out for H1 involvement in HR. (see Results 3.1). 
Since T. brucei H1 is encoded by a multigene family, complete H1-null mutants were 
difficult to generate. A loss-of-function approach was used in which RNAi-mediated 
knockdown of all H1 variants allowed a reduction in total H1 levels. Two H1-mutant 
clones were used throughout the work to study the effects of H1 depletion in the 
several topics referred above (see Results 3.1). 
To test the role of H1 in VSG transcription, we adapted the method of 4-thiouridine 
(4sU)-metabolic labeling of nascent transcripts to T. brucei for the first time. Due to the 
potential promising applications of this method in the study of T. brucei transcription, 
part of my thesis was devoted to improve this method in T. brucei (see Results 3.3). 






3.1 TRYPANOSOMA BRUCEI HISTONE H1 INHIBITS RNA POLYMERASE I 
TRANSCRIPTION 
 
The majority of results presented below were published in the Molecular Microbiology 
peer-reviewed journal. The article in the publication format can be found in the 
Annexes. 
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3.1.2 RESULTS 
3.1.2.1 T. brucei histone H1 family comprises three hypothetical protein classes 
 The current version of T. brucei genome (Berriman et al., 2005) indicates that 
there are five unique H1 genes on chromosome 11. As previously suggested (Gruter & 
Betschart, 2001), these genes are organized in two clusters belonging to a single 
polycistronic unit and are interspersed by five non-histone genes. We showed by PCR 
and Southern blot that this gene organization is correct in the T. brucei Lister 427 
strain, although other H1 alleles may be missing from the genome database (Fig. S1). 
Since each gene is predicted to encode a unique protein, we assigned them paralogue 
numbers from H1.1 to H1.5 according to the most recent nomenclature for histone 
variants (Talbert et al., 2012) (Fig. 1A). Alignment of the five H1 protein sequences 
reveals that the first seven aa define three different types of N-terminal sequences 
(Fig. 1B) (Gruter & Betschart, 2001). We classified them accordingly and named them 
MAKTT (H1.1), MAKASA (H1.2, H1.3 and H1.5) and MNNTT (H1.4). The sequence of the 
3′UTRs is almost identical between H1 classes (96% on average), whereas the 5′UTRs 
are less conserved and specific for each of the three classes of H1 genes (Fig. S2). 
Previous studies reported that one H1 protein variant/PTM was predominant in BSFs 
(identified by Triton acid-urea and SDS-tricine PAGE) (Burri et al., 1994, Schlimme et 






Figure 1. Histone H1 variants in T. brucei. (A) Diagram shows that in T. brucei H1 gene family is 
encoded by five genes (H1.1-H1.5) in two clusters ∼14.5 kb apart of the same polycistronic unit 
in chromosome 11. Arrow indicates the transcription start site and direction of transcription. 
Primers used for qPCR are indicated by colour-code: orange – primer specific for MAKTT 5’UTR; 
purple – primer specific for MAKASA 5’UTR; grey – primer specific for MNNTT 5’UTR; black – 
primers that anneal with the 3’UTRs, which are conserved across all H1 genes. Coding sequences 
are coloured according to the 5’UTR and N terminal sequence (see panel B). Gene IDs 
correspond to T. brucei TREU 927, which has a more complete genome annotation (TriTrypDB 
9.0). (B) Alignment of the predicted amino acid (aa) sequences of H1 variants. Divergent aa are 
shadowed in grey. Gaps (-) were introduced for best alignment. H1 variants were grouped into 
three classes according to the N-terminal sequences: MAKTT (orange), MAKASA (purple) and 
MNNTT (grey). (C) MAKASA is the most abundant histone H1 class at the RNA level. Transcript 
levels of each H1 class were quantified by qPCR and normalized to the total transcripts of all H1 
classes. Eleven independent experiments were analyzed. Results are shown as mean ± SEM. 
Statistical significance was determined by non-parametric Mann-Whitney U tests. * P < 0.05, ** 




To quantify the mRNA levels of H1 variants we performed quantitative real-time PCR 
(qPCR) with primer pairs specific for each class of linker histones (Fig. S3). Transcripts 
of class MAKASA are clearly the most abundant in BSF, 3-fold more relative to classes 
MAKTT and MNNTT (P < 0.001) (Fig. 1C). MNNTT and MAKTT have comparable 
transcript levels although MAKTT transcripts are slightly more abundant (P  0.05). The 
observed transcript levels follow the gene copy number for each H1 class. According to 
the genome database MAKASA class contains 3 gene copies while MAKTT and MNNTT 
are encoded by a single gene. Assuming that transcription rate is the same for all H1 
genes (inside the same polycistronic unit) this suggests that gene copy number is the 
main determinant of H1 mRNA levels in the BSF stage. Altogether, our results support 
the previous studies where one of the H1 protein variants was found to be more 
expressed, and show that the most abundant H1 in BSF of T. brucei, at the mRNA level, 
is class MAKASA. 
 
3.1.2.2 Depletion of H1 causes no considerable changes in parasite growth in 
culture 
 To address the function of H1 in T. brucei, we generated RNAi cell-lines that 
allowed simultaneous inducible depletion of all classes of H1. The RNAi cell-lines were 
created by transfecting the PL1S cell-line with an H1 RNAi construct that contained a 
MAKASA sequence (H1.5 CDS and 3’UTR) under the control of two tetracycline-
inducible opposing T7 RNA polymerase promoters that would generate double-
stranded RNA (dsRNA) of the MAKASA sequence in the presence of tetracycline. The 
construct was designed to integrate by single cross-over in the rDNA spacer region (Fig. 
2A). PL1S cell-line expresses T7 RNA polymerase constitutively (Alibu et al., 2005), has 
BES2 active (VSG9) and bears a reporter luciferase gene (LUC) at silent BES1 (VSG2) 
(Yang et al., 2009) (Fig. 4A). Because H1 genes are 89% identical, we expected that 
small interfering RNAs (siRNAs) generated from a dsRNA of a MAKASA gene would 
successfully knock-down all classes of H1 transcripts. Indeed, after inducing RNAi in 
two independent clones (C1 and C2), the mRNA levels of each of the three H1 classes 
were diminished to 39% on average during 6 days indicating that the knock-down was 




significant differences in H1 depletion levels were observed between day 2, 4 and 6 of 
RNAi induction. A clear reduction in H1 protein level was also observed after RNAi 
induction in a cell-line where one of the MAKASA variants is HA-tagged (Fig. 2C). The 
non-induced clones also showed a reduction of H1 transcripts (a decrease on average 
of 30% of the parental cell-line PL1S, P < 0.05) (Fig. S4B), which is likely due to the 
previously described leaky expression of the RNAi cassette (Alsford et al., 2005a). In 
induced clones we observed that depletion of H1 resulted in a minor growth defect in 
vitro. The doubling times were slightly longer in C1 (7:16 h) and C2 (7:44 h) compared 
with the parental cell-line PL1S (6:32 h) (P < 0.01 and P < 0.001, respectively) (Fig. 3A). 
This is consistent with previous observations (Povelones et al., 2012). 
 Because proper expression of histones is necessary for a normal cell cycle 
progression (Marzluff, 2005), we decided to characterize the effect of histone H1 
depletion in T. brucei cell cycle. DNA was stained with propidium iodide (PI) in ethanol-
fixed cells and the percentage of single cells (Fig. S5A) in each cell cycle stage was 
measured by fluorescence activated cell sorting (FACS) according to its DNA content 
(Fig. 3B). We did not observe any significant perturbations in cell cycle phases or in 
populations with abnormal ploidy (< 2C or > 4C) in both clone C1 and C2 during 6 days 
of RNAi induction (Fig. 3C). Similar results were obtained in live parasites stained with 
Vybrant® DyeCycle™ Violet (DCV) vital DNA dye (Fig. S5B). Given that there were no 
substantial cell cycle alterations, the small reduction in growth could be due to 
increased cell death induced by H1 depletion. We quantified dead cells by FACS in non-
fixed parasites stained with PI. Because an intact cell membrane is not permeable to 
PI, only cells were cell membrane is compromised will be stained, that is, dead or dying 
cells. In PL1S parental cell-line there are always ~0.5% of dead cells in the population. 
Equivalent frequencies of dead cells were observed for clone C1. However, parasite 
populations from clone C2 have ~1.5% dead cells throughout the 6 days of RNAi, which 
probably explains why this clone has a longer doubling time. Although these mutants 
are not a complete knockout of the histone H1 gene family, our data suggest that H1 is 




Figure 2. H1 RNAi depletes ~60% of the transcripts from all histone H1 classes. (A) Scheme 
showing the H1 RNAi construct, pLF100i, used to generate the transgenic H1 RNAi cell-line used 
in this study. Below is shown the integration region in the genome, the rDNA spacer, and 
pLF100i after integration. AmpR, ampicilin resistance gene; EcoRV, EcoRV restriction site; HYGR, 
hygromycin resistance gene; rDNA P, rDNA promoter; T7 T, T7 terminator; T7 P, T7 promoter; 
TetO, tetracycline operator; 18S, 18S rDNA gene; 3’ actin A, 3’UTR of actin A gene; 5’ actin A, 
5’UTR of actin A gene. (B) Efficiency of transcript depletion for all H1 classes and for each H1 
class during RNAi induction for 2, 4 and 6 days. Transcript levels were measured by qPCR and are 
shown as an average of the two histone H1 RNAi clones relative to the parental cell-line PL1S. 
Three independent experiments were analyzed. Results are shown as mean ± SEM. Statistical 
significance was determined by non-parametric Mann-Whitney U tests. * P < 0.05, ** P < 0.01, 
***P < 0.001 (C) Depletion of H1 MAKASA protein after four days of RNAi. Cell extracts were 
prepared after 4 days of RNAi for the MAKASA::HA cell-line LMF52.1. This cell-line was generated 
in the single-marker (SM) background, which was used as a negative control for HA detection. 
Total cell extracts were subjected to Western blotting with an anti-HA antibody to detect histone 
H1 MAKASA (HA). The levels of β-tubulin (β-TUB) and histone H3 proteins were detected as 






3.1.2.3 H1 compacts chromatin at different levels across the genome 
 It has been previously demonstrated, using in vitro systems, that T. brucei H1 
can condense chromatin (Burri et al., 1994, Burri et al., 1995). More recently, 
Figure 3. H1 depletion causes no major growth defect in vitro. (A) Cumulative growth in 
culture of BSFs of T. brucei upon H1 RNAi depletion during 2, 4 and 6 days. Mean doubling 
times (DT) are shown for each cell-line.  Five to nine independent experiments were analyzed. 
Results are shown as mean ± SEM. Statistical significance was determined by a non-parametric 
Mann-Whitney U test. * P < 0.05, ** P < 0.01, ***P < 0.001 (B) Overlay of FACS histograms of 
cell cycle profiles of PL1S (grey), C1 RNAi (blue) and C2 RNAi (red) after 4 days of RNAi. DNA 
content was measured by propidium iodide (PI) staining in ethanol-fixed parasites. Frequency 
of parasites is normalized to mode (most frequent value of PI intensity). A representation of 
the gates used to quantify the proportion of each cell cycle stage is shown. < 2C, DNA content 
lower than the diploid chromosome number; > 4C, DNA content higher than the tetraploid 
chromosome number. (C) Depletion of H1 causes no significant changes in cell cycle. 
Proportion of T. brucei parasites in each cell cycle stage, determined by FACS as represented in 
(B). Measurements at day 2, 4 and 6 of RNAi were pooled from one independent experiment. 
Results are shown as mean ± SEM. (D) H1 depletion seems to induce T. brucei cell death. FACS 
dot plots showing PI intensity in the x-axis and FL1 intensity in the y-axis at day 6 of RNAi. Dead 
parasites were measured by PI staining in live parasites. The percentage of PI- and PI+ 
parasites are shown in each plot. (E) Percentage of dead, PI+ parasites, at 2, 4 and 6 days of 




Povelones et al. used electron-microscopy analysis and micrococcal sensitivity assays 
to show that H1 plays a role in heterochromatin formation in vivo. Here we 
investigated the role of H1 in chromatin condensation using an alternative approach: 
FAIRE (formaldehyde-assisted isolation of regulatory elements) of H1-depleted clones 
subjected to RNAi induction for 6 days. By performing a phenol-chloroform extraction 
on a cross-linked and sheared chromatin sample, FAIRE fractionates DNA that is 
preferentially less tightly associated to proteins (such as histones) (Giresi et al., 2007). 
Quantitative PCR was used to quantify such enrichment and a plasmid spike with an 
ampicillin-resistance gene (AmpR) was used as a normalizer for DNA input. Strikingly, 
silent BES promoter regions (97 bp downstream of transcription start site) were among 
the loci in which chromatin opened the most (Fig. 4). In both H1-depleted clones (C1 
and C2), chromatin of the silent BES promoter regions opened on average 10-fold 
compared to the parental cell-line PL1S (P < 0.001) (Fig. 4B; Fig. S6A). The chromatin 
also opened at the luciferase gene (LUC), which is 1.2 kb downstream of a silent BES 
promoter, although in a slightly smaller degree (sevenfold relatively to PL1S; P < 
0.001). In most other loci, loss of H1 resulted in a 1.8- to 4-fold increase in FAIRE 
enrichment (Fig. 4B), suggesting that chromatin becomes globally more accessible. 
These include silent VSGs from bloodstream and metacyclic expression sites (VSG2, 
VSG3, VSG18, MVSG; P < 0.01), the procyclin promoter region and procyclin EP2 gene, 
typically transcribed in procyclic stages (P < 0.01), transcription start sites of Pol II 
polycistronic units containing either β-tubulin (β-tub-PR; P < 0.01) or structural 
maintenance of chromosome 3 gene (SMC3-PR; P < 0.01) and a number of Pol II-
transcribed genes (very abundant β-tub and at lower levels ISP, SMC3 and PAG3). 
Three loci showed a non-significant tendency for a more open chromatin 
conformation: the BES2 actively transcribed genes (blasticidin resistance gene, BSDR, 
and VSG9) and the 18S rDNA, all of which had been previously shown to have a very 
open, perhaps close to maximal, chromatin conformation (Figueiredo & Cross, 2010, 




Figure 4. H1 compacts chromatin at different levels across genome. (A) Diagram indicates the 
amplicons (bars) amplified by qPCR for loci in BESs, procyclin loci, rDNA loci and a Pol II-
transcribed polycistronic unit. Procyclin loci are partially transcribed in BSFs, as represented by a 
dashed arrow. Primers for EP2 procyclin are located in the 3′UTR (light grey). Chromatin opening 
was measured by FAIRE (B) and nucleosome occupancy was determined by histone H3 
chromatin immunoprecipitation (ChIP) (C) at several gene loci in parental cell-line PL1S and 
histone H1 RNAi clones 6 days after induction. DNA isolated by FAIRE was quantified by qPCR 
and an enrichment corresponds to a more open chromatin. An AmpR gene contained in a 
plasmid spike was used as a normalizer for DNA input. For H3 ChIP, DNA was quantified by qPCR, 
compared to total input material and normalized to 18S rDNA. Results are expressed as fold-
change relatively to parental cell-line PL1S. Note that FAIRE enrichment is represented in a 
logarithmic scale. Data for individual clones prior to normalization to the parental PL1S are 
shown in Fig. S5. Statistical significance was calculated using an empirical Bayes approach. 







 The FAIRE results were further confirmed by chromatin immunoprecipitation 
(ChIP) of histone H3 (as a read out of nucleosome density). As previously shown 
(Figueiredo & Cross, 2010), FAIRE and H3 ChIP are highly consistent techniques and, 
globally, they reflect almost a mirror image from each other: for most loci, when 
chromatin becomes more open, we detect an increase in FAIRE enrichment and a 
decrease in H3 ChIP for both clones (Fig. 4B–C and Fig. S6). A comparison between the 
P-values of FAIRE and H3 ChIP experiments further confirms the consistency of the two 
techniques (Table S1). We observe, by ChIP, that most genes lost around 30% of 
nucleosomes. As expected, ChIP revealed that silent BES promoters are the loci that, 
upon loss of histone H1, lost more histone H3 (close to 60%). Interestingly, although 
FAIRE did not detect a very dramatic change in chromatin condensation of the 
procyclin promoter region, H3 ChIP detected a reduction of nucleosomes more 
pronounced than average (48%). Also, FAIRE did not detect a significant change in 
chromatin condensation of genes in active BES, but ChIP could detect a significant but 
modest loss of histone H3 at the promoter region and at the active VSG gene. As 
expected, a gene encoded by the mitochondrial genome (cytochrome c oxidase 
subunit III, COIII, whose genome is not organized around nucleosomes), showed only 
background levels of histone H3 (Fig. S6B, P > 0.05). Overall, these results confirmed 
that when H1 is depleted there is a global loss of histone H3 across multiple loci of the 
genome, except for silent BES promoters, which opened 10-fold more (60% loss of 
histone H3) and procyclin promoters to a lesser extent. Moreover, our data greatly 
strengthen FAIRE as a robust method to study global changes in chromatin 
condensation. 
Figure 4. (continued from previous page) Two to three independent experiments were 
analyzed. Results are shown in mean ± SEM. BSDR, blasticidin resistance gene; BES-P, promoter 
region of silent BESs; β-TUB, β-tubulin gene; β-TUB-PR, promoter region of β-TUB polycistronic 
unit; EP2, procyclin EP2 gene; ISP, inhibitor of serine peptidase gene; LUC, luciferase gene; 
MVSG, metacyclic VSG gene; Pro-P, procyclin promoter region; PURR, puromycin resistance 
gene; PAG3, procyclin associated gene 3; rDNA-P, rDNA promoter region; 18S, ribosomal 18S 
gene; SMC3, structural maintenance of chromosome 3 gene; SMC3-PR, promoter region of 




3.1.2.4 H1 regulates expression of Pol I-transcribed genes 
 Given the global role of H1 in chromatin condensation, we next tested how 
changes in chromatin structure affected expression genome-wide. We used RNA-Seq 
to compare the expression profile of H1-depleted clones (at day 4 of RNAi) and 
parental cell-line PL1S (Fig. 5, Fig. S7). H1 depletion resulted in significant changes 
(false discovery rate (FDR) adjusted P-value < 0.05) in the expression of 26 out of 8996 
expressed genes (Fig. 5A). Interestingly, all were upregulated and all but one gene are 




Figure 5. (previous page) H1 inhibits expression of RNA Pol I-transcribed genes. Genes with 
altered expression upon H1 depletion (4 days of RNAi) were identified by genome-wide RNA 
sequencing in BSFs of T. brucei. (A) Volcano plot analysis of differentially expressed genes 
between RNAi clones C1 and C2 relative to two biological replicates of the parental cell-line PL1S 
shows that H1 regulates a small set of genes, mainly located in procyclin loci (red filled circles) 
and bloodstream expression sites (BESs) (red filled squares). Each point represents a gene, with 
log2 fold-change (RNAi/PL1S) of gene expression across samples plotted on the x-axis and the 
corresponding statistical significance (−log10 P-value) plotted on the y-axis. Genes statistically 
significant (FDR-adjusted P < 0.05) are indicated in red; in grey are non-significant genes; in blue 
are those genes which would be significant if a less conservative statistical method had been 
used (FDR-adjusted P > 0.05 and P < 0.05). (B) Heatmap showing the z-scores calculated for the 
normalized DESeq expression levels of differentially expressed genes (FDR-adjusted P < 0.05) 
obtained by genome-wide RNA sequencing in BSFs of T. brucei. Genes are ordered by decreasing 
fold-change of expression, as in panel C. (C) Bar-plot showing the fold-change of expression of 
annotated differentially expressed genes in RNAi clones C1 and C2 relative to the parental cell-
line PL1S. For VSG genes that are inside a BES, the respective BES number in shown in brackets. 
(D) Gene set enrichment analysis for genes located in BESs and procyclin loci. Blue line indicates 
the enrichment score distribution across genes ranked by decreasing statistical evidence of 
differential expression. Grey line represents 95th percentile of the enrichment scores obtained 
by 1000 random permutations of the gene ranks. The histogram at the top-right corner of the 
figure represents the distribution of maximum scores obtained by random permutation, with the 
arrow indicating the experimental enrichment score (i.e. the ‘peak’ in the main plot). The 
diagram at the bottom shows where the members of this gene set (i.e. genes located in BESs and 
procyclin loci) appear in the ranked list of genes. An FDR-adjusted P < 0.001 was obtained for this 
gene set, as described in Experimental procedures. Genes with undetermined fold-change due to 
too low unique read counts were excluded from the analysis. 
 Most of these genes (18) are BES-associated genes (VSGs and ESAGs) or genes 
located in procyclin loci (EP procyclin genes and PAGs), which are normally silent in this 
stage of the parasite life cycle. In H1-depleted mutants, BES-associated VSGs are on 
average 18-fold more expressed, with a maximal derepression within this subset close 
to 65-fold (VSG8) (Fig. 5C). Other eight VSGs annotated as outside a BES were also 
upregulated. Because we do not know the genomic location of these VSGs, we cannot 
evaluate whether there is a nearby promoter or polycistronic unit that could read 
through these VSGs. The transcript levels of 592 expressed VSGs did not change 
significantly, which is not surprising because in general VSG genes are located in 
tandem arrays that lack a functional promoter (Marcello & Barry, 2007). Most VSGs are 
not expressed and thus were not included in our analysis. H1 depletion also lead to an 
increased expression of the puromycin resistance (PURR) and the luciferase genes (Fig. 
5C), both located immediately downstream of a silent BES promoter (BES1) (Fig. 3A), 
thus indicating that derepression occurred throughout the entire BES locus. However, 




from the full activation seen in active BES, indicating that silent BESs are only partially 
derepressed. Only one of the ESAGs was found differentially expressed (ESAG2 from 
BES12) most probably because the repetitive nature of ESAGs prevented unambiguous 
read alignment and were thus not included in the analysis. Due to too low unique read 
counts, the fold change of ESAG2 remained undetermined. Although PAGs are located 
in multiple copies in the genome, in Pol II transcription units (Kim et al., 2013) or 
within the procyclin loci (Haenni et al., 2006), the differentially expressed members of 
PAG2, PAG4 and PAG5 are specifically located in these latter loci. For example, 
although there are two PAG2 genes, one in the procyclin locus and the other in a 
polycistronic unit on the same chromosome 10, the only gene that is significantly 
upregulated when H1 is depleted is the one within the procyclin locus. The results 
above strongly suggest that H1 predominantly inhibits expression of Pol I genes. 
 We used gene set enrichment analysis (GSEA) (Subramanian et al., 2005) to 
investigate if specific gene sets are enriched or depleted among differentially 
expressed genes. We found that genes located in BESs and procyclin loci are very 
significantly enriched in our list of differentially expressed genes (FDR-adjusted P < 
0.001), as illustrated by the large difference between the detected enrichment score 
distribution and the 95th percentile of the enrichment scores obtained by random 
permutations (blue and grey lines, respectively, in Fig. 5D) This enrichment is also 
observed if the two sets of genes are analyzed independently (Fig. S8). This analysis 
further indicates that H1 plays an important role in the expression of Pol I-dependent 
genes. RNA-Seq results were confirmed at the RNA level by qPCR (Fig. 6A–B; Fig. S9) 
and at the protein level by luciferase activity assay (Fig. 6C). First we checked the 
correlation between qPCR and RNA-Seq fold-changes of gene expression of 34 genes 
selected so that we would cover a wide range of expression levels. We observed a very 
high Pearson’s correlation (r = 0.90) between the two types of experimental data, 
suggesting that qPCR and RNA-Seq are highly consistent (Fig. 6A). To further confirm 
the observation that Pol I, but not Pol II genes become derepressed when H1 is 
depleted, we measured by qPCR the transcript levels in the two RNAi clones induced 
for 2, 4 and 6 days (Fig. 6B, Fig. S10). These were normalized to 18S transcript levels 




with chromatin largely insensitive to H1 depletion (Fig. 4B). It should be noted that 
rRNA genes could not be included in our RNA-Seq analysis due to their repetitive 
nature.We confirmed that H1 depletion did not affect any of the tested Pol II 
transcribed genes nor the actively transcribed VSG9. As detected by RNA-Seq, VSGs in 
silent BESs (VSG2 and VSG3) were significantly derepressed (P < 0.001) (Fig. 6B), 
although the level of derepression was slightly smaller by qPCR (5- to 12-fold) than 
RNA-Seq (9- to 21-fold). We also confirmed that procyclin EP2 was fivefold 
derepressed. Another VSG in a silent BES (VSG18) and a VSG from a metacyclic 
expression site (MVSG; Tb427-639 (Cross et al., 2014)) were found to be four- to 
fivefold derepressed by qPCR (P < 0.001) but were not detected as being differentially 
expressed in the RNA-Seq data. This inconsistency might be due to the fact that silent 
VSGs and MVSGs are expressed at a very low level in bloodstream forms (Donelson, 
2003) and for this type of genes, statistical tests for differential expression based on 
RNA-Seq data are not very powerful. Finally, BES derepression was further confirmed 
at the protein level by measuring the activity of luciferase in the entire population. We 
observed an increase in luciferase activity of 7- to 10-fold (P < 0.001; Fig. 6C), thus 
confirming RNA-Seq and qPCR data that silent BES1 was derepressed (P < 0.001; Fig. 
6B). Overall, qPCR and luciferase activity assays confirmed/validated the RNASeq data. 
We conclude that, like in genome-wide studies in mammalian cells and yeast (Hellauer 
et al., 2001, Fan et al., 2005), T. brucei H1 is not a global transcription repressor. It 
rather regulates a particular subset of genes, by repressing expression of Pol I-
dependent genes. It is clear that the most significant subgroup of genes that is 
derepressed are genes from BESs or procyclin loci, confirming that H1 is essential for 
keeping these specific loci silent. 
To examine whether the upregulation of silent VSG transcripts triggered by H1 
depletion would induce loss of monoallelic expression of a single type of VSG protein 
at the parasite surface, we analyzed the expression of two silent VSGs, VSG2 and 
VSG13 at the cell surface by FACS (Fig.7). Live parasites of both C1 and C2 RNAi clones 
were stained with specific antibodies against VSG2 and VSG13 at day 2, 4 and 6 of RNAi 
induction. Dead parasites were excluded from the analysis by gating on the negative 




Figure 6. RNA-Seq data are validated by qPCR and luciferase assays. (A) Scatter plot of fold-
changes of gene expression in RNAi clones C1 and C2 relative to the parental cell-line PL1S. 
Thirty-four genes with mean expression levels ranging from 12 to 512,586 RPKMs by RNA-Seq 
were randomly selected and quantified by qPCR. Pearson’s correlation coefficients (r) are 
indicated. (B) Quantification of mRNA expression after 2, 4 and 6 days of RNAi induction. 
Transcript levels were measured by qPCR. Transcript levels are plotted as an average of the fold-
change of RNAi clones C1 and C2 relatively to the parental cell-line PL1S. Significant (P < 0.05) 
fold-change of all RNAi days is shown above dashed line. Three independent experiments were 
analyzed. Results are shown as mean ± SEM. (C) Derepression of silent BESs was assessed by 
quantification of luminescence throughout 2, 4 and 6 days of RNAi induction. A luciferase 
reporter gene located downstream of the promoter of silent BES1 (see diagram Fig. 4A) allows 
the monitoring of its transcriptional activity by measuring the luminescence emitted (AU, 
arbitrary units). Horizontal line indicates average of luminescence levels for each experimental 
group. PL1A refers to a cell-line that is isogenic of PL1S, but in which BES1 is active and therefore 
luciferase gene is transcribed at maximal levels. Three to four independent experiments were 
analyzed. Statistical significance was calculated by non-parametric Mann-Whitney U tests.* P < 







 The percentage of both VSG2 and VSG13 expressing parasites (VSG2+ and 
VSG13+) is maintained low but increases throughout RNAi induction up to 2- to 3-fold 
(0.3-0.4% of total parasites) when compared with PL1S parental parasites (Fig. 7B). 
This indicates that upon H1 depletion the increase in mRNA levels of silent VSGs 
induced by H1 depletion leads to the abnormally high levels of parasites with a silent 
VSG at the surface. Importantly, the percentage of double-expressors (VSG2+ and 
VSG13+) also augments, particularly at day 6 of RNAi (10-fold compared with PL1S), 
indicating that part of the silent VSG expressors display more than one silent VSG at 
the surface (Fig. 7A, B). When compared with PL1S, the increase in parasites expressing 
Figure 7. H1 depletion leads to the expression of more than one silent VSG at the surface. (A) 
FACS dot plots showing VSG2 and VSG13 expression at the cell surface after 6 days of RNAi. Live 
parasites were stained with anti-VSG2, anti-VSG13 and propidium iodide (PI). Cell populations 
were gated in the live, PI- cells as shown in Figure 3D. The first plot depicts a positive control 
were C1 RNAi parasites were mixed with ~1% of a VSG2-expressing parasite cell-line + ~1% of a 
VSG13-expressing cell-line. The four gates and respective percentages of cells per each are 
shown. (B) Percentages of VSG2+VSG13-, VSG2-VSG13+ and VSG2+VSG13+ populations after day 
2, 4 and 6 of RNAi. Percentages were quantified by FACS analysis using the indicated gates, as 




silent VSGs at the surface seems to come from parasites in which expression levels of 
silent VSGs are as high as in parasites where those VSGs are active (Fig. 7A). This 
suggest that depletion of histone H1 leads to an increase in VSG switching rates, as was 
reported before (Povelones et al., 2012) and reinforces the implications of histone H1 
for antigenic variation. Nevertheless, this experiment was only performed once. 
Therefore it should be repeated in order to verify the reproducibility of our 
observations and confirm our conclusions. 
 
3.1.2.5 H1 inhibits transcription from silent BESs and procyclin sites 
 We next sought to understand how H1 depletion leads to an increase of steady-
state mRNA levels of the silent VSGs and procyclins. Because H1 depletion leads to a 
more relaxed chromatin at Pol I promoter regions (especially at the silent BES 
promoters), we hypothesized that the increase in mRNA levels resulted from an 
increase in transcription rates at these loci. To test this hypothesis we used metabolic 
labeling of nascent transcripts with 4-thiouridine (4sU) (see Results 3.3.). This method 
allows the quantification of newly synthesized RNA in live cells, therefore the direct 
measurement of RNA transcription rates with minimal interference on gene expression 
and cell viability (Dolken et al., 2008). After incubating T. brucei BSF parasites with 4sU, 
total RNA was extracted, thiol-specific biotinylated and subsequently purified on 
streptavidin-coated magnetic beads. qPCR was then used to quantify the newly 
transcribed RNAs purified. We analyzed the kinetics of 4sU incorporation into RNA in T. 
brucei during 2, 5, and 10 min of labeling. Since newly transcribed RNA contains higher 
amounts of unprocessed, primary transcripts, we determined the levels of nascent 
transcripts by quantifying the ratio of intergenic relative to coding sequence 
expression for 18S and β-tubulin transcripts (Fig. 8A). As expected, we observed a rapid 
increase in the levels of 4sU-tagged RNA with increased duration of labeling (Fig. 8B). 
Based on this result and on previous reports (Rabani et al., 2011, Windhager et al., 
2012), we chose 10 min as an appropriate 4sU-labeling time to estimate transcription 
rates. We next compared the levels of nascent transcripts of individual genes in a 
metabolically labeled sample relative to the total RNA. Although the yield of 




the labeled samples had 7- to 20-fold more nascent transcripts than non-labeled 
samples (Fig. 8C), indicating that the levels of labeled transcripts are significantly 
enriched over the background. To test if the 4sU-labeled RNAs are a product of 
transcription, we repeated the labeling experiment in cells that were previously 
treated for 5 min with actinomycin D (ActD), a well-known transcription inhibitor. We 
observed that, upon transcription inhibition, the levels of 4sU-labeled RNAs recovered 
by MACS were dramatically reduced to the same low levels detected in the NO 4sU 
samples (Fig. 8D). Altogether these results further confirmed that 4sU-labeled RNAs 
are a reflection of the transcription happening inside live parasites.  
 4sU metabolic labeling was next used to test whether H1 depletion results in a 
higher transcription rate from BESs and procyclin promoters. For this, RNAi was first 
induced for 2 days in clones C1 and C2 and, at the end of this period, RNAi clones and 
parental PL1S parasites were incubated with 4sU. After 10 min the 4sU-labeling 
reaction was stopped and total RNA was extracted. The relative abundance of 
intergenic transcripts for 18S and β-tubulin genes showed that purification of newly 
transcribed RNA was equally efficient in all cell-lines (Fig. 8E). Analysis of newly 
transcribed RNA revealed that H1 depletion indeed increases the transcription rate 
from silent BES promoters, resulting in higher abundance of precursor transcripts from 
the BES promoter region BES-P (P < 0.001) and the downstream luciferase gene (P < 
0.001). When H1 is depleted, transcription rate is also higher from procyclin 
promoters, since we detected significantly more nascent transcripts from the procyclin 
promoter region (P < 0.01) and at the EP2 procyclin gene (P < 0.001) (Fig. 8F). These 
results show that when H1 is depleted, there seems to be a higher transcription rate of 
silent BESs and procyclin loci, most likely due to an increase of transcription initiation 
from the promoter. A Pol II gene (β-tubulin) showed no change in transcription rate, 
confirming the qPCR analysis of steady state RNA levels (Fig. 6B). Curiously, the BES 
promoter regions are the loci in which the levels of nascent transcripts have increased 
the most (sixfold), which is consistent with the fact that the most dramatic changes in 
chromatin condensation observed upon H1 depletion were at the silent BES 
promoters. This may suggest a more significant role for H1 at silent BESs. We also 




of the active BES promoter, consistent with the decrease in H3 detected by ChIP. 
Taken together, these results not only support our RNA-Seq data but provide 
additional mechanistic insight, showing that histone H1 is an effective regulator of 





3.1.2.6 Depletion of H1 increases resistance to MMS-induced DNA damage 
 The fact that H1 is required for global chromatin compaction, but it has a very 
limited role in global transcription regulation, led us to hypothesize that H1 may play 
other functions in the cell. Povelones et al. have recently shown that H1 inhibits 
recombination of telomeric VSG genes, but not of a reporter gene URA3 (Povelones et 
al., 2012). In yeast, H1 suppresses HR thus inhibiting DNA repair and promoting 
genome stability (Downs et al., 2003). To test if DNA repair is affected in T. brucei, we 
treated H1-depleted clones with a DNA damaging agent, methyl methanesulphonate 
(MMS), and measured the subsequent cell survival. MMS is an alkylating agent that 
stalls replication forks, a damage that can induce formation of DSBs and be repaired by 
HR (Lundin et al., 2005, Nikolova et al., 2010, Ma et al., 2011). 
 Parasites in log-phase growth were exposed to MMS for 2 days, after which cell 
viability (metabolic function) was measured with Alamar Blue® (Raz et al., 1997). RNAi 
induction started 2 days before MMS treatment and continued throughout MMS 
exposure. We observed that both H1-depleted clones were clearly more resistant to 
MMS-damage than the parental cell-line PL1S (Fig. 9A). Half maximal inhibitory 
Figure 8. (previous page) H1 depletion results in increased transcription rate in silent BESs and 
procyclin loci. Nascent transcripts were labeled with 4sU for 10 min, biotinylated and 
streptavidin-purified. RNAs were quantified by qPCR, compared with non-labeled sample and 
normalized to 18S rRNA transcripts. (A) Diagram indicates the amplicons (bars) amplified by 
qPCR for precursor and mature rRNA and β-tubulin transcripts. (B) Kinetics of 4sU-labeling of 
newly transcribed RNA measured by the ratio of intergenic/CDS transcripts. (C) Percentage of 
4sU-labeled RNA relative to total RNA for several loci with 10 min of 4sU-labeling. NO 4sU, n=2; 
10’ 4sU, n=7 (D) Relative transcript levels in 4sU-labeled RNA in the absence or presence of a 5 
min treatment with actinomycin D (ActD), which inhibits transcription, prior to 4sU-labeling for 
10 min. PL1S, C1 and C2, n=3-7 (E) Enrichment in nascent transcripts in PL1S and H1-depleted 
mutants with 10 min of 4sU-labeling. (F) Fold increase in nascent transcripts in H1-depleted 
mutants in comparison with PL1S parental cell-line. Results are shown as mean ± SEM. Two 
independent experiments were performed, n = 3–4 for each cell-line. Significant fold-change (P < 
0.05) was calculated using an empirical Bayes approach and is shown above dashed line. Primers 
used to amplify 18S Int were the same used to amplify downstream promoter region of rDNA 
(rRNA-P). BES-P, promoter region of silent BESs; BSDR, blasticidin resistance gene; β-tub, β-
tubulin gene; β-tub Int, β-tubulin intergenic region; EP2, procyclin EP2 gene; LUC, luciferase 
gene; Pro-P, procyclin promoter region; TSS, transcription start site; undet, undetermined - 





concentration (IC50) determined from dose–response curve was on average 2.76 parts 
per million (ppm) for PL1S and significantly higher for C1 and C2, 4.45 and 4.59 ppm 
respectively (P < 0.01) (Fig. 9B). This result indicates that DNA repair is more effective 
when H1 levels are reduced. This could be because H1 limits access to DNA repair 
machinery and, as a result, suppresses HR. This is likely the case since HR-mediated 
repair dominates in T. brucei (Burton et al., 2007, Glover et al., 2008). 
Figure 9. H1 depletion increases resistance to MMS-induced DNA damage. Dose–response 
curves of BSF of T. brucei to exposure to MMS (A) or phleomycin (C), in parental and H1-
depleted clones. Curves were obtained by fitting a non-linear regression with variable slope to 
the data. Cell viability was assessed by AlamarBlue® staining at the end of the treatment. IC50 
values calculated from the corresponding regressions generated for MMS (B) and phleomycin 
(D) treatments. MMS concentration is expressed in parts per million (ppm) of volume and 
phleomycin is expressed in μg.ml-1. Seven to five independent experiments were analyzed for 
MMS treatment. Three to four independent experiments were analyzed for phleomycin 
treatment. Results are expressed in mean ± SEM. Statistical significance was determined by a 





 We also tested the sensitivity of H1-depleted parasites to another DNA 
damaging drug, phleomycin, which generates single-strand and double-strand DNA 
breaks (Giloni et al., 1981). Sensitivity to phleomycin has been frequently used to study 
DNA repair in T. brucei (Proudfoot & McCulloch, 2006, Glover et al., 2011). However, 
we did not observe significant changes in sensitivity to phleomycin and its respective 
IC50 values between PL1S parental cell-line and RNAi clones (Fig.9C-D). The distinct 
responses of H1-depleted parasites to MMS- and phelomycin-induced damage might 
be explained by the different DNA damage mechanisms and the extension of DNA 
lesions produced by the two drugs (Glover & Horn, 2012). 
 
3.1.3 MATERIALS AND METHODS 
 
CELL-LINES AND GROWTH MEDIUM 
Trypanosoma brucei brucei bloodstream form (BSF) parasites (strain Lister 427, 
antigenic type MiTat 1.2, clone 221a) (Johnson & Cross, 1979) were cultured in HMI-11 
as described in Hirumi and Hirumi (1989). Cells were diluted according to their 
doubling times (around 6-7 h) in order to maintain log-phase growth. Parasite growth 
was measured by counting cells in a Neubauer chamber. 
PL1S cell-line was described in Yang et al. (2009). H1 RNAi cell-line clones (C1 and C2) 
were obtained by transfecting T. brucei PL1S cells with a H1 RNAi construct (pLF100i) 
(formerly generated by Luísa Figueiredo). To generate pLF100i, a MAKASA H1 
sequence (H1.5) containing the CDS and the 3’UTR was PCR amplified from a cDNA 
library of T. brucei Lister 427 and inserted into a p2T7TA RNAi vector (Alibu et al., 
2005). In this vector the target sequence is cloned in-between two opposing T7 
promoters that are inducible with tetracycline due to the presence of tetracycline 
operator sequences downstream of each one the promoters (Fig. 2A). H1 protein 
levels were measured in the cell-line LMF52.1, which has a single-marker background 
(Wirtz et al., 1999), contains the H1 RNAi construct (pLF100i) and one H1 MAKASA 




Luísa Figueiredo). RNAi was induced by adding 1 μg.ml-1 of tetracyclin (Fisher Scientific) 
to the medium for a maximum of 6 days. 
 
RNA EXTRACTION AND REAL-TIME QUANTITATIVE PCR ANALYSIS  
Parasites were harvested by centrifugation at 650 g for 10 min, 4°C and immediately 
resuspended in PureZOL (BioRad) or TRIzol (Invitrogen). RNA was isolated following the 
manufacturer’s instructions and RNA quantity and quality was assessed on a NanoDrop 
2000 (Thermo Scientific). The procedure used to isolate nascent RNA labelled with 4sU 
is described in a section below. cDNA was generated using a Superscript cDNA 
Synthesis Kit (Invitrogen), according to manufacturer’s protocol. Quantitative PCR 
(qPCR) was performed using 1 × SYBR Green PCR Master Mix (Applied Biosystems). 
Negative controls lacking reverse transcriptase were confirmed by qPCR. Primer 
efficiencies were determined using standard curves with 3-logs coverage. Amplification 
reactions were performed in duplicates. Relative quantification was performed based 
on the CT (cycle threshold) value and the PCR efficiency-corrected method of Pfaffl 
(Pfaffl, 2001). DNA and transcript levels were normalized to those of 18S, which did 
not change significantly after histone H1 depletion. Primer sequences are listed in 
Table S2. 
 
DETECTION OF H1 PROTEIN BY WESTERN BLOTTING 
Depletion of H1 protein after H1 RNAi induction was detected using the MAKASA::HA 
LMF52.1 cell-line. Whole cell lysates were prepared by resuspending 1-2x106 BSF 
parasites in 1x Laemmeli buffer at a concentration of 105 cells.μl-1, boiled for 10 min, 
loaded onto a Mini-Protean TGX pre-cast PAGE gels (BioRad) and separated by SDS-
PAGE. Transfer to a nitrocellulose membrane was done with an iBlot Gel Transfer 
Device (Thermo Fischer Scientific) for 7 min, according to the manufacturer’s protocol. 
Nitrocellulose membrane was blocked for 1 h at RT with PBS/0.1% Tween 20/5% milk, 
probed overnight at 4°C with polyclonal mouse anti-HA HA RU 1:5000 (Memorial 




given by Keith Gull) or polyclonal rabbit anti-H3 1:100 000 (custom-made in Pineda) as 
primary antibodies diluted in PBS/0.1% Tween20/3% milk. After washing the 
membrane 3x with PBS/0.1% Tween20 at RT, it was incubated with the secondary 
antibodies, sheep anti-mouse IgG-HRP 1:10 000 (GE Healthcare Life Sciences; NA931) 
or donkey anti-rabbit IgG-HRP 1:10 000 (GE Healthcare Life Sciences; NA934) diluted in 
PBS/0.1% Tween20/3% milk, for 1 h at RT. After washing 3x in washing buffer the blot 
was developed, protected from light, with Western Lightening ECL Plus (PerkinElmer) 
and light emission was detected in an X-ray film with 10 sec. exposure. 
 
FLOW CYTOMETRY ANALYSIS OF CELL CYCLE 
Fluorescence-activated cell sorting (FACS) analysis of cell cycle profiles with propidium 
iodide (PI) staining was done basically as described (Janzen et al., 2006b). At day 2, 4, 
and 6 after H1 RNAi induction, 2x106 of BSF parasites were collected from culture by 
centrifugation at 1300 g, 10 min 4°C, washed 1x with trypanosome dilution buffer 
(TDB) (5 mM KCl, 80 mM NaCl, 1 mM MgSO4, 20mM Na2HPO4, 2 mM NaH2PO4, 20 mM 
glucose, pH 7.7) (Cross, 1975), resuspended in 1 ml cold PBS/2mM EDTA, and fixed by 
adding drop-wise 2.5 ml cold 95% ethanol while gently vortexing. Cells were fixed and 
stored during 1-5 days at 4°C, after which they were washed 1x with 1 ml PBS/2mM 
EDTA at RT and resuspended in 1 ml of PBS/2mM EDTA plus 10 μg RNAse A (Carl Roth). 
Incubation proceeded at 37°C for 30 min. DNA was stained by adding 1 mg propidium 
iodide (PI) and incubated at RT for 30 min. Cells were kept on ice until analysis on a BD 
LSRFortessa (BD Biosciences) flow cytometer. Cell cycle analysis was completemented 
by staining live parasites with the vital dye Vybrant DyeCycle Violet Stain (Thermo 
Fischer Scientific). Briefly, 1x106 BSF parasites grown in culture cells were resuspended 
in 1 ml 2% HMI-11 medium to which 0.5 μl of dye Vybrant DyeCycle Violet Stain was 
added per ml of cell suspension. Cells were incubated at 37°C for 10 min, protected 
from light and preceded to analysis in a BD LSRFortessa (BD Biosciences) flow 






FLOW CYTOMETRY ANALYSIS OF VSG SURFACE EXPRESSION 
Surface expression of VSGs was analyzed by FACS in live BSFs essentially as described 
before (Figueiredo et al., 2008). 0.5x106 of BSF from culture were centrifuged in a 
previously chilled eppendorf at 2800 g for 4 min at 4°C. Cells were resuspended in 50 
μl of cold HMI-11 to which has been added 1:500 rabbit anti-VSG2 Alexa Fluor 488 
conjugated antibody and 1:5000 rabbit anti-VSG13 Alexa Fluor 647 conjugated 
antibody (described before (Figueiredo et al., 2008) and kindly gifted by George Cross). 
Cells were incubated for 15 min at 4°C with gentle shaking and protected from light. 
Cells were washed 3x in 1.3 ml of cold HMI-11, collected by centrifugation at 2800 g, 
4min, 4°C and resuspended in 500 μl of cold HMI-11. Cells were kept on ice until 
analysis in a BD LSRFortessa (BD Biosciences) flow cytometer. To stain dead cells, 1 min 
before FACS analysis, 1 mg of propidium iodide (PI) was added to each sample. PI is a 
fluorophore that intercalates into nucleic acids. Because cell membrane is 
compromised in dying/dead cells, PI can diffuse inside these cells and stain their DNA. 
Data was analyzed on FlowJo v.X software. Dead cells were gated on the PI positive 
population and discarded from the analysis of VSG expression. 
 
FAIRE 
Formaldehyde-assisted isolation of regulatory elements (FAIRE) was adapted to T. 
brucei as described previously (Figueiredo & Cross, 2010). 1 x 107 BSFs were collected, 
cross-linking was performed in 1.1% formaldehyde in HM1-11 medium for 10 min at RT 
and reaction was stopped by adding glycine to a final concentration of 110 mM. To 
control for DNA input, an external DNA spike was added to each sample prior to 
sonication. The spike consisted in the commercial vector pBluescript-SK (Promega) (70 
ng/sample) that contained an AmpR gene. Chromatin was sonicated using a Bioruptor 
(Diagenode) for 10 cycles (30 sec on / 30 sec off) and subsequently submitted to two 
consecutive phenol-chloroform extractions. DNA was Na-Acetate/ethanol precipitated 
in the presence of 20 μg/ml of glycogen, overnight at -20°C, resuspended in elution 
buffer (Qiagen) and treated with 100 μg/ml of RNase at 37°C for 1-2 h. Finally, DNA 




gene copy number, a ‘total non-cross-linked DNA’ control was included in which the 
same protocol was followed except that cross-linking was omitted. Quantification of 
DNA isolated by FAIRE and in the toal non-cross-linked DNA samples was performed by 
real-time qPCR as described above. FAIRE enrichment was calculated by normalizing 
the DNA levels in FAIRE samples with DNA levels in non-cross-linked samples and total 
DNA input was controlled for by normalizing to the AmpR levels from spike. 
 
CHROMATIN IMMUNOPRECIPITATION 
Chromatin immunoprecipitation (ChIP) was performed essentially as described (Siegel 
et al., 2009). BSFs (4-6 x 107 parasites) were collected, cells were fixed with 1.1% 
formaldehyde in HM1-11 medium for 20 min at RT. Fixation was stopped by adding 
glycine to a final concentration of 110 mM. After cell lysis, chromatin was sheared by 
sonication using a Bioruptor (Diagenode) for 10 cycles (30 sec on / 30 sec off). 
Immunoprecipitation was performed overnight at 4°C with IgG-coated magnetic beads 
(Dynabeads Protein G, Thermo Fischer Scientific) coupled with 10 μg of custom-made 
monoclonal anti-H3 antibody (kindly provided by Christian Janzen). Beads were 
washed with cold RIPA buffer (50 mM HEPES-KOH, pKa 7.55, 500 mM LiCl, 1 mM EDTA, 
1.0% NP-40, 0.7% Na-Deoxycholate) and eluted with elution buffer (50 mM Tris-Hcl, pH 
8.0, 10 mM EDTA, 1% SDS). Cross-linking was reverted at 65°C for 9-15 h. Samples 
were treated with RNAse A (80 μg/sample) for 37°C, 2 h followed by treatment with 
proteinase K (80 μg/sample) at 55°C for 2 h. Immunoprecipitated DNA was purified 
using a QIAquick Gel Extraction Kit (Qiagen) To control for the total input of chromatin 
in-between samples, a ‘total input sample’ was prepared in parallel in which the same 
protocol was performed except the immunoprecipitation step. DNA was analysed by 
real-time qPCR has described above. Levels of DNA isolated by ChIP were calculated by 








RNA-SEQ DATA ANALYSIS 
Total RNA was extracted 4 days after induction of H1 depletion in vitro. Ribosomal RNA 
was depleted with RiboMinus kit (Invitrogen). PolyA-containing RNA was purified using 
Dynabeads oligo-(dT) (Invitrogen) and cDNA was synthesized using random hexamers 
according to Complete RNA-seq Library System kit (NuGEN) instructions. Samples were 
sequenced in an Illumina HiSeq2000 platform (EMBL). Sequence reads were 100 
nucleotides long and paired-ended. Their quality was accessed using the FASTQC 
quality control tool (http://www.bioinformatics.babraham.ac.uk/projects/ fastqc/). 
Contiguous read segments for which the quality score at each base was greater than 
28 (-h 28), and longer than 25 nucleotides (-l 25) were selected using the DynamicTrim 
and LengthSort Perl-based software respectively (Cock et al., 2010). The sequencing 
data were then aligned to a hybrid genome composed of the TREU 927/4 genome 
(TriTrypDB 4.1), in which the VSG coding regions in subtelomeric VSG arrays were 
removed and replaced with the Tb427 VSG coding regions as a separate chromosome. 
Alignments were obtained using bowtie 2 (Langmead et al., 2009), allowing for one 
mismatch. Non-unique reads (i.e. aligning in different locations) were excluded and the 
number of reads mapping to each feature (gene) was measured with the htseq-count 
software (http://www-huber.embl.de/users/anders/HTSeq/ doc/count.html) using the 
‘intersection-strict’ mode. These sequence data have been submitted to the 
ArrayExpress database (EBI-EMBL) under Accession No. E-MTAB-1715. Differential 
gene expression was analysed in R (v 3.0.2), using DESeq (v 1.14.0) (Anders & Huber, 
2010) from Bioconductor (v 2.6). DESeq uses the negative binomial distribution for 
modelling read counts per genomic feature. We first estimated the relative library 
sizes with the function estimateSizeFactors: for a matrix of raw read counts (where 
samples are represented in columns and genes in rows), each column is divided by the 
geometric means of the rows and the median of these ratios is used as the size factor 
for that specific column. Then, we used the function estimateDispersions: for each 
condition, it first computes an empirical distribution value for each gene, then fits by 
regression a dispersion-mean relationship and finally chooses for each gene, from the 
empirical and the fitted value, a dispersion parameter that will be used in subsequent 




base means of the two conditions (RNAi and PL1S in this case). Feature regions were 
defined as gene coding sequence (CDS) regions, except in cases where the number of 
uniquely mappable positions inside the CDS is smaller than 100, in which case UTRs 
(annotated by Nilsson et al., 2010) were also included. To determine uniquely 
mappable positions we extracted all 100bp sequences (pseudo-reads) appearing in the 
reference genome and mapped them back using the same software and parameters 
used previously. After filtering out non-unique alignments, positions where one 
pseudo-read was successfully mapped were considered mappable. We corrected for 
multiple comparisons by controlling the FDR, following the Benjamini-Hochberg 
procedure (Benjamini & Hochberg, 1995), which relies on the P-values being uniformly 
distributed under the null hypothesis consists of sorting the P-values in ascending 
order, and then dividing each observed P-value by its percentile rank to get an 
estimated FDR (Noble, 2009). Genes with a FDR-adjusted P-value < 0.05 were 
considered significant. 
 
GENE SET ENRICHMENT ANALYSIS 
Gene set enrichment analysis (GSEA) was performed as described before 
(Subramanian et al., 2005). GSEA allows us to investigate if specific gene sets (i.e. 
groups of genes that share common biological properties of interest) show statistically 
significant, concordant differences between two biological states and are therefore 
correlated with the phenotypic distinction under study. Non-expressed genes were 
removed from the analysis and the remaining were ranked by differential expression P-
value. For a given gene set S (in Fig. 5D ‘Genes inside BESs and procyclin loci’; in Fig. S8 
‘Genes inside BESs’, ‘VSGs inside BESs’, ‘VSGs outside BESs’ and ‘Genes inside procyclin 
loci’), an enrichment score was calculated by walking down the ranked list of genes 
increasing a running-sum statistic when the gene is in S and decreasing it otherwise 
and extracting its maximum value at the end. Thus, a high enrichment score indicates a 
preference for the genes in S to be among the more significantly differentially 
expressed genes. Statistical significance of this enrichment was determined by 




distribution of maximum scores obtained by randomly permuting the gene ranks 1000 
times (histogram in the top right corner), allowing the estimate of the associated FDR-
adjusted P-value. That significance is also illustrated by comparing the distribution of 
scores across observed gene ranks (blue line) with a simulation of scores distribution if 
gene ranks were randomly selected (grey line). This simulation was generated by 1000 
random permutations of the gene ranks and represented as the 95th percentile of the 
enrichment scores obtained. 
 
LUCIFERASE ACTIVITY 
Luciferase activity was measured with a Firefly Luciferase Kit (Biotium) from 1.5 × 106 
parasites following the manufacturer’s protocol. Luminescence was measured in an 
Infi- nite M200 plate reader (Tecan). 
 
4SU-LABELLING AND PURIFICATION OF NASCENT TRANSCRIPTS 
For metabolic labelling of newly transcribed RNA, 1.5–1.85 x 108 BSFs were collected 
by centrifugation at 970 g for 10 min, at room temp. and, washed three times each 
with 25, 50 and 2 ml of trypanosome dilution buffer (TDB) (5 mM KCl, 80 mM NaCl, 1 
mM MgSO4, 20 mM Na2HPO4, 2 mM NaH2PO4, 20 mM glucose, pH 7.7). Cells were 
resuspended in 2 ml of TDB and 4-thiouridine (4sU) (Sigma) was added to a final 
concentration of 500 μM for 2, 5 or 10 min at 37°C. In experiments where transcription 
was inhibited, actinomycin D (Sigma) was added to a final concentration of 20 μg ml−1, 
5 min before starting 4sU-labelling. A negative control sample, with parasites with no 
4sU addition (NO 4sU sample), was also included for each experiment. Total RNA was 
extracted using TRIzol reagent (Invitrogen) following the manufacturer’s protocol and 
RNA was dissolved in RNasefree Tris-EDTA buffer (TE) (10 mM Tris-HCl pH 8, 1 mM 
EDTA). Sample quantity and quality was assessed in a NanoDrop2000 (Thermo 
Scientific). Biotinylation and purification of 4sU-labelled RNA was performed 
essentially as described before (Dolken et al., 2008). Labelled RNA was biotinylated 




reaction was carried out in labelling buffer (10 mM Tris-HCl pH 8, 1 mM EDTA) and 0.2 
mg ml−1 Biotin-HPDP for 1.5 h at room temperature. An amount of 50–90 μg of total 
RNA was used for the biotinylation reaction. Unbound Biotin-HPDP was removed by 
chloroform/isoamyl alcohol (24:1) extraction. RNA was precipitated with a 1:10 
volume of 5 M NaCl, an equal volume of isopropanol and 15 μg of GlicoBlue (Life 
Technologies) at 20000 g for 20 min, 4°C. The pellet was washed with an equal volume 
of 75% ethanol and resuspended in RNase-free TE. Biotinylated RNA was captured 
using μMACS streptavidin beads and columns (Miltenyi). Up to 58 μg of biotinylated 
RNA was incubated with 100 μl of beads for 15 min at room temperature, with 
rotation. Beads were magnetically fixed and washed 3× with washing buffer (100 mM 
Tris-HCl pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween20) at 65°C followed by 3× washes 
with washing buffer at room temperature. 4sU-labelled RNA was eluted in two rounds 
by adding 100 μl of freshly prepared 100 mM dithiothreitol (DTT). Eluted RNA was 
precipitated with a 1:10 volume of 5 M NaCl, 2.5× volume of 100% ethanol and 30 μg 
of GlicoBlue, at −80°C for at least 30 min. RNA was washed in 75% ethanol and 
recovered by centrifugation as described above and resuspended in RNase-free water. 
cDNA synthesis and qPCR analysis was performed as described in a previous section. 
Levels of nascent transcripts were assessed by calculating the ratio of intergenic/CDS 
levels for 18S and β-tub. In this case, an internal normalization for 18S was not needed 
since two types of transcripts are being compared inside the same sample. The fold-
change relative to NO 4sU samples was then calculated and plotted. In the experiment 
where transcription was blocked by actinomycin D treatment, an equal amount of RNA 
was used to synthesize cDNA and no further normalization was applied. Transcript 
levels for each locus in the MACS-isolated fraction were plotted as foldchange to the 
NO 4sU sample. To compare nascent transcript levels in H1 RNAi clones relative to 
PL1S, qPCR levels were first normalized to those of 18S transcripts and afterwards fold-







MMS AND PHLEOMYCIN-INDUCED DNA DAMAGE 
Parasites in which RNAi has been pre-induced for 2 days with tetracycline (1 μg ml−1 ), 
were incubated in a 96-well plate (200 μl per well) with sixfold range dilutions of 
methyl methanesulphonate (MMS; Sigma) or phleomycin (Cayla) in HMI-11, at a final 
concentration of 0.5–4 × 104 cells ml−1 . After 2 days, cell viability was measured with 
AlamarBlue® (Sigma). Ten microlitres of Alamar Blue® was added per well followed by 
incubation at 37°C, 4 h and fluorescence was measured (530ex/590em nm). RNAi 
induction with tetracycline and selection with Hygromycin was maintained during the 




To estimate statistical significance of data from FAIRE, ChIP and 4sU experiments 
calculated as a fold increase, we computed a log-normal posterior distribution of the 
fold-change, using an empirical Bayes approach. The statistical significance for 
remaining comparisons was given by non-parametric Mann–Whitney U tests. A P-value 
< 0.05 was considered significant. For the statistical analysis of RNA-Seq data, see RNA-





Figure S1. Genotyping of histone H1 loci. (A) Diagram of H1 loci with hybridization probes and 
restriction enzyme target sequences represented. H1 loci are colored according to the code 
associated with the 5’UTR-specific primers and protein N-terminal sequences defined for Figure 
1. (B) Southern blot analysis from T. brucei Lister427 genomic DNA. DNA was double-digested 
with SmaI (S) and BamHI (B) (SB lane) and single digested with NheI (N lane). DNA restriction 
fragments were separated by standard agarose gel electrophoresis. DNA probes were made by 
PCR amplification of specific gene sequences (probe A GeneID: Tb927.11.1890; probe B GeneID: 
Tb927.11.1780; probe C GeneID: Tb927.11.1850; probe D GeneID: Tb927.11.1820 and probe H1 
GeneID: Tb927.11.1800) and 32P-radiolabeled. Blots were hybridized and visualized by phosphor 
imaging. There were three unexpected bands (*) which suggest the existence of an additional H1 
locus. (C) Summary table of PCR and sequencing results of each H1 loci. A putative new locus 
was identified by PCR amplification and sequencing, being composed by a unique histone H1 
gene. 










Figure S2. Each histone H1 class has a unique 5’UTR. (A) Alignment of the predominant 5’UTRs 
and (B) 3’UTRs of histone H1 variants of T. brucei. Average percentage of sequence identity 
between each variant is shown on the left and sequence length on the right of each sequence. 
Divergent nucleotides are indicated in gray. Gaps (-) were introduced for best alignment. 








Figure S3. Specificity of histone H1 primers. (A) Class-specific amplification of histone H1 was 
obtained by using forward primers that annealed with the class-specific 5’UTR and a reverse 
primer that annealed with the conserved 3’UTR sequence common to all H1 classes. 
Amplification of all H1 classes was obtained by using a forward and a reverse primer that 
annealed both to 3’UTR sequences common to all H1 classes. (B) Class-specificity of the primers 
was confirmed by PCR using as a template plasmids containing, either MAKASA, MAKTT or 






























Figure S4. Efficiency of Histone H1 depletion. (A) Percentage of depletion of histone H1 classes 
during RNAi induction for 2, 4 and 6 days in RNAi clones C1 and C2 relatively to the parental cell-
line PL1S. Primers for all H1 classes and primers specific for each H1 classes were used. Three 
independent experiments were analyzed. (B) Non-induced RNAi clones C1 and C2 show a 
reduction of histone H1 from 77% to 63% of PL1S levels. One and two independent experiments 
were analyzed for C1 and C2, respectively. Results are shown as mean ± SEM. Statistical 
significance was determined by a non-parametric Mann-Whitney test. * P < 0.05, ** P < 0.01, 










Figure S5. H1 depletion causes no major changes in cell cycle. (A) Gating strategy used in FACS 
to select trypanosomes. Trypanosomes were gated using SSC-A and FSC-A, and singlets were 
selected from the gated trypanosomes, using FSC-A and FSC-H. (B) FACS histograms of cell cycle 
profiles of PL1S, C1 RNAi and C2 RNAi after 6 days of RNAi. DNA content was measured by 
Vybrant® DyeCycle™ Violet (DCV) staining in live parasites. Frequency of parasites is normalized 
to mode (most frequent value of DCV intensity). Gates used to quantify the fraction of each cell 
cycle stage are shown. < 2C, DNA content lower than the diploid chromosome number; > 4C, 





Figure S6. H1 compacts chromatin at different levels across genome. (A) FAIRE enrichment and 
(B) H3 ChIP levels in individual H1 RNAi clones C1 and C2 after 6 days of RNAi induction. For 
FAIRE an AmpR gene contained in a plasmid spike was used as a normalizer for DNA input. For 
H3 ChIP, DNA was quantified by qPCR, compared to the total input material and normalized to 
18S DNA. Results are expressed as fold-change relatively to parental cell-line PL1S. Note that 
FAIRE enrichment is represented in a logarithmic scale. Two to three independent experiments 
were analyzed. Results are shown in mean ± SEM. BSDR, blasticidin resistance gene; VSG, variant 
surface glycoprotein gene; BES-P, promoter region of silent BESs; LUC, luciferase gene; MVSG, 
metacyclic VSG gene; Pro-P, procyclin promoter region; EP2, procyclin EP2 gene; rDNA-P, rDNA 
promoter region; 18S, ribosomal 18S gene; -tub, -tubulin gene; SMC3, structural maintenance 
of chromosome 3 gene; -tub-PR, promoter region of -tub polycistronic unit; SMC3-PR, 
promoter region of SMC3 polycistronic unit; ISP, inhibitor of serine peptidase gene; PAG3, 























Figure S7. Gene expression MA-plot of H1-depleted clones relative to parental clone. Mean 
expression levels (normalized counts) across samples are plotted on the x-axis and the 
corresponding log2 fold-changes between H1 RNAi and PL1S samples are plotted on the y-axis. 
Each point represents a gene. Genes with false discovery rate (FDR) adjusted P-values<0.05 are 




Figure S8. H1 regulates transcription of genes located in bloodstream expression sites and 
procyclin loci. Gene set enrichment analysis plots showing, for the subset of genes in each plot 
title, the enrichment score distributions across genes ranked by decreasing statistical evidence 
of differential expression (blue line). Light gray line represents 95th percentile of the enrichment 
scores obtained by 1,000 random permutations of the gene ranks. The histogram at the top-right 
corner of the figure represents the distribution of maximum scores obtained by random 
permutation, with the arrow indicating the experimental enrichment score (i.e. the “peak” in the 
main plot). The diagrams at the bottom show where the members of each gene set appear in the 











Figure S9. Validation of RNA-Seq results by qPCR. Scatter plots of log2 qPCR levels and log2 
RNA-Seq RPKMs for each sample (PL1S and H1-depleted clones, C1 and C2). 34 genes with mean 
expression levels ranging from 12 to 512,586 RPKMs by RNA-Seq were randomly selected and 












Table S1. Comparison of P-values for fold-change levels of H1-depleted clones relative to 






Fold relative to PL1S P value 
Loci FAIRE ChIP-H3 FAIRE ChIP-H3 
BSD 1.28 0.59 7.8155e-02 4.3350e-02 
VSG9 1.25 0.74 1.1154e-01 3.8466e-02 
BES-P 10.42 0.38 2.3594e-45 1.2662e-08 
LUC 7.08 0.47 1.1271e-32 4.3546e-07 
VSG2 2.59 0.70 2.7651e-08 5.1371e-03 
VSG3 2.05 0.59 8.0545e-06 3.8335e-04 
VSG18 2.77 0.68 3.5050e-09 4.0048e-03 
MVSG 2.30 0.63 2.3810e-07 1.6109e-03 
Pro-P 1.95 0.53 3.1702e-05 6.1951e-05 
EP2 3.60 0.60 2.1755e-14 1.7638e-03 
rDNA-P 1.18 0.86 1.9650e-01 2.3235e-01 
18S 1.29 1.00 6.1862e-02 - 
-tub-PR 1.67 0.77 1.9647e-03 3.4793e-02 
SMC3-PR 2.12 0.61 1.3259e-05 7.5486e-04 
-tub 2.99 0.75 4.0836e-10 1.5674e-02 
SMC3 1.79 0.70 2.2672e-04 1.2807e-02 
ISP 2.98 0.62 1.9575e-10 6.7962e-04 
PAG3 3.80 0.71 2.8251e-15 5.3581e-04 
Figure S10. (previous page) Loss of histone H1 leads to VSG derepression. Quantification of 
gene expression 2, 4 and 6 days after RNAi induction in clone C1 (A) and clone C2 (B), relative to 
the parental-cell line PL1S. Silent BESs and VSGs become derepressed when histone H1 is 
depleted. Three independent experiments were analyzed. Results are shown as mean ± SEM. 
Statistical significance was calculated using a non-parametric Mann-Whitney test. Significant 











Amplified region Forward primer (5’-3’) Reverse primer (5’-3’) 
All H1 
 
All classes of H1 genes GGAGAGAGCTGTCACACG ATGGCGGTACATAAGACGC 
BES-P 
 





Blasticidin resistance gene CGGCTACAATCAACAGCATC ACGATACAAGTCAGGTTGCC 
β-tub  b-tubulin gene TTCAGGCTGGCCAATGCG TACGGAGTCCATTGTACCTG 
β-tub-PR 
 
b-tubulin promoter region AGCCGCTACTCGATTTCACA TCGCCATACCGACACAGC 
COIII 
 
Cytochrome c oxidase subunit III gene GAGGGAACGGGAGAGGAACG TGTTTCTGCAAACAATCTCATCTGG 
EP1  Procyclin EP2 gene (3’UTR) AATGTCTTATTAACCATCGCCTG AAAATTATGGAATACGCAACCG 
EP2  Procyclin EP2 gene (3’UTR) GGTGGCCCCAGTTATTTCTTT    TATGCAAGTGTCCTGTCGCC 
ISP 
 
Inhibitor of serine peptidase gene GTCGTGTGATGGAGGATGG TGAAGTGCTTGGTCGGAAC 
LUC  Luciferase reporter gene ATGTCCGTTCGGTTGGCAG CATACTGTTGAGCAATTCACG 
MAKTT 
 
MAKTT class H1 gene GGAAAGTAGAAAGGAAAATAAAAT TCTAATAGCGGGCAGCAG 
MAKASA 
 
MNNTT class H1 gene TCGCAATCTTATCAACACTCG TCTAATAGCGGGCAGCAG 
MNNTT 
 
MAKASA class H1 gene CTTTATCGACTCCCCACAAG TCTAATAGCGGGCAGCAG 
MVSG 
 
Metacyclic variant surface glycoprotein 639 gene TCGCACTTTCAGCTCTGCTC GCCGACCACTCGCTGTCC 
PAG3 
 
Procyclin-associated gene 3 GCAAATGCTCCTCTTCTCC TGGCTGCCGAAGCAAGCG 
Pro-P 
 
Procyclin promoter region (10bp downstream TSS) AGTTTAAGATGTTCTCGTGAT CTTTTTGGTGTAATTGAAGTC 
rDNA-P = 18S Int 
 
Ribosomal DNA promoter region (15bp downstream TSS) CTGACCGCTCTCAGACCG ACACACGTATTACACACACTC 
SMC3  Structural maintenance of chromosome 3 gene GAGGCTGGATGATGAGAGG ATTCAGCTTCACTGATGATGG 
SMC3-PR 
 
SMC3 promoter region GGCGGTGTGGGTGTATCC ATCGTCGCCCCTAAGTGC 
VSG2  Variant surface glycoprotein 2 gene AGCAGCCAAGAGGTAACAGC CAACTGCAGCTTGCAAGGAA 
VSG3  Variant surface glycoprotein 3 gene GCTTATTTTGTGTCTGTCGC GACGCAGCAGAATCAACAC 
VSG9  Variant surface glycoprotein 9 gene ACTAAGCTCGTGGCGCAC CGCGTAGTTGACGCATGAC 
VSG13  Variant surface glycoprotein 13 gene ATAACGCATGGCCATCTTGAC GTCGTTGCTGTGGATTGCTC 
VSG18  Variant surface glycoprotein 18 gene ACAGACCGCCGACAGTATC GTATCTTTGTAGGCCGCTGC 
VSG21  Variant surface glycoprotein 21 gene CAGCGCAAGTACAGGACG TGCTTCGTCGTCGCTTAC 
18S 
 
18S ribosomal DNA ACGGAATGGCACCACAAGAC GTCCGTTGACGGAATCAACC 
Tb927.10.2080  hypothetical protein, conserved AGCTGCAGCCACAGATATTC TTGTTGCATTGGTGGCGTAC 






Tb11.02.5800  calmodulin, putative ACGCGTGAGTATTTGAAGCG TCGTAGTCTGCTTCAGCCTTC 
Tb927.7.4520  hypothetical protein, conserved ACAAGAAAGCAACGGGGAAG TGGTGAAGCTCTGCAAGAAC 
Tb09.211.2140  hypothetical protein, unlikely CGTTCCTTTTATTTCGCTCACG AGATGATAAAGCAATGGGAGCTC 
Tb09.211.4750  hypothetical protein, unlikely GGTGGCATGGTTGGGTAAAG TTCCGGGTGTATGCAATTGC 
Tb11.03.0370  hypothetical protein, conserved AGCAGCCTCTTTTGTGCTTC CGTGATACGCAAAAGGGAAAC 
Tb927.4.3430  hypothetical protein, conserved ATCCATGGCTTTCGCAAACG ACGACACATTTCTGGAACGC 
Tb09.211.3190  hypothetical protein, unlikely TGGGCGGTGATTCTCTTAAT TTTAACCGAGGTGTAACGTGAA 
Tb09.160.0380  hypothetical protein, conserved TCAGTTGTTGCGGAATGTCC AACATCACGCACGCCATTG 
Tb927.10.10760  hypothetical protein TTCCACGAGAGCGAAAAGTG TCGAGCATTGACAAGGAACC 
Tb927.10.11060  hypothetical protein, conserved TATGTTCGTGAACCGCACTG AAAAGTCATCGTCGCGACTC 
Tb09.160.2440  hypothetical protein, conserved TTTTCTTCTGGCAGCATCGC AACCCGCGCTGTAACAATTC 
Tb927.8.2470  hypothetical protein, conserved TGTTCAGCGCGAGAAAGTAC ACTTTGGGCTATGCTCCTTCTC 
Tb11.03.0935  RNA polymerase subunit, putative (RPB6z) GCACGCCAAATTGTGAATGG ATGAATAGGATCGACGGATGCC 
Tb09.211.2150  Nuclear poly(A)-binding protein 1 (PABP2), putative (PABP2) AGACATGCGGAACAAACAGC ATGCGCGTGTTCATGAAGTG 
Tb11.01.6220  procyclin-associated gene 4 (PAG4) protein, putative TGGAAACGAAAAGGGCAAGG ATGACTTTCGTTCGCCCATG 
Tb927.10.2100  elongation factor 1-alpha,EF-1-alpha (TEF1) AACATGATCACCGGCACATC TGTTGCAGCACACAACCATC 
Tb09.244.2400  BARP protein (BARP) AGTGTACTGATACAGCGGAAGG TGCCGCAACTTTCTAGCAAC 
Tb927.10.12100  RNA-binding protein, putative (RBP7B) TTCTACGGTGATGTGCTGCA TTGTGAAGTCCGAGGATGGC 
Tb927.7.5940  Protein Associated with Differentiation (TbPAD2) ATCGCAGCGTTCTCAAATGG TTGTTGCGTGTACCACTCAC 
Tb11.02.0740  60S ribosomal protein L44 GCGAAGACGACCAAGAAGATTG TTGTCGTTCAGCTCGAAGTG 






3.2 HISTONE H1 IS IMPORTANT FOR T. BRUCEI FITNESS IN VIVO 
 
Results from the first part of this section (Results 3.2.2.1. H1 depletion impairs 
progression of acute infection in mice) were published, together with the previous 
results section (Results 3.1. Trypanosoma brucei histone H1 inhibits RNA polymerase I) 
in the Molecular Microbiology peer-reviewed journal. The article in the publication 
format can be found in the Annexes. 
Ana C. Pena1 and Luisa M. Figueiredo1 
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Prof. Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal. 
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3.2.2.1 H1 depletion impairs progression of acute infection in mice 
 Given the involvement of T. brucei H1 in resistance to DNA damage, VSG 
transcription and global chromatin condensation, it might be surprising how H1-
depleted parasites can grow so well in culture (Results 1.3.1., Fig. 1A). A 50% reduction 
in H1 levels in mice is lethal (Fan et al., 2003). In contrast, histone H1 is not necessary 
for growth or survival in vitro in the unicellular eukaryotes S. cerevisiae and T. 
thermophila (Shen et al., 1995, Shen & Gorovsky, 1996, Patterton et al., 1998). On the 
other hand, in another kinetoplastid parasite, Leishmania major, overexpression of 




Thus, we decided to investigate the effect of H1 depletion during an in vivo infection, a 
setting where the parasite is exposed to a much more challenging environment 
compared with culture conditions. With this objective, we established infections in 
mice. We inoculated C57BL/6 mice with 100 parasites of the parental cell-line, PL1S, or 
H1-depleted clones. In the latter, RNAi was pre-induced for two days with tetracycline 
in culture. As previously published, mice also received doxycycline, a tetracycline 
analogue, in water two days before infection and during entire infection (Lecordier et 
al., 2005). Doxycycline had no effect on PL1S-infected mice (Fig. S1). Interestingly, mice 
infected with H1-depleted parasites survived longer (P < 0.01 for C1 and P < 0.001 for 
C2) (Fig. 1A). Indeed, whereas 55% of the PL1S-infected mice died in the first nine days 
of infection, the majority of C1 or C2-infected mice survived until day 13 and 15, 
respectively. Such prolonged life-span was associated with a delay in parasite 
appearance in the blood (Fig. 1B; Fig. S2). In fact, whereas parental parasites reached 
detectable parasitaemia within 4–7 days of infection, H1-depleted clones took 4–15 
days. This is much later than what would be expected from the growth delay measured 
in vitro (detectable parasitaemia should be reached at day 4–5), which indicates that 
host factors must have contributed to this diminished parasitaemia.  
 It is interesting to note that the least virulent clone (C2) was the one with the 
most efficient H1 depletion (P < 0.05; Fig. 1A–C), suggestive of a dose-dependent 
response. Consistent with the fact that in ‘non-induced’ RNAi clones H1 transcripts are 
in fact 20% lower than in parental strain (Results 1.5., Fig. S4B), in mice we observed 
that clone C2 caused a slight increase in life-span (P < 0.01) (Fig. 1A and Fig. S1). These 
results clearly indicate that although H1-depleted cells have hardly any growth defect 
in vitro, H1 is essential for parasite fitness in vivo.  
 In around 50% of the mice infected with the parental cell-line PL1S and 40–75% 
of the mice infected with H1 depleted clones, two peaks of parasitaemia were 
detected (Fig. 1B; Fig. S2). In the majority of the remaining mice infected with H1-
depleted parasites, a single peak of parasitaemia appeared later, after nine days of 
infection. In order to test if parasites detected in the second peak of H1-depleted 
clones were RNAi revertants, i.e. parasites that have lost the capacity of performing 




observed that H1 transcripts were still reduced to around 40% and 12%, confirming 
that parasites were still depleted of H1 (P  0.05) (Fig. 1C), indicating that parasites 
that grow later in infection are not RNAi revertants. 
 Typically in a T. brucei infection, parasites in the second peak of parasitaemia 
express a VSG different from the one expressed in the initial parasite population. In 
Figure 1. H1 depletion compromises T. brucei fitness in vivo. (A) Survival of mice infected with 
100 parasites of parental cell-line PL1S or the two H1-depleted clones (C1 or C2). Three to four 
independent experiments were analyzed. Mice n = 20–35 per group. Survival curves were 
statistically compared by a Log-rank (Mantel-Cox) test. (B) Representative examples of 
parasitaemia in the blood of mice infected with T. brucei parasites depleted of H1. While PL1S 
parasites typically reached a peak in parasite number in 7–12 days, histone H1-depleted 
parasites had a delay of several days in parasitaemia. (C) Depletion of histone H1 in T. brucei 
parasites isolated from the blood of infected mice. PL1S parasites were collected at day 7 post-
infection and C1 and C2 parasites at days 9–14 post-infection. Transcript levels of histone H1 
were quantified with primers for all histone H1 classes by qPCR. Results are shown as percentage 
of transcript levels relative to PL1S levels. (D) Quantification of VSG9 expression in parasites 
isolated from the blood of mice (same parasites analyzed in (C)). C1 and C2 parasites underwent 
VSG switching and no longer express VSG9. Transcript levels were measured by qPCR. Mice n = 
3–4 per group. Results are shown as mean ± SEM. Statistical significance was determined by 




order to confirm that VSG switching took place, we collected C1 and C2 parasites from 
the blood on days 9–14 post-infection and tested whether they were still expressing 
the original VSG9 or if this VSG had become silent. By qPCR we confirmed that in H1-
depleted parasites VSG9 was no longer transcribed confirming that these mutant 
parasites had switched VSGs (P  0.05) (Fig. 1D). This included the H1-depleted 
parasites that generated a single delayed peak of parasitaemia, confirming that this 
corresponded indeed to a second peak. Overall, these results show that when H1 is 
depleted, parasite fitness becomes compromised, but parasites are still capable of 
switching their VSGs. 
 Even though depletion of H1 significantly disturbs infection in vivo, eventually 
H1-depleted parasites generate a second peak of parasitaemia, which reaches high 
parasite numbers (107-109 parasites.ml-1) and results in mice death. Only one exception 
to this occurred in one (out of 21) mouse infected with clone C2, which never showed 
high parasitaemia and survived until the end of RNAi induction, 24 days after infection.  
 
3.2.2.2 In vivo, H1 depleted parasites adapt and regain fitness 
 Given that H1 depletion is maintained until the end of infection (Fig. 1C), the 
observed re-establishment of parasite fitness in H1-depleted parasites could not be 
explained by the appearance of RNAi revertants. Intrigued by this observation, we 
asked whether fitness recovery in H1 mutants was underlined by transitory or stable 
modifications occurring in the parasite. To answer this question, we transferred T. 
brucei H1-depleted parasites from the first peak and the second peak of parasitaemia 
into naïve mice. Induction of RNAi was kept in these mice by administration of 
doxycycline in water. We observed that H1-depleted parasites transferred from the 
first peak replicated more slowly and lead to prolonged mouse survival (Fig. 2A-C), 
reproducing what was observed previously in an infection initiated by H1-depleted 
parasites coming from in vitro culture (Fig 1.A,B). In contrast, H1-depleted parasites 
transferred from the second peak rapidly replicated in the blood and lead to mice 
death within 8-9 days, similarly to the parental PL1S parasites (Fig. 2A,B,D). These 




host, ultimately H1-depleted parasites can undergo modifications that are stable and 
transmissible to the following generations and which compensate for the functions of 













Figure 2. H1-depleted parasites can stably recover their fitness in vivo. T. brucei parasites at 
different peaks of parasitaemia were transferred from the blood of infected mice into naïve 
mice. (A) Survival of mice that received 100 parasites from the parental cell-line PL1S from the 
first peak of parasitaemia, the H1-depleted clone C1 from the first peak of parasitaemia or the 
H1-depleted clone C2 from the second peak of parasitaemia. One independent experiment was 
analyzed. Mice n = 3 per group. (B) Parasitaemia in the blood of mice that received PL1S 
parasites from the first peak of parasitaemia, (C) C1 parasites from the first peak of parasitaemia 
and (D) C2 parasites from the second peak of parasitaemia. After parasite transfer, PL1S 
parasites reached a peak in parasitaemia in 7-8 days, while C1 parasites from the first peak 
maintained a delay of several days in growth. On the contrary, C2 parasites from the second 




3.2.2.3 H1 is important for T. brucei ability to evade the host immune system 
 We observed that appearance of H1-depleted parasites in the blood of mice is 
delayed up to 10 days relative to the predicted from their doubling times in vitro (Fig. 
1B; Fig. S2). This suggests that when histone H1 levels are below normal, T. brucei 
parasites are less efficient in adapting to drastic changes in their environment, such as 
those encountered when entering the mouse host. An obvious difference between 
culture and mouse is the presence of immune system. Thus we investigated whether 
the immune system played a role in parasite growth delay. For this, we established 
infections in Rag2-/-c-/- mice (also known as Rag2-/-Il2rg-/-), a mouse strain in which 
recombinase activating gene-2 (Rag2) and common cytokine receptor  chain (c) were 
knocked-out resulting in a severe immunodeficiency characterized by the complete 
absence of T, B and natural killer lymphocytes (Mazurier et al., 1999). As a 
consequence, these mice have a wide-range of immune responses compromised: lack 
of adaptive immunity, lack of natural killer-mediated innate immune response and 
several other innate immunity defects (Shultz et al., 2007). 
 As expected, due to the absence of major immune responses, PL1S parasites 
replicate rapidly and lead to mice death up to seven days earlier in Rag2-/-c-/- mice 
when compared with wild-type mice (P  0.05) (Fig. 3A). Strikingly, the delay in 
parasite appearance in the blood and the prolonged survival of mice, distinctive of an 
infection by H1-depleted parasites, was completely abolished in Rag2-/-c-/- mice. While 
in wild-type mice infected with C2 parasites, 50% of the mice survived eight days 
longer than PL1S-infected mice (P < 0.01), Rag2-/-c-/- mice infected with C2 died within 
the first 7-8 days of infection, as fast as when infected with PL1S parental parasites (P-
value non-significant) (Fig. 3A). In agreement with this, parasitaemia in blood and 
parasite replication rates were identical in C2 and PL1S-infected Rag2-/-c-/- mice. In 
these mice, both C2 and PL1S parasites generated only one peak of parasitaemia and 
replication rates were similar to those of parasites growing in vitro (Fig. 3D,E). This 
result shows that the mouse immune system is a limiting factor for parasite 
progression under subnormal H1 levels, and contradicts the contribution of other 






Figure 3. Histone H1 is important for T. brucei immune evasion. (A) Survival of wild-type and 
Rag2-/-c-/- mice infected with 100 parasites of the parental cell-line PL1S or the H1-depleted 
clone C2. (B) Parasitaemia in the blood of wild-type mice infected with PL1S and (C) H1-depleted 
clone C2 parasites. (D) Parasitaemia in the blood of Rag2-/-c-/-mice infected with PL1S and (E) 
H1-depleted clone C2 parasites. In Rag2-/-c-/-mice the delay in parasitaemia observed between 
PL1S and C2 parasites is abolished and both parasite cell-lines grow at fast rates. One 
independent experiment was analyzed. Mice n = 3–6 per group. Survival curves were statistically 
compared by a Log-rank (Mantel-Cox) test. ns, non-significant P-value. * P < 0.05, ** P < 0.01, 




 As described in Figure 1, infection in wild-type mice resulted in two peaks of 
parasitaemia in more than 50% of the mice infected either with C2 or PL1S parental 
cell-line (Fig. 3B,C). Interestingly, one mouse infected with C2 clone even exhibited five 
peaks of parasitaemia and survived, apparently healthy, for 87 days after which it was 
sacrificed (doxycycline treatment was stopped at day 31 after infection). It is therefore 
possible that C2 parasites were actually cleared by the immune system in this mouse.  
 Altogether, our results clearly demonstrate that the host immune system is a 
key factor behind disturbance of T. brucei fitness and adaptation to the host 
environment in vivo, induced by H1 depletion. Curiously, this implies that H1-depleted 
parasites are somehow more susceptible to recognition and/or destruction by the host 
immune system and consequently that histone H1 is important for T. brucei immune 
evasion, even if indirectly. 
 
3.2.3 MATERIALS AND METHODS 
 
MOUSE INFECTIONS 
Inbred C57BL/6 wild-type mice (Charles River) and Rag2-/-c-/- (kind gift of Bruno Silva-
Santos laboratory) were housed in the pathogen-free facilities of the Instituto de 
Medicina Molecular (IMM). The animal facility and the experimental procedures 
complied with European Guideline 86/609/EC, followed the Federation of European 
Laboratory Animal Science Associations (FELASA) guidelines and recommendations 
concerning laboratory animal welfare and were approved by the Instituto de Medicina 
Molecular Animal Care and Ethics Committee (AEC_2011_006_LF_TBrucei _IMM). 
Mice were infected intraperitoneally with 100 parasites of T. brucei Lister 427 PL1S and 
RNAi clones C1 and C2 (with and without induction). RNAi induction was initiated in 
culture with 1 μg ml−1 tetracycline 2 days prior to mouse infection. RNAi was 
maintained in vivo in mice by watering them with 1 mg ml−1 of doxycycline 
(doxycycline hyclate, Sigma). Mice received doxycycline 2 days prior to infection and 




infection by collecting 1 μl of blood from the mouse tail, diluting it in 1:150 in HMI-11 
medium and counting in a Neubauer chamber. In parasite transfer experiments, blood 
was collected by cardiac puncture from C1- or C2-infected mice, at the 1st peak or 2nd 
peak of parasitaemia, respectively, in 20 μl of heparin solution (50 UI/ml). Blood was 
diluted in HM1-11 media to a final concentration of 500 parasites/ml. Each naïve 
C57BL/6 mouse was infected intraperitoneally with 200 μl of this suspension, 
containing 100 parasites. 
 
REAL-TIME QUANTITATIVE PCR ANALYSIS  
For RNA extraction of parasites in the blood, between day 7 and 14 post-infection, 25–
30 μl of blood from the tail of infected mice (parasitaemia ∼108 parasites ml−1 of 
blood) was collected in red blood cell lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 1 
mM EDTA.Na2, pH 7.4), washed in 1× TDB and extracted with PureZOL, according to 
manufacturer’s instructions (Bio-Rad). cDNA synthesis and qPCR were performed as 
described above (see Results 3.1). Primers are listed in Table S2. 
 
STATISTICAL ANALYSIS 
Survival curves were compared by a Log-rank (Mantel-Cox) test. The statistical 
significance for remaining comparisons was given by Mann–Whitney U tests. A P-value 


















Figure S1. Survival of PL1S, C1 RNAi clone 
and C2 RNAi clone, when RNAi was non-
induced (-) or induced (+) with doxycycline. 
Mice n = 6-21 per group. Two to four 
independent experiments were analyzed.  
Figure S2. Histone H1 depletion 
delays parasite appearance in vivo. 
Representative example of 
parasitaemia (number of parasites 
per ml of blood) in mice infected 
with PL1S and H1-depleted C1 and 
C2 RNAi clones. Three to four 
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 For decades nuclear run-on has been the gold standard method to analyze and 
quantify nascent RNAs. Typically, in nuclear run-on assays, nuclei are isolated and 
transcription is allowed to resume in vitro in the presence of radiolabeled nucleosides. 
Because run-on reaction times are short, only nascent RNAs will be radiolabeled, which 
are then detected and quantified by hybridization with DNA probes. In T. brucei, 
nuclear run-on assays were instrumental to show for the first time that VSG and 
procyclins are not transcribed by Pol II (Rudenko et al., 1989, Kooter & Borst, 1984). 
However, despite recent improvements on its precision and genome coverage (Core et 
al., 2008), nuclear run-on assays remain conditioned by the fact that transcription is 
measured in vitro and in isolated nuclei. In these conditions we cannot exclude, for 




vivo transcriptional status. Indeed, in T. brucei nuclear run-on assays, nascent 
transcript levels can vary significantly with different nuclei preparations (Kooter & 
Borst, 1984, Rudenko et al., 1989). 
 In recent years, more sophisticated methods were developed to directly 
analyze nascent RNAs, based on RNA metabolic labeling. In these methodologies, 
endogenous RNA is labeled with a non-radioactive modified precursor of uridine-5'-
triphosphate (UTP) [e.g., 4-thiouracil (4TU), 4-thiouridine (4sU), 5-etyniluridine and 5'-
bromo-uridine] followed by separation of the tagged RNAs by affinity or 
immunopurification (Perez-Ortin et al., 2013, Tani & Akimitsu, 2012). These new 
technologies have the advantage of addressing RNA dynamics in unperturbed cells 
since the uptake of the modified precursor is done though nucleotide or nucleoside 
cell membrane receptors with no need for nuclei isolation.  
 4sU labeling can also be used to measure RNA half-lives and decay kinetics 
without the need of using transcription-blocking drugs, such as ActD. This is because 
an important property of this method is that newly transcribed (labeled) and pre-
existing (unlabeled) RNA fractions can be fractionated and characterized separately by 
genome-wide sequencing. Thus, contrary to nuclear-run on, newly transcribed RNA 
can be quantified directly with no interference from steady-state RNA levels. Because 
the modified UTP precursor will only be incorporated into RNA synthesized de novo, 
the labeled RNA represents a ‘snapshot’ of the combined effects of RNA transcription 
and degradation during the timeframe of labeling. Therefore, depending on the 
duration of labeling and the RNA fraction quantified (total, labeled, unlabeled), 
mathematical models can be applied to determine RNA transcription rates, RNA half-
lives and decay kinetics with whole genome coverage (Tani & Akimitsu, 2012). 
 4sU is one of the modified nucleotides most used to metabolically label RNA. 
The technique has been applied in a broad range of organisms including mammals, 
insects (Drosophila), amphibians (Xenopus), plants (Arabidopsis) and yeast (Dolken et 
al., 2008, Friedel et al., 2009, Rabani et al., 2011, Sabo et al., 2014, Miller et al., 2011, 
Sidaway-Lee et al., 2014) 4sU is a naturally occurring modified uridine that offers the 




isolation and minimal interference in cell growth and mRNA expression in several cell-
types (Cleary et al., 2005, Kenzelmann et al., 2007, Dolken et al., 2008, Friedel et al., 
2009). In T. brucei 4sU is reported to be non toxic up to 1 mM during 72h (Ali et al., 
2013).Due to its incorporation efficiency, 4sU has the advantage of enabling very short 
labeling times (as little as 5 min) (Windhager et al., 2012, Dolken et al., 2008). When 
sufficiently short, the labeled-RNAs will mostly be inside the nucleus and not subjected 
to degradation, reflecting active transcription. Besides, short labeling pulses allow high 
temporal resolution and detection of short-term changes in RNA synthesis and 
degradation such as those occurring in primary signaling events. Taking advantage of 
this capacity, Dölken et al. identified for the first time a network of short-lived 
transcripts downregulated during fibroblast response to interferon (Dolken et al., 
2008).  
 Recent studies combined short 4sU-labeling times (10 min) with microarrays or 
RNA-Seq to determine with high temporal precision the contributions of RNA synthesis 
and decay to changes in total RNA levels during stress and immune responses in yeast 
and murine cells, respectively.(Rabani et al., 2011, Miller et al., 2011) The technique 
also gave a major contribution in disclosing gene sets directly activated or repressed by 
the transcription factor Myc (Sabo et al., 2014). 4sU-labeling technology also offers the 
possibility to follow not only RNA transcription and decay but also RNA processing 
dynamics. Ultra-short and progressively 4sU-labeling times (from 5 to 60 min) 
combined with RNA-Seq revealed the kinetics of RNA splicing and non-coding RNA 
processing at nucleotide resolution, in human B-cells (Windhager et al., 2012). 
 Metabolic labeling displays important advantages including the analysis of 
unperturbed cells, with higher temporal resolution and sensitivity and the capacity to 
perform a dynamic transcriptome analysis, distinguishing the contributions of 
transcription, splicing and RNA decay to total cellular RNA levels. Such a technique 
could be highly valuable to reveal many aspects of RNA dynamics in T.brucei whose 





 4sU metabolic labeling starts with 4sU incubation with cells for a given labeling 
duration. Cells rapidly uptake 4sU and phosphorylate it to 4sU-5’-triphosphate (4sUTP) 
which is then incorporated into newly transcribed RNA. Following isolation of total 
cellular RNA, the 4sU-labeled RNA fraction is thiol-specifically biotinylated generating a 
disulfide bond between biotin and the 4sU-RNA. Total RNA is then separated into 
labeled (newly transcribed) and unlabeled (pre-existing RNA) RNA fractions of high 
purity using magnetic-activated cell sorting (MACS) columns loaded with streptavidin-
coated magnetic beads. The unlabeled fraction is collected from the flow-through and 
column washing steps while the labeled RNA is recovered from beads by adding a 
reducing agent (e.g. dithiothreitol) that cleaves the disulfide bond and releases the 













Figure 1. A standard protocol of 4-thiouridine labeling and purification of nascent RNA. Cells 
are incubated for a short time (e.g. 10 min) with 4-thiouridine (4sU), which is uptaken and 
incorporated mostly in nascent pre-RNAs These RNAs have not be processed yet into mature 
RNAs by the addition of the spliced leader (SL) and the polyA tail (AAA). A Pol I-transcribed loci is 
used as an example. After the labeling reaction, total RNA is extracted and biotinylated. During 
the biotinylation reaction, biotin molecules binds to thiol group of 4sU residues in a 1:1 
stoichiometry. By magnetic-activated cell sorting (MACS) with streptavidin beads, biotin-4sU 
containing RNA molecules are purified from total RNA. Labeled RNA is then recovered by 
collecting the flow-through after addition of a reductive agent (e.g. dithiothreitol) that cleaved 




 As explained above (see Results 3.1.2.5, Fig. 8F), we used 4sU metabolic 
labeling to show that T. brucei histone H1 inhibits transcription at BESs and procyclin 
loci. While testing 4sU-labeling in T. brucei, we observed that 4sU-labeled RNA was 
increasingly enriched in primary transcripts with increasing labeling times and no 
recovery of 4sU-labeled RNA was possible when transcription was blocked (see Results 
3.1.2.5, Fig. 8B, D). These results validated the application of 4sU metabolic labeling to 
tag and purify newly transcribed RNAs in T. brucei. 
 The efficiency of recovery of nascent RNA in T. brucei was still far from that 
reported in mammalian cell-lines. Whereas in human B-cells, 10 min labeling time with 
500 M of 4sU leads to a recovery of around 1.5 % of total RNA (Windhager et al., 
2012), in T. brucei we recovered only 0.015–0.025% (even though the labeled RNA 
levels were clearly over the background corresponding to non-labeled RNA (see 
Results 3.1.2.5, Fig. 8C). To confirm that our protocol was working, we purified nascent 
RNA from B-cells. With a 15 min 4sU labeling, we were able to reproducibly obtain 1-
2% of nascent RNA, confirming that our reagents and methodology was successful for 
mammalian cells. The purity and quantity of 4sU-labeled RNA is critical for instance to 
pursue genome-wide studies and use high-throughput technologies such as RNA-Seq. 
Bearing this in mind, we did various attempts to improve the yield of 4sU-labeled RNA 
recovered in T. brucei. We systematically tested several changes to the protocol and 
monitored potential problems that could be limiting the three major steps in the 
protocol: 4sU labeling; biotinylation; MACS separation. Table 1 summarizes all the 
attempts to improve the 4sU-labeling efficiency in T. brucei. 
 
3.3.2.1 Labeling efficiency 
 We started by addressing potential problems in the labeling step, which is a 
result of 4sU uptake and RNA incorporation processes. Because the latter directly 
depends on 4sU concentration and transcriptional activity of cells (Radle et al., 2013), 
we tested if labeling with two times more 4sU (1000 μM) increased the yield. 
Purification and quantifications were performed as described above. We observed no 





 Next we tested cell density. In our protocol labeling is performed in a small 
volume (2 ml) with parasites at a high cell density ( 0.8x107 cells.ml-1). Because 
labeling times are very short (2, 5, 10 min), we did not expect major changes in 
transcription due to cell density. However, because parasites in culture at densities > 
1.5x106 cells.ml-1 arrest growth and undergo cell death after some hours, some 
transcriptional inhibition might have be occurring with the parasite densities used. 
Therefore, we repeated the 4sU labeling and purification protocol with parasites at a 
normal cell density (0.9x106 cells.ml-1). We observed that the quantity of 4sU-labeled 
RNA recovered was not significantly improved with a lower parasite density. 
 
3.3.2.2 4sU transport across the membrane 
 Next, we hypothesized that 4sU uptake could be limited by inefficient transport 
across the membrane. Trypanosomes possess both salvage and biosynthesis routes for 
pyrimidines (de Koning et al., 2005). This means that T. brucei parasites can both 
synthetize de novo or highjack the host’s nucleobases or nucleosides to produce their 
own pyrimidine nucleotides. The only pyrimidine transporter identified so far in T. 
brucei bloodstream forms, T. brucei uracil transporter 3 (TbU3), uptakes uracil with 
high affinity (Km = 0.54 M) and uridine with much lower affinity (Km = 9500 M), 
salvaging them into its own UTP production (Ali et al., 2013). Since efficiency of uracil 
transport is greater than uridine, we hypothesized that labeling with 4-thiouracil (4TU) 
might improve the yield of labeled RNA. Contrary to 4sU, the transport of 4TU was 
previously studied in T. brucei BSFs and shown to occur with lower affinity than uracil 
but higher than uridine (Ki = 159 M). Metabolic RNA labeling with 4TU can be 
achieved essentially following the same basic protocol as for 4sU labeling and it has 
been applied successfully in mice, Drosophila and in the protists Toxoplasma gondii 
and Karenia brevis (Gay et al., 2014, Miller et al., 2009, Cleary et al., 2005, Morey & 












Table 1. Tests performed in order to improve yield of purification/recovery of 4sU-labeled RNA in T. brucei. 












1000 M 4sU TDB 4sU 5 n = 1 same yield 
Cell density and 
labeling media 
normal cell density TDB / HMI-11 4sU 10 n = 2 same yield 
4TU and labeling 
media 
500uM, 1000 M 4TU, 
normal cell density 
TDB / HMI-11 4TU 10 n = 3 same yield 
Permeabilization 0.4 M digitonin, 10 min Transcription 
buffer 
4sU 5, 15, 30 n = 3 decreases yield 
Labeling media HMI-11, high cell density HMI-11 4sU 10 n = 1 same yield 
RNA editing 
qPCR for ND7 pre/post-
edited; ActD treatment 
TDB 4sU 10 n = 1 





Proteinase K treatment HMI-11 4sU / 4TU 10 n = 2 same yield 
Coomassie staining TDB / HMI-11 4sU 10 n = 6 
no protein detected in RNA 
sample before biotinylation 
Western blotting anti-VSG TDB / HMI-11 4sU 10 n = 4 
no VSG detected in RNA 
sample before biotinylation 
Bradford TDB / HMI-11 4sU / 4TU 10 n = 7 
2-10 g protein/100 g RNA; 
probably inaccurate 
RNA degradation Agarose gel TDB / HM1-11 4sU / 4TU 10 n = 19 no RNA degradation 
MACS 
separation 




 We tested labeling of T. brucei with 4TU at 500 M and 1000 M, for 10 min, 
with parasites at a normal cell density. Again, 4TU labeling did not improve the yield of 
nascent RNA recovery when compared with 4sU labeling. 
 Next we tested if cell membrane permeabilization would improve recovery of 
4sU-labeled RNAs by increasing 4sU entry into the parasite. Basically, we followed the 
protocol described for labeling nascent RNAs with 5-bromouridine-5’-triphophate (Br-
UTP) for immunofluorescence in T. brucei (Navarro & Gull, 2001), with the difference 
that trypanosomes were permeabilized with digitonin in conditions already tested in 
our lab. Instead of improving, the levels of 4sU-labeled RNAs were lower for several 
genes, when compared with the non-permeabilized trypanosomes, probably due to 
perturbation of cellular homeostasis as a result of membrane impairment. 
 A possible explanation for the reduced levels of 4sU or 4TU tagging could be 
competition by other routes of UTP metabolism during 4sU/4TU uptake or 
incorporation into RNA. During in vitro culture T. brucei is exposed to extremely 
nutrient-rich conditions. The HMI-11 media contains aspartate and glutamine, which 
can be uptaken by the parasite and diverted for de novo biosynthesis of UTP. Besides, 
uracil and uridine present in the serum can enter through TbU3 to the salvage pathway 
(Ong et al., 2013), most likely dominating over 4sU and 4TU transport. To exclude the 
effect of these external sources, we decided to compare 4sU and 4TU-labeling of 
trypanosomes in HMI-11 media with labeling in trypanosome dilution buffer (TDB), a 
buffer which only contains salts and glucose (Cross, 1975). At normal cell densities 
labeling in TDB did not make any difference in the yields of both for 4sU or 4TU 
labeled-RNAs. The same was true for 4sU labeling in TDB at high cell densities. 
 
3.3.2.3 4sU deviation by RNA editing 
 An additional hypothesis was that RNA editing competes with transcription for 
the 4sU nucleotide, which would contribute to poor yield of 4sU incorporation into 
nuclear transcripts. Using pairs of primers that amplify pre-edited and post-edited 
transcripts of the pan edited mitochondrial NADH dehydrogenase subunit 7 (ND7) 




similar to nuclear transcripts upon actinomycin D treatment, suggesting that 4sU 









 In summary, we were not able to improve the yield of 4sU-labeled RNA despite 
our efforts to increase 4sU uptake or incorporation. Thus, we next addressed potential 
limitations in the downstream steps of the protocol.  
 
3.3.2.4 Protein contamination 
 Biotinylation is carried out by biotin-HPDP Trypanosoma brucei, which adds a 
biotin residue to a thiol group by forming a disulfide bond between the two. If present, 
any other molecules that bear a thiol group will potentially compete with 4sU-RNA for 
the biotinylation reaction and decrease its efficiency. Proteins rich in thiol groups are 
the most probable contaminants of this kind when extracting RNA. To exclude the 
possibility of a protein contaminant, we used different methods to test the presence of 
proteins in total RNA samples prior to biotinylation. First, we analysed samples by 
sodium dodecyl sulfate-polyacrilamide gel electrophoresis (SDS-PAGE), stained by 
Coomassie Blue or subjected to Western blotting with an anti-VSG antibody. We did 
not detect any proteins in several RNA samples (n = 4-6) with any of the methods.  
Figure 2. 4sU is mainly incorporated during transcription and not via RNA editing. Prior to 4sU-
labeling, transcription was inhibited by actinomycin D (ActD) for 5 min. Relative transcript levels 
in 4sU-labeled RNA was measured as described before (see. 3.1. Results). Recovery of 4sU-
labeled ND7 edited RNA is blocked with ActD, indicating that 4sU incorporation is mostly 
dependent on transcription and not on editing. One independent experiment was performed. β-
tub, β-tubulin gene; β-tub Int, β-tubulin intergenic region; ND7Pre, ND7 RNA pre-edited; 




 We further examined the presence of proteins with the Bradford method, a 
colorimetric assay that can quantify protein concentrations as low as 1 g.ml-1. The 
assay detected 2 – 10 g of protein / 100 g RNA in all except one of the tested 
samples of total RNA before biotinylation (n = 7). However, we should be cautious 
when interpreting the protein levels given by Bradford. First, with all dye-based 
methods for protein quantification, one should use a protein standard that gives a 
similar color yield to that of the protein being assayed. Since we ignore which protein 
contaminants could be present in our RNA samples, we used a regularly used standard, 
bovine serum albumin, which typically has dye color development greater than most 
proteins, resulting in overestimation of the protein concentration.  
 Another important fact is that nucleic acids such as RNA can actually react with 
Bradford dye with 10-20% of color yields when compared with equivalent amounts of 
protein (Wenrich & Trumbo, 2012). In fact, that level of interference is in agreement 
with the 2-10% of protein mass calculated in our RNA samples. Taken together with 
the fact that staining of SDS-PAGE gel with Coomassie Blue (which in our lab was 
shown to detect down to 500 ng of protein) was not consistent with Bradford 
measurements, we consider Bradford quantifications as inaccurate, not confirming the 
existence of protein contamination in total RNA samples. In agreement with these 
results, treating RNA before biotinylation with proteinase K did not ameliorate the final 
yields of labeled RNA, labeled either with 4sU or 4TU. Overall these results suggest 
that no significant contamination of RNA with proteins was precluding biotinylation 
reaction. 
 
3.3.2.5 RNA integrity 
 Finally, we tested if RNA was being degraded during the protocol. We 
monitored RNA integrity by agarose gel electrophoresis in RNA samples taken at the 
three major steps of the protocol: Total RNA, biotinylated RNA and MACS-separated 
RNA. In all the tested samples of total and biotinylated RNA (n = 19), the typical RNA 
band profile of T. brucei was visible. The three bands between 1-2 kb corresponding to 




were well-defined and represented the most abundant RNAs, as expected for intact 
RNA moieties. Less abundant transcripts of lower molecular weight corresponding to 
mRNAs and tRNAs were also visible (Fig. 3A) indicating RNA sample was of very good 
quality. Biotinylated RNA from B-cells processed in parallel with T. brucei RNA also 
displayed no considerable degradation, exhibiting the two intense bands of 28S and 














Figure 3. No RNA degradation occurred during 4sU-labeling protocol. Agarose gel 
electrophoresis analysis of RNA samples after biotinylation and separation by MACS. RNA was 
run in a native 1% agarose gel, stained with GelRed™ and detected under UV light. (A) RNA 
detection after 5 sec (B) and 10 sec of UV exposure. RNA from B-cells and trypanosomes not 
labeled (NO) and labeled with 4sU is shown; RNA fractions corresponding to total biotinylated 
RNA (B) and separated by MACS (M) were analyzed as well as RNA from cells (-) not treated or 
(+) treated with ActD 5 min prior to 4sU labeling. White arrow indicates the smear of nascent 




 After purification by MACS, agarose gel electrophoresis was not sensitive 
enough to detect RNA in most of the samples (n = 26). However, in one of the 
experiments, a smear of nascent transcripts could be detected with prolonged UV 
exposure (Fig. 3B). The smear of newly transcribed RNAs contained significantly less 
mature rRNAs and transcripts in a higher range of molecular weights, as reported 
before (Radle et al., 2013). As expected, nascent RNA was present in the purified RNA 
from 4sU-labeled trypanosomes but not in the RNA of trypanosomes not exposed to 
4sU or where transcription had been blocked with ActD (Fig. 3B). Nascent transcripts 
purified from B-cells also distributed as a smear, validating the interpretation done for 
T. brucei RNA (Fig. 3A). However, the abundance of nascent RNAs is greater in B-cells 
than in trypanosomes, in agreement with the low yields of 4sU-labeled RNA in T. 
brucei. Altogether, the electrophoretic RNA profiles indicate that no significant RNA 
degradation occurred throughout the entire protocol of 4sU labeling. 
 In summary, despite our efforts we did not succeed in improving the recovery 
yield of 4sU labeled nascent RNA. However we can exclude the influence of the 
following factors: inefficient labeling due to low 4sU concentration, high cell-density or 
labeling media; poor 4sU transport across the membrane; deviation of 4sU by RNA 
editing; protein contaminants or RNA degradation throughout the protocol. 
 
3.3.3 MATERIALS AND METHODS 
 
CELL-LINES AND 4SU-LABELING CONDITIONS 
T. brucei BSF parasites were cultured as described before (see 3.1.3 Materials and 
Methods). 4sU-labeling and nascent RNA purification from B lymphocytes was used as 
a positive control of the protocol. B lymphocytes (immortalized lymphoblastoid cell-
line GM16113; NIGMS Human Genetic Cell Repository, Coriell Institute for Medical 
Research) were cultured in RPMI 1640 medium (Gibco) supplemented with 18% heat-
inactivated serum, 2mM non-essential amino acid solution (Gibco) and 2mM L-




Metabolic labeling was essentially performed as described before (see 3.1.3. Materials 
and Methods) but different labeling conditions were tested: 4sU at a higher 
concentration of 1000 μM; labeling with 500 μM or 1000 μM of 4-thiouracil (4TU) 
(Sigma); labeling reactions carried out in HMI-11 media (Hirumi & Hirumi, 1989); 
labeling reaction performed at normal parasite densities of ~1x106 cells/ml in 120 ml of 
TDB (5 mM KCl, 80 mM NaCl, 1 mM MgSO4, 20mM Na2HPO4, 2 mM NaH2PO4, 20 mM 
glucose, pH 7.7) or HMI-11 media. In these reactions no TDB washes prior to labeling 
were done and 4sU or 4TU were added directly to parasites resuspended in TDB or 
parasites cultured in HM1-11 media. 4sU-labeling reaction in permeabilized parasites is 
described below. 
 
4SU-LABELING IN PERMEABILIZED PARASITES 
For testing 4sU labeling in permeabilized cells we adapted a previously established 
protocol for labeling nascent RNA with Br-UTP in T. brucei (Navarro & Gull, 2001). 1 x 
108 BSF parasites were collected as described before (see 3.1.3. Materials and 
Methods). After the first TDB wash, cells were resuspended in 50 ml of TDB with 0.4 
μM digitonin and incubated at RT for 10 min. Parasites were collected by 
centrifugation at 970 g for 10 min at RT, washed in 2 ml of TDB and carefully 
resuspended in 2 ml of transcription buffer (50 mM HEPES pH7.9, 100 mM KCl 5 mM 
MgCl2 and 0.5 mM EGTA; 5 mM DTT, 1x protease inhibitor cocktail (P8340, Sigma) and 
80 U/ml RNAse inhibitor (Thermo Fischer Scientific)) to a final concentration of 5x107 
cells/ml. Labeling reaction was started by adding a mix of ribonucleotide 5’-
triphosphates to the following final concentrations: ATP, 2000 μM; CTP, 1000 μM; GTP, 
1000 μM (Thermo Fish Scientific) and 4sU 500 μM (Sigma). To the non-permeabilized 
cell controls no rNTPs was added except 4sU. Labeling reaction was performed in 
transcription buffer with rNTPs at 33°C for 5, 15 or 30 min, after which cells were 
collected by centrifugation at 2500g for 5 min at 4°C and resuspended in 3 ml of TRIzol 





PROTEINASE K TREATMENT OF TOTAL RNA 
1.4 x 108 BSFs were labeled with 500 μM 4sU or 1000 μM 4TU for 10 min at 37°C at 
normal cell densities (~1.2x106 cells/ml) in HMI-11. No TDB washes were performed 
and 4sU or 4TU were added directly to parasites in HMI-11. Cells were collected, 
resuspended in TRIzol and total RNA was extracted as described previously (see 3.1.3. 
Materials and Methods). Total RNA (91 μg/sample) was treated with 200 μg/ml 
proteinase K (Fischer Scientific) in TE buffer (10 mM Tris-HCl pH 8, 1 mM EDTA) with 
0.5% SDS in a final volume of 400 μl, for 2h at 37°C. Afterwards, RNA was extracted by 
a standard phenol:chloroform:isoamylic alcohol.extraction, followed by precipitation 
with 1:10 volume of 5 M NaCl and 1x volume of isopropanol and dissolution in TE. 
Biotinylation and capture of nascent RNAs by MACS was subsequently performed as 
already described (see 3.1.3. Materials and Methods). 
 
DETECTION OF PROTEIN CONTAMINANTS BY WESTERN BLOTTING 
To detect eventual contamination of RNA samples with VSG protein, total RNA samples 
(20-30 μg/sample) were suspended in 1x Laemmeli buffer at a final volume of 30 μl, 
boiled for 10 min and loaded onto a Mini-Protean TGX pre-cast PAGE gels (BioRad). 
SDS-PAGE and transfer to a nitrocellulose membrane was performed as described 
previously (see 3.1.3. Materials and Methods). Before incubation with antibodies, the 
nitrocellulose membrane was stained for 30 min at RT in a Coomassie Blue solution 
(40% distilled water, 10% acetic acid, 50% methanol, 0.25% by weight Coomassie 
Brilliant Blue R-250) and destained for 3:30 h in destaining solution (60% distilled 
water, 10% acetic acid, 40% methanol). Nitrocellulose membrane was blocked for 1 h 
at RT with PBS/0.1% Tween 20/5% milk, probed overnight at 4°C with the primary 
antibody, a rabbit polyclonal antibody anti-VSG1.13 not CRD-depleted (kindly provided 
by George Cross) 1:1000 in PBS/0.1% Tween20/3% milk. CRD stands for cross-reactive 
determinant and comprises a region of the C-terminal domain of VSG which displays 
immunological cross-reactivity. Antisera not CRD-depleted contains antibodies that 
recognize CRD and cross-react with several VSG variants (Barbet & McGuire, 1978). 




secondary antibody donkey anti-rabbit-HRP (GE Healthcare Life Sciences; NA934) 1:10 
000 in PBS/0.1% Tween20/3% milk for 1 h at RT. After washing 3x in washing buffer 
the blot was developed, protected from light, with Western Lightening ECL Plus 
(PerkinElmer; sensitivity of 1-10 pg of protein). Light emission was detected in a 
ChemiDoc XRS+ System (BioRad) for 5-30 min and afterwards in an X-ray film with 1 h 
of exposure. 
 
BRADFORD QUANTIFICATION OF PROTEINS 
Protein Assay Dye Reagent Concentrate (BioRad) was added to total RNA samples (1:4) 
or to bovine serum albumin standards (1:4) to reach a final volume of 50 μl. Samples 
were incubated for 5-10 min at RT, after which absorbance was read at 595 nm in 2 μl 
per sample in a NanoDrop2000 (Thermo Scientific). A standard curve for protein 
concentration was calculated using serial dilutions of bovine serum albumin prepared 
in TE buffer, the same solvent of RNA samples. Linear range of detection determined 
by standard curve was ~8-100 ng/μl of protein concentration. 
 
ANALYSIS OF RNA INTEGRITY 
To examine whether RNA degradation was occuring at any step of 4sU-labeling 
protocol, several samples of total, biotinylated and MACS-separated RNA were loaded 
into 1% agarose gels prepared in TBE buffer 0.5x (45 mM Tris-borate, 1 mM EDTA pH 
8.0 in RNAse-free water) and run in the same buffer. Each sample loaded contained 
~100-150 ng of RNA according to the quantity measured by NanoDrop 2000 (Thermo 
Scientific). Nucleic acids were detected by gel post-staining gel with GelRed (Biotium) 








REAL-TIME QUANTITATIVE PCR ANALYSIS OF RNA EDITED TRANSCRIPTS 
To assess wether 4sU was being significantly incorporated via RNA editing we 
compared the levels of pre-edited and post-edited transcripts of ND7, measured by 
qPCR, before and after transcription inhibition in 4sU-labeled parasites. Transcription 
inhibition by ActD (Sigma) and 4sU-labeling (10 min) was done as described before (see 
3.1.3. Materials and Methods). RNA extraction, cDNA synthesis and qPCR conditions 
were reported in a previous section (see 3.1.3. Materials and Methods). Transcript 
levels were normalized to NO 4sU control and are plotted as fold-change relative to 
this sample. An equal amount of RNA was used to synthesize cDNA and therefore no 
additional normalization was applied. Primers used to amplify pre-edited and after 






4 GENERAL DISCUSSION 
 
4.1 H1 CONDENSES CHROMATIN GLOBALLY BUT HAS A MORE 
PRONOUNCED EFFECT AT SILENT POL I TRANSCRIPTION UNITS 
 The first section of results of my thesis work (see Results 3.1.) can be 
summarized in the following conclusions: (i) in T.brucei BSFs, H1 is necessary for 
widespread chromatin compaction with special impact at the chromatin of silent BESs 
promoters; (ii) H1 is not a global regulator of gene expression in T. brucei and (iii) H1 
predominantly represses transcription of silent Pol I genes. 
 In this thesis, using FAIRE and ChIP of H3, we showed that depletion of H1 
resulted in a global increase of chromatin accessibility (2.9-fold) and a 36% reduction 
of histone H3 in most loci, suggesting that H1 maintains chromatin compacted 
throughout the genome (Results 3.1., Figure 4A,B). This was expected in the context of 
what is known about the importance of H1 to global chromatin compaction in several 
eukaryotes (Barra et al., 2000, Fan et al., 2005, Masina et al., 2007, Hashimoto et al., 
2010) and in T. brucei (Povelones et al., 2012, Burri et al., 1995). Indeed, in mammalian 
embryonic cells, a ~50% reduction in H1 levels leads to a general decondensation of 
polynucleosome fibers and reduction in nucleosome repeat length (Fan et al., 2005). In 
agreement, in the kinetoplastid L. major, in which H1 histones are structurally similar 
to T. brucei, overexpression of H1 globally compacts chromatin (Masina et al., 2007). 
Importantly, our data is consistent with (Povelones et al., 2012) who showed that in T. 
brucei H1 depletion increases chromatin accessibility and reduces putative 
heterochromatin domains dispersed in the nucleus (Povelones et al., 2012). 
 In our observations we detected loci in which chromatin was not significantly 
affected by H1 depletion: in the actively transcribed VSG and BSDR genes (BES1) and 
rDNA 18S gene, which probably already have a maximal chromatin decompaction and 
therefore chromatin remained essentially open in the presence of normal or reduced 
levels of H1. The most important exception to this general trend was the chromatin of 
silent BESs promoters, which became 10-fold more open and lost more than 60% of 




but a significant drop in H3 content (48%), suggesting that the chromatin of these loci 
is also relatively sensitive to H1 loss. A similar trend at silent BESs promoters was 
observed by (Povelones et al., 2012) using an MNase sensitivity assay which, similarly 
to FAIRE, addresses chromatin accessibility. ChIP also showed that silent BES 
promoters have more H1 than procyclin promoters (Povelones et al., 2012), which may 
explain why depletion of H1 results in a more dramatic chromatin opening at the silent 
BESs than procyclin promoter regions.  
 The use of complementary methods for assessing chromatin condensation 
(ChIP and FAIRE) allowed us to corroborate former evidence and detect further 
changes in chromatin condensation with higher sensitivity. In particular, FAIRE 
enriches for DNA not bound to proteins, and consequently for nucleosome-depleted 
regions of chromatin (Giresi et al., 2007). This obviates a limitation existent in the 
MNase sensitivity approach followed by Povelones et al. (2012), which quantifies 
mononucleosome DNA and does not determine the levels of DNA free of nucleosomes. 
This is probably one of the reasons why we were able to detect significant chromatin 
opening at several loci throughout the genome by FAIRE while Povelones et al. did not. 
Overall, our data solidly allows us to conclude that although T. brucei H1 has a global 
role in chromatin condensation, there are genomic sites, such as the BES promoter, in 
which H1 role seems to be more important or less redundant. 
 Consistent with an important function of H1 in the chromatin of BESs and 
somewhat procyclin promoter regions, in our RNA-Seq study almost all derepressed 
genes identified are from Pol I loci (VSGs, EP procyclin genes and PAGs) (Results 3.1., 
Figure 5C). To test if H1 acts at the transcriptional level, we chose to measure 
transcription rates by metabolically labeling nascent transcripts with 4sU nucleoside 
analog. The advantage of this approach over the classic nuclear run-on is that the assay 
is done in unperturbed cells, instead of permeabilized cells or isolated nuclei. Despite a 
low yield of recovery, we clearly show that a 4sU-labeled RNA sample is enriched in 
molecules of RNA that contain intergenic sequences, which are present in primary 
unprocessed transcripts (which we called nascent transcripts) (Results 3.1., Fig. 8B,C). 




dependent on transcription, suggesting that the transcript levels in 4sU-labeled RNAs 
are a reflection of transcription rates of these genes (Results 3.1, Fig. 8D).  
 We observed that depletion of H1 apparently leads to an increased 
transcription rate of silent procyclin loci and BESs, but no changes in transcription of 
Pol II loci (Results 3.1., Figure 8F). Because we detected BESs derepression with a pair 
of primers located immediately downstream of the silent BESs and procyclin 
promoters, we can conclude that probably H1 acts, at least in part, as an inhibitor of 
Pol I transcription initiation. In addition, we observed a stronger increase in nascent 
transcripts at silent BESs promoters when compared with proyclin loci promoters 
(Results 3.1., Fig. 8F). This suggests that H1 is particularly important for repressing 
transcription initiation at silent BESs, contributing to a less extent to transcriptional 
inhibition at procyclin loci. This agrees with our observations of a more modest impact 
of H1 depletion in chromatin decondensation at procyclin loci (Results 3.1., Fig. 3B). 
Also in support of this, it was shown by ChIP that chromatin of silenced procyclin 
promoters in BSFs and fully activated procyclin promoters in PFs contain comparable 
levels of H1, while H1 markedly binds more to silent BESs promoters than active BES 
(Povelones et al., 2012). 
 Based on our results with 4sU-metabolic labeling, we propose a role for histone 
H1 in the inhibition of Pol I transcription initiation at silent BES promoters. Our results 
are consistent with a recently published work showing that BES monoallelic 
transcription is controlled at least partially at the level of transcription initiation, which 
is dependent on the presence of the CITFA transcription factor complex (Nguyen et al., 
2014). Additional evidence for our hypothesis could be obtained by determining Pol I 
occupancy at BES promoters before and after H1 depletion. We did several attempts 
to determine Pol I occupancy at promoter regions using ChIP in cell-lines where 
different Pol I subunit genes were tagged with different tags (TY1::RPB6z, HA::RPB6z or 
TY1::RPB5z), but for unknown reasons we were never able to consistently 
immunoprecipitate more DNA from Pol I loci than Pol II loci. TY1 and HA epitopes could 
be too small and/or become inaccessible to antibodies when embedded in the folded 
protein or in the Pol I complex. In fact, tandem affinity purification (Nguyen et al., 




terminally tagged with a PTP tag (Park et al., 2011, Nguyen et al., 2014), which bears 
two epitope domains and a protease cleavage site and is considerably larger than TY1 
or HA. 
 Collectively our data indicates that H1 controls to some extent transcription 
initiation at Pol I promoters. To our knowledge this is the first mechanistic evidence in 
T. brucei on how depletion of a chromatin component results in an increase of steady-
state transcripts by increasing transcription rate, particularly at BESs. It is interesting to 
notice that, upon H1 depletion, the FAIRE analysis revealed that chromatin of a silent 
BES opened 10-fold at the promoter, 7-fold at the luciferase gene (1.2 kb downstream 
of BES promoter) and 2.6-fold at VSG2 (56.4 kb downstream BES promoter) (Results 
3.1., Fig. 4B). Such gradual decreasing effect of chromatin decompaction with 
increasing proximity to telomeres was also detected by H3 ChIP and it suggests that 
changes in chromatin are not homogeneous throughout the entire BES. These 
chromatin changes are also reflected in the steady-state RNA levels, since by RNA-Seq 
it was detected that the luciferase gene was more derepressed than VSG2, which is at 
the telomeric end of the same BES (Results 3.1., Fig. 5C).  
 Such disparities of derepression at the beginning and end of a silent BES have 
been observed in other mutants for chromatin-associated factors. Namely, in mutants 
for histone H3, histone chaperones TbFACT (TbSPT16), TbNLP, TbASF1A and TbCAF-1b 
and histone deacetylase TbDAC3 the BES promoter region is derepressed, but not VSGs 
(Denninger & Rudenko, 2014, Alsford et al., 2012, Denninger et al., 2010, Wang et al., 
2010, Hughes et al., 2007, Narayanan et al., 2011). In contrast, depletion of TbRAP1 or 
deletion of TbMCM-BP results in a stronger derepression of VSG genes rather than 
silent BES promoters (Yang et al., 2009, Kim et al., 2013). Although it is not clear how 
these regulate VSG expression, they fit the current view that BES transcriptional 
silencing is the net result of two forces: i) promoter-proximal inhibition of Pol I 
transcription initiation/elongation; ii) a repressive gradient emanating from telomeres 
which prevents transcription elongation and/or RNA processing (Gunzl et al., 2014). In 
light of this view, we postulate that histone H1 helps maintaining a compact chromatin 
structure throughout silent BESs, but with a predominant role at the promoter regions 




opens dramatically, which probably facilitates the recruitment of transcription factors 
and Pol I machinery. At the telomeric end of BESs, H1 depletion also leads to opening 
of chromatin but not so dramatically, thus contributing at a lower extent to inhibition 
of transcription elongation and, perhaps, RNA splicing or polyadenylation. 
Intriguingly, 9 out of the 25 upregulated loci in H1-depleted trypanosomes 
correspond to VSG sequences outside BESs:  a metacyclic VSG (Tb427-397 (Cross et al., 
2014)), three complete VSGs located at arrays (Tb437-631/636/655; (Cross et al., 
2014)) and five partial VSG sequences probably located at arrays. Since no promoters 
were ever found at VSG arrays or minichromosomes, we ignore how VSG sequences 
located at these loci are transcribed. Derepression of a minichromosomal VSG was 
reported in parallel with derepression of silent BES-linked VSGs and procyclin genes in 
a TbMCM-BP knock-out strain, but no explanation for this was put forward by the 
authors (Kim et al., 2013). Transcription also increases significantly in 
minichromosomes and VSG arrays in TbNLP and TbISWI depleted mutants when a BES 
promoter was inserted at these loci (Stanne et al., 2011, Narayanan et al., 2011). This 
suggests that these VSG loci, which are normally regarded as transcriptionally inactive 
can be transcribed when its chromatin is perturbed. 
A possible explanation for our observations is an increase in pervasive 
transcription by Pol II. Pol II pervasively transcribes a large part of the non-coding 
genome in yeast and mammals (Jensen et al., 2013). Assembly of pre-initiation 
complexes and recruitment of Pol II to cryptic transcription origins (‘cryptic 
promoters’) occurs typically at nucleosome-depleted regions. Pol II cryptic 
transcription increases when nucleosome occupancy is reduced or when nucleosome 
position is disturbed (Hennig & Fischer, 2013). This happens, for instance, in yeast 
mutants for chromatin proteins such as histone H3, FACT and ISWI (Kaplan et al., 2003, 
Cheung et al., 2008).  
In T. brucei, the promoter-independent activity of Pol II and potentially higher 
transcription initiation at higher genome accessibility levels (McAndrew et al., 1998) 
argues in favor of its DNA template unspecificity. Therefore, we hypothesize that a Pol 




H1 content is reduced. If such hypothesis is correct, we expect that in H1 RNAi clones 
chromatin decondenses at VSG arrays. Besides, transcripts from other inactive and/or 
non-coding loci, such as intergenic regions or transposable elements, might also 
increase. Moreover, if Pol II is the polymerase involved, then the levels of cryptic 
transcripts should be sensitive to Pol II inhibitors and novel sites of transcription 
initiation may be present. 
Silent BESs have high levels of H1 when compared with active Pol I loci such as 
rDNA or active BES (Povelones et al., 2012). On the other hand, active BES is highly 
depleted of H1, in agreement with the observation that active BES is very nucleosome-
depleted relative to silent BESs (Stanne & Rudenko, 2010, Figueiredo & Cross, 2010). 
Altogether, it seems clear that H1 is essential to establish a compacted chromatin at 
silent BESs and, conversely, its absence or reduced levels is most probably necessary to 
maintain an open and transcriptionally active chromatin at the active BES. 
Therefore, and important question arises: How is histone H1 recruited to silent 
BESs and how is it kept away from the active BES? It is tempting to think that one of 
the factors influencing such distribution of H1 is TDP-1. TDP-1 is an HMGB protein 
enriched at active Pol I loci (rDNA and BES), particularly at promoter proximal regions 
TDP-1 distribution is inversely correlated with histone occupancy, including histone H1, 
and when it is depleted, chromatin at active BES and rDNA condenses and 
transcription is downregulated (Narayanan & Rudenko, 2013). Therefore, the presence 
of TDP-1 seems essential for excluding nucleosomes and maintain an open chromatin 
conformation at Pol I loci which facilitates transcription (Narayanan & Rudenko, 2013). 
In metazoans H1 and HMGB bind to linker DNA and the exchange of H1 by HMGB 
proteins has been shown to drive opposite chromatin transitions, with H1 associated 
with a compacted chromatin and its replacement by HMGB1 leading to a more open 
chromatin (Travers, 2003, Nightingale et al., 1996).  
We hypothesize that in T. brucei H1 and TDP-1 act in a similar fashion. Perhaps 
the inter-change between H1 and TDP-1 is one of the first steps in the establishment of 
opposed chromatin structures associated with BES activation and silencing. Together 




(Misteli et al., 2000, Lever et al., 2000) might have made of this histone the perfect 
choice to direct the rapid transcriptional changes that are essential for T. brucei 
survival such as during and in situ switch of BES in BSFs or BES shutdown and procyclin 
loci full activation during differentiation to PFs. In this sense, H1 would act as an 
important ruler of facultative heterochromatin at silent BESs and procyclin loci. 
One can argue that the structural divergence between metazoan H1 and T. 
brucei H1, which lacks a globular domain, stands against the proposal that H1 
dynamics shares similarities between both organisms. However, remarkably, several 
mutational analysis of the C-terminal domain of metazoan H1 have shown that this 
domain is what basically determined the dynamics and high-affinity binding of H1 to 
chromatin (Hendzel et al., 2004). Noticeably, it was recently shown in human cells that 
the C-terminal domain of H1 is the one functionally implied in the interaction with 
important gene expression regulators. C-terminal of H1 physically interacts with tumor 
suppressor PTEN and mediates the global chromatin condensation pattern thought to 
underlie the gene expression program directed by PTEN (Chen et al., 2014). Because T. 
brucei H1 essentially resembles the basic, lysine rich C-terminal of higher eukaryotes, it 
seems reasonable to assume that it retains, in general, comparable binding kinetics 
and protein-interaction abilities. In support of this hypothesis, the heterologous 
addition of H1 from T. brucei and L. major recapitulates endogenous activity of 
mammalian H1 in chromatin condensation and cell cycle regulation (Smirlis et al., 
2006, Burri et al., 1995)  
Remarkably, in human cells, displacement of histone H1 is intrinsically necessary 
for the first steps of promoter transcriptional activation during hormone stimulation 
(Vicent et al., 2011). Such displacement happens extremely fast, in the first minute of 
stimulation and is preceded by the coordinated recruitment of several chromatin 
remodeling complexes, histone modifying enzymes and kinases, and accompanied by 
H1 phosphorylation and other PTMs at core histones (Vicent et al., 2011). Perhaps a 
similar multistep mechanism operates at BESs where displacement or deposition of 





We can speculate about the involvement in this process of some chromatin 
remodelers and histone chaperones already characterized in T. brucei. In Drosophila, 
the chromatin remodeler ISWI appears essential for the specific assembly of H1 into 
chromatin in vivo and its activity in global chromatin compaction (Corona et al., 2007, 
Siriaco et al., 2009). Reciprocally, in human cells, nucleosome rearrangement by 
SWI/SNF chromatin remodelers is modulated by H1 (Ramachandran et al., 2003). T. 
brucei TbISWI (SWI/SNF family) is necessary for repressing transcription at procyclin 
loci and silent BESs, especially at the promoter regions of the later (Stanne & Rudenko, 
2010, Hughes et al., 2007). Therefore, TbISWI is a potential candidate involved in the 
assembly of H1 into silent Pol I promoters BESs. In addition, the T. brucei putative 
histone chaperone TbNLP might also regulate the targeted deposition of H1. TbNLP is a 
member of the nucleophosmin/nucleoplasmin family of nuclear chaperones and 
regulates transcription at active and silent BESs and procyclin loci (Narayanan et al., 
2011). In humans, a protein nucleophosmin is a chaperone of the linker histone and 
directly regulates H1 deposition into chromatin (Gadad et al., 2011). Interestingly, in 
support of this hypothesis, TbISWI and TbNLP co-localize at both active and silent Pol I 
loci (rDNA, active/silent BESs and procyclin loci) in BSFs (Stanne et al., 2011, Narayanan 
et al., 2011, Stanne et al., 2015) and were recently shown to interact and, together 
with two other chromatin-associated proteins, compose the T. brucei ISWI remodeling 
complex (Stanne et al., 2015). 
Although depletion of H1 caused global changes in chromatin condensation, by 
RNA-Seq we detected a very low number of genes with significantly altered expression 
levels (only 26 out of 8996 expressed genes). Similar trends have been observed in the 
past: only 26 of over 6000 genes were downregulated in H1 knock-out mutants of 
yeast, (Hellauer et al., 2001); and 29 genes in mammalian cells showed an altered 
expression of more than 2-fold (Fan et al., 2005). In contrast to these organisms, 
however, T. brucei H1 acts only as a negative-regulator of gene expression, since H1 
depletion results in higher transcripts levels for all significant genes. The fact that H1 is 
important for global chromatin condensation but only regulates a specific set of genes 
both in lower eukaryotes, such as T. brucei, and in the evolutionarily distant mammals 




underlying control of gene expression mediated by these histones. This also supports 
the use of less complex and amenable to genetic engineering organisms such as T. 
brucei as models to study H1 roles in gene expression. 
The apparently specific role of histone H1 in T. brucei Pol I loci is likely due to the 
fact that Pol I genes are probably the only ones that are transcriptionally regulated in 
T. brucei. In fact, because most Pol II-dependent genes are organized in polycistronic 
units, their expression is believed to be constitutive and gene regulation of Pol II to 
occur mainly post-transcriptionally. The levels of H1 in Pol II-transcribed loci were 
similar to silent BESs, which, together with our observations, corroborates the 
hypothesis that chromatin compaction does not impact considerably on Pol II 
transcription (Povelones et al., 2012). We cannot exclude that in H1 RNAi clones, the 
remaining levels of H1 (~40% at the mRNA level) (Results 3.1. Fig. 2B) are enough to 
avoid transcriptional alterations at Pol II-transcribed genes. Establishing a complete H1 
knockout would be most appropriate to address this question. We attempted to do 
such an H1 KO but the existence of five H1 genes and eventually more, not annotated 
in the genome (Results 3.1., Fig. S1) has precluded this so far. 
 
4.2 H1 PLAYS A ROLE IN DNA REPAIR  
The noticeable discrepancy between a global role of H1 in chromatin compaction 
and the limited role in transcription regulation also observed in other organisms (Fan 
et al., 2005, Hellauer et al., 2001) suggests that T. brucei H1 plays important but yet 
unsolved roles that go beyond transcription regulation. Indeed, in T. brucei, H1 is 
inhibitory of DNA repair induced by MMS (Results 3.1., Fig.9). This could be due to the 
role of H1 in keeping chromatin closed and thus refractory to DNA repair machinery. 
Since HR-mediated DNA repair dominates in T. brucei (Burton et al., 2007, Glover et al., 
2008), it is likely that H1 is a suppressor of HR in this parasite. These results are also 
consistent with the observations that H1 depleted cells undergo more frequent VSG 





In yeast, H1 suppresses HR-mediated DNA repair and recombination between 
repeated DNA regions such as telomeres and rDNA transcription units, maintaining 
genome stability and prolonged life-span (Downs et al., 2003, Li et al., 2008). Thus, in 
T. brucei, since H1 ubiquitously contributes to chromatin condensation we could 
hypothesize that is also plays a more general role in suppressing widespread 
illegitimate HR and maintaining genome stability. The role of H1 in HR inhibition could 
then be particularly relevant to prevent recombination at highly repeated regions such 
as BESs. The fact that we did not see any severe growth or cell cycle defects in H1-
depleted cells (Results 3.1., Fig. 3) suggests that either enough H1 levels exist in 
depleted cells to avoid deleterious genome instability while facilitating DNA repair, or 
that H1 is not necessary for maintaining fundamental genome integrity. An H1 KO cell-
line would clarify this issue. Also, to sort out if increased resistance to DNA damage in 
H1-depleted parasites is dependent on HR, we could examine the response to DNA 
damage in H1-depleted HR-mutant T. brucei parasites, such as mutants for RAD51 and 
RAD51-related proteins (McCulloch & Barry, 1999, Proudfoot & McCulloch, 2005). 
Finally, we observed that depletion of H1 increases resistance to MMS-induced 
DNA damage but not to DNA damage induced by phleomycin. This might rely on the 
fact that phleomycin triggers a more extensive DNA damage than MMS. Phleomycin 
can create DSBs across the genome, whereas MMS stalls replication forks, which are 
only present at discrete regions of the genome at any given time during the S-phase of 
the cell cycle. Perhaps the widespread damage caused by phleomycin counteracts the 
beneficial effect of H1 depletion in facilitating the recruitment of DNA repair 
machinery. Indeed, a study in T. brucei shows that histone γH2A, a common marker of 
DNA damage in eukaryotes, is detected in restricted nuclear foci or in the entire 
nucleus, depending if the damage is induced by MMS or phleomycin, respectively 
(Glover & Horn, 2012). 
In the future, the sensitivity of H1 mutants to other DNA-damaging agents that 
induce DSBs such as exposure to ionizing radiation should be tested. Also, HR could be 
tested by different and more direct methods. For instance by analyzing the frequency 





4.3 H1 IS IMPORTANT FOR PARASITE FITNESS IN VIVO 
Consistent with previous observations, we detected a significant but modest 
defect on cell growth in cultivated bloodstream parasites when ~60% of H1 is depleted 
in T. brucei (Results 3.1, Fig. 3A) (Povelones et al., 2012). This suggests that, like in 
other lower eukaryotes (Shen et al., 1995, Shen & Gorovsky, 1996, Patterton et al., 
1998, Barra et al., 2000), H1 may not be essential for T. brucei survival in culture. An 
alternative explanation is that the remaining H1 (~40%) is sufficient for T. brucei 
survival. A full knock-out of the entire H1 gene family would allow us to discriminate 
between the two possibilities. With the advent of CRISPR/Cas9 system, which has been 
used to engineer parasites such as P. falciparum (Ghorbal et al., 2014), knock-out of a 
multigene family in T. brucei may be foreseen in the near future. 
When we infected mice with H1 depleted parasites, these mutant parasites 
were substantially less infective, allowing mice to survive up to twice longer (Results 
3.2, Fig. 1A, B). This survival phenotype was associated with a lower parasitaemia in 
the first days of infection. The lower parasitaemia cannot be simply explained by the 
slower parasite growth rate detected in vitro. Indeed, based on in vitro growth rates, 
we estimated a delay in parasitaemia of up to one day, but in vivo the delay ranged 
from 1-10 days, which indicates that H1 is necessary for adapting to the host 
environment at the onset of infection. Consistent with a role of H1 in host adaptation, 
overexpression of H1 in L. major or L. donovani also results in a delay in differentiation 
of promastigotes into amastigotes (Smirlis et al., 2006, Alexandratos et al., 2013). 
When a second population of parasites established (switchers) (Results 3.2, Fig. 
1D), parasitaemia increased very rapidly, eventually killing the mouse (Results 3.2, Fig. 
1B; Fig. S2). This second population of parasites did not inactivate or loose H1 RNAi 
cassette (Results 3.2, Fig. 1C). One possible explanation for this apparent gain-of-
fitness is that, after 9-14 days of infection, parasites have activated a compensatory 
pathway for H1 function. This could involve, for instance, replacement by other small 
linker DNA-binding proteins such as HMGB proteins, which have been shown to 
interchange or associate with H1, either antagonizing or synergizing its chromatin 
interactions, respectively (Thomas & Stott, 2012, El Gazzar et al., 2009). Interestingly, 




establishing a novel infection in mice, indicating that the H1 putative compensatory 
mechanism is inheritable (Results 3.2, Fig. 2). A proteome or transcriptome analysis of 
these H1-depleted parasites could allow us to identify such compensatory mechanism.  
When we asked why H1 depleted parasites took longer to reach high numbers 
in the bloodstream of the mammal, one of the most plausible hypothesis was that, 
somehow, these parasites were less resistant to the host immune system. Supporting 
this hypothesis was our former observation that monoallelic expression of VSGs, 
crucial for parasite immune evasion, was impaired by H1 depletion. Confirming our 
predictions, in the highly immune-compromised Rag2-/-c-/- mice, H1-depleted 
parasites behaved essentially as the parental parasites containing normal H1 levels 
(Results, 3.2. Fig. 3). Importantly, this observation allowed us to rule out the possibility 
that severe parasite growth defects inexistent in culture could have arisen exclusively 
in vivo. On the contrary, our data strongly suggests that H1 is necessary for T. brucei 
full capacity of evading the host immune system. Future studies are needed to dissect 
the mechanism behind this. Rag2-/-c-/- mice are severely compromised in several 
innate and acquired immunity components (Mazurier et al., 1999, Shultz et al., 2007). 
One could perform infections in mice with more restricted immune deficiencies to 
narrow down which components of the immune system does T. brucei fails to 
circumvent when H1 is depleted. 
Different mechanisms could explain the reduced fitness of H1 depleted 
parasites in immune-competent animals. First, it is possible that deregulation of gene 
expression could have a negative impact on putative mechanisms that may allow 
trypanosomes to sense and resist to the host immune system. These genes could be 
among the 26 differentially expressed genes or other genes whose repetitive nature 
prevents unambiguous mapping of RNA-Seq reads and accurate expression analysis 
(ESAGs and rRNAs, for example). We should also consider that gene expression 
probably differs between parasites growing in vivo and in vitro. Therefore, we cannot 
exclude that in vivo H1 depletion could alter the expression of Pol II transcribed genes 




Second, it is appealing to associate the transient loss-of-fitness in H1-depleted 
parasites with the observed alterations in VSG expression. Povelones et al. showed 
that deletion of H1 results in a slight increase in VSG switching in culture (Povelones et 
al., 2012). We could speculate that derepression of several silent VSGs or increased 
VSG switching frequency could raise heterogeneity in the first peak of parasitaemia 
with abnormal exposure of multiple VSGs. Mixed VSG coats could enhance activation 
of the immune system and be more easily controlled by it. Indeed, the proportion of 
parasites expressing one or more silent VSGs at the surface seems to increase in vitro 
when H1 is depleted (Results 3.1, Fig. 7) even though such abnormal VSG expressors 
are present in low proportions (maximum 0.4%) in the overall population. However, 
this hypothesis is inconsistent with the observation that trypanosomes expressing a 
mosaic coat of two different VSGs are equally infective (Munoz-Jordan et al., 1996), 
are cleared by the immune system at normal kinetics and actually escape early 
detection by host B-cells (Dubois et al., 2005). 
One should note that in these studies only two different VSGs were expressed 
simultaneously and constitutively at equal or comparable amounts. In H1-depleted 
trypanosomes, multiple silent VSGs are expressed and not in a constitutive way but 
rather dependent on H1 RNAi induction. The exposure of multiple VSGs at variable 
levels could have a different outcome. Besides, the appearance of multiple VSG 
expressors might be significantly higher in vivo. In the H1-depleted clone C2, which 
displayed the stronger loss-of-fitness, H1 levels were much lower in vivo (~10% of 
parental mRNA levels) than in culture (~40% of parental mRNA levels) (Results 3.2, Fig. 
1C) and thus in vivo the H1-mutant phenotype may be more pronounced. Also, in 
mouse infections, trypanosomes are not subject to drug selection of a single BES. 
Therefore, we can speculate that derepression of silent VSGs and VSG switching 
frequencies are also increased in H1-depleted parasites growing in vivo. 
In immune-competent mice, H1-depleted parasites display a delay in 
parasitemia detected already four days post-infection. Thus, the intervening host 
immune components must rapidly target these parasites after inoculation. VSG-
specific antibodies only reach enough titres to induce parasite clearance around seven 




explain alone the early impairment in parasitaemia of H1-depleted parasites. 
Considering the fast host response, innate immune effectors are likely candidates. One 
possibility is an increased recognition by the complement system. The host alternative 
complement pathway is activated and triggers cell lysis in T. brucei parasites that lack a 
VSG coat (Ferrante & Allison, 1983). A study proposes that even a minimal and 
experimentally undetectable perturbation of the VSG coat is enough to trigger 
clearance of trypanosomes in 12 h due to increased recognition by the complement or 
by another unrelated mouse lytic factor (Sheader et al., 2005). 
We might speculate that under increased H1 depletion in vivo, there are 
alterations in the VSG coat not detected in culture. When ectopic expression of a 
second VSG is induced, there is temporary silencing of the active VSG at the mRNA and 
protein levels (Batram et al., 2014). It is not clear how this occurs, and if the additional 
VSG copies are sensed only at the RNA level or if VSG protein synthesis and trafficking 
also respond to excessive VSG levels. In light of these observations, perhaps a partial 
downregulation of the active VSG also happens in H1-depleted parasites due to 
simultaneous derepression of several silent VSGs. This reduction in VSG levels would 
be certainly small since low VSG mRNA levels rapidly induce cell cycle arrest and 
translation block (Sheader et al., 2005, Smith et al., 2009). If such defects were 
occurring in H1-depleted trypanosomes, parasite growth would be impaired in 
immune-compromised mice, which was not the case (Results 3.2, Fig. 3E). As proposed 
by others, a minor reduction in the number of surface VSG molecules could be 
sufficient to expose other membrane epitopes normally shielded by the VSGs, trigger 
complement activation and parasite lysis or phagocytosis by macrophages. 
These hypotheses, though, remain speculative and need to be tested in the 
future. Transcriptome and/or proteome analysis would determine the relative levels of 
silent and active VSGs in H1-depleted trypanosomes growing in vivo. Infections in mice 
deficient in complement or other components of the immune system could potentially 
reveal the host effectors involved. 
In summary, our results uncover the functional relevance of T. brucei H1 in the 




differences that emerge when trypanosomes are living in culture or inside its 
mammalian host in vivo, pointing out the importance of adressing the host-pathogen 





5 CONCLUDING REMARKS 
 
In my PhD work I showed that in T. brucei H1 keeps chromatin globally compact, 
inhibits DNA repair and represses the transcription of Pol I silent genes, including VSGs 
and procyclins. My data suggests that histone H1 acts as an inhibitor of Pol I 
transcription initiation and elongation, probably by controlling chromatin accessibility 
to transcription factors and Pol I machinery. In light of what is known about the 
dynamics of H1 binding and control of transcriptional activation in higher eukaryotes 
we propose that H1 assembly or displacement is a prerequisite for transcriptional 
silencing or activation of Pol I in T. brucei. It would be interesting to study the role of 
H1 during differentiation of bloodstream forms in procyclic parasites, in which fast 
shutdown of active BES occurs, accompanied by full transcriptional activation of 
procyclin loci. According to the hypothesis that H1 acts in the first steps of BES 
transcriptional silencing, we would expect that H1 depletion would delay BES 
transcriptional repression during differentiation. 
A future interesting direction is the study of the predicted H1 variants present 
in T. brucei. There is evidence in higher and lower eukaryotes that specific H1 variants 
occupy distinct genome locations and participate in the regulation of particular subsets 
of genes. Maybe a specific T. brucei H1 variant associates with and inhibits 
transcription at Pol I loci. H1 variants might also exhibit different PTMs namely 
different phosphorylation patterns since H1 isoforms differ in the number and position 
of serine/threonine residues at their N-terminal domain. H1 variants with particular 
phosphorylation patterns associate with Pol I or Pol II transcribed loci in human cells, 
which tempt us to hypothesize that a similar mechanism could also happen in T. 
brucei. Possible approaches to investigate the functional relevance of H1 variants in T. 
brucei could be by determining the genomic distribution of each H1 variant (e.g. ChIP 
sequencing) and by analysing the phenotype of mutant parasites in which each variant 
was deleted or overexpressed. 
I also demonstrated that H1 is important for parasite fitness during mammalian 




is depleted, mechanistically we ignore how this occurs. It shows nevertheless that H1 is 
important for T. brucei adaptation to its natural host, and parasites seem to rapidly 
develop a compensatory mechanism to overcome the deleterious effects of losing H1. 
Understanding why H1-depleted parasites are less resistant to the mammalian 
immune system is a challenge ahead. In the future, this question should be addressed 
using a pleomorphic T. brucei cell-line, which more closely resembles natural T. brucei 
populations and allows us to examine the role of H1 in the differentiation of the 
transmissible stumpy stages. 
Finally, during my PhD work, I adapted metabolic labeling of RNA with 4sU to T. 
brucei. Several attempts were done to improve the final 4sU-RNA yield, even though 
all of them failed. Additional tests could be performed such has RNA fragmentation 
before biotinylation, which was successfully applied for 4TU metabolic labeling (Gay et 
al., 2014) or using methanethiosulfonate instead of HPDP to covalently bind biotin, 
which strongly increases 4sU-RNA yields (Duffy et al., 2015). If further attempts to 
improve the efficiency of 4sU-labeling continue to fail, alternative technologies for 
purification and quantification of nascent RNAs in T. brucei should be explored. 
Metabolic labeling of RNA with 4sU has the important advantage of allowing 
the measurement of transcription de novo in virtually unperturbed cells, contrarily to 
nuclear run-on, which has been the gold-standard for measuring transcription in 
trypanosomes. 4sU-labeled RNAs are suitable for high-throughput outputs such as 
RNA-Seq.and are a potentially valuable tool to study with high resolution and whole 
genome coverage topics whose study has been precluded by technical limitations in T. 
brucei. For instance, one of the most important enigmas this method could solve is the 
exact position of Pol II transcription start sites across the genome, which has been 
precluded by the fact that no Pol II promoter motifs have been identified until now for 
the vast majority of T. brucei genes. This methodology could also confirm (or not) the 
dogma in the field that all Pol II-transcribed PTUs are transcribed in the same levels. 
Besides, in the context of my PhD work, it can be used to temporally follow Pol I 




Compared with Pol II transcription, much less in known about Pol I regulation in 
eukaryotes. My work contributes to this knowledge by directly showing the 
importance of histone H1 in the control of transcription levels at Pol I loci. In other 
organisms, H1-mediated control of specific genes has been observed but only for Pol II-
transcribed genes. It would be interesting to determine if, in these organisms, H1 also 
conserves similar roles as those we found in T. brucei regarding the control of Pol I 
transcription. 
In sum, collectively my data demonstrates that T. brucei H1 has ‘broad skills’ 
when it comes to chromatin condensation since it is necessary for chromatin 
compaction globally throughout the genome; but H1 also has ‘specific functions’ in 







Acosta-Serrano, A., R. N. Cole, A. Mehlert, M. G. Lee, M. A. Ferguson & P. T. Englund, (1999) 
The procyclin repertoire of Trypanosoma brucei. Identification and structural 
characterization of the Glu-Pro-rich polypeptides. The Journal of biological chemistry 
274: 29763-29771. 
Acosta-Serrano, A., E. Vassella, M. Liniger, C. Kunz Renggli, R. Brun, I. Roditi & P. T. Englund, 
(2001) The surface coat of procyclic Trypanosoma brucei: programmed expression and 
proteolytic cleavage of procyclin in the tsetse fly. Proceedings of the National Academy 
of Sciences of the United States of America 98: 1513-1518. 
Adl, S. M., A. G. Simpson, C. E. Lane, J. Lukes, D. Bass, S. S. Bowser, M. W. Brown, F. Burki, M. 
Dunthorn, V. Hampl, A. Heiss, M. Hoppenrath, E. Lara, L. Le Gall, D. H. Lynn, H. 
McManus, E. A. Mitchell, S. E. Mozley-Stanridge, L. W. Parfrey, J. Pawlowski, S. 
Rueckert, R. S. Shadwick, C. L. Schoch, A. Smirnov & F. W. Spiegel, (2012) The revised 
classification of eukaryotes. The Journal of eukaryotic microbiology 59: 429-493. 
Aitcheson, N., S. Talbot, J. Shapiro, K. Hughes, C. Adkin, T. Butt, K. Sheader & G. Rudenko, 
(2005) VSG switching in Trypanosoma brucei: antigenic variation analysed using RNAi 
in the absence of immune selection. Molecular microbiology 57: 1608-1622. 
Akiyoshi, B. & K. Gull, (2014) Discovery of unconventional kinetochores in kinetoplastids. Cell 
156: 1247-1258. 
Alarcon, C. M., H. J. Son, T. Hall & J. E. Donelson, (1994) A monocistronic transcript for a 
trypanosome variant surface glycoprotein. Molecular and cellular biology 14: 5579-
5591. 
Albert, B., J. Perez-Fernandez, I. Leger-Silvestre & O. Gadal, (2012) Regulation of ribosomal 
RNA production by RNA polymerase I: does elongation come first? Genetics research 
international 2012: 276948. 
Alexandratos, A., J. Clos, M. Samiotaki, A. Efstathiou, G. Panayotou, K. Soteriadou & D. Smirlis, 
(2013) The loss of virulence of histone H1 overexpressing Leishmania donovani 
parasites is directly associated with a reduction of HSP83 rate of translation. Molecular 
microbiology 88: 1015-1031. 
Ali, J. A., D. J. Creek, K. Burgess, H. C. Allison, M. C. Field, P. Maser & H. P. De Koning, (2013) 
Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal 
action of halogenated pyrimidines. Molecular pharmacology 83: 439-453. 
Alibu, V. P., L. Storm, S. Haile, C. Clayton & D. Horn, (2005) A doubly inducible system for RNA 
interference and rapid RNAi plasmid construction in Trypanosoma brucei. Molecular 
and biochemical parasitology 139: 75-82. 
Allan, J., P. G. Hartman, C. Crane-Robinson & F. X. Aviles, (1980) The structure of histone H1 
and its location in chromatin. Nature 288: 675-679. 
Allan, J., T. Mitchell, N. Harborne, L. Bohm & C. Crane-Robinson, (1986) Roles of H1 domains in 
determining higher order chromatin structure and H1 location. Journal of molecular 
biology 187: 591-601. 
Alsford, N. S., M. Navarro, H. R. Jamnadass, H. Dunbar, M. Ackroyd, N. B. Murphy, K. Gull & K. 
Ersfeld, (2003) The identification of circular extrachromosomal DNA in the nuclear 
genome of Trypanosoma brucei. Molecular microbiology 47: 277-289. 
Alsford, S., K. duBois, D. Horn & M. C. Field, (2012) Epigenetic mechanisms, nuclear 
architecture and the control of gene expression in trypanosomes. Expert Rev Mol Med 
14: e13. 
Alsford, S., L. Glover & D. Horn, (2005a) Multiplex analysis of RNA interference defects in 
Trypanosoma brucei. Molecular and biochemical parasitology 139: 129-132. 
Alsford, S. & D. Horn, (2004) Trypanosomatid histones. Molecular microbiology 53: 365-372. 
Alsford, S. & D. Horn, (2011) Elongator protein 3b negatively regulates ribosomal DNA 




Alsford, S. & D. Horn, (2012) Cell-cycle-regulated control of VSG expression site silencing by 
histones and histone chaperones ASF1A and CAF-1b in Trypanosoma brucei. Nucleic 
acids research. 
Alsford, S., T. Kawahara, L. Glover & D. Horn, (2005b) Tagging a T. brucei RRNA locus improves 
stable transfection efficiency and circumvents inducible expression position effects. 
Molecular and biochemical parasitology 144: 142-148. 
Alsford, S., T. Kawahara, C. Isamah & D. Horn, (2007) A sirtuin in the African trypanosome is 
involved in both DNA repair and telomeric gene silencing but is not required for 
antigenic variation. Molecular microbiology 63: 724-736. 
Amiguet-Vercher, A., D. Perez-Morga, A. Pays, P. Poelvoorde, H. Van Xong, P. Tebabi, L. 
Vanhamme & E. Pays, (2004) Loss of the mono-allelic control of the VSG expression 
sites during the development of Trypanosoma brucei in the bloodstream. Molecular 
microbiology 51: 1577-1588. 
Anders, S. & W. Huber, (2010) Differential expression analysis for sequence count data. 
Genome biology 11: R106. 
Ansorge, I., D. Steverding, S. Melville, C. Hartmann & C. Clayton, (1999) Transcription of 
'inactive' expression sites in African trypanosomes leads to expression of multiple 
transferrin receptor RNAs in bloodstream forms. Molecular and biochemical 
parasitology 101: 81-94. 
Archer, S. K., D. Inchaustegui, R. Queiroz & C. Clayton, (2011) The cell cycle regulated 
transcriptome of Trypanosoma brucei. PloS one 6: e18425. 
Barbet, A. F. & T. C. McGuire, (1978) Crossreacting determinants in variant-specific surface 
antigens of African trypanosomes. Proceedings of the National Academy of Sciences of 
the United States of America 75: 1989-1993. 
Barbour, A. G., C. J. Carter & C. D. Sohaskey, (2000) Surface protein variation by expression site 
switching in the relapsing fever agent Borrelia hermsii. Infection and immunity 68: 
7114-7121. 
Baron, D. M., K. S. Ralston, Z. P. Kabututu & K. L. Hill, (2007) Functional genomics in 
Trypanosoma brucei identifies evolutionarily conserved components of motile flagella. 
Journal of cell science 120: 478-491. 
Barra, J. L., L. Rhounim, J. L. Rossignol & G. Faugeron, (2000) Histone H1 is dispensable for 
methylation-associated gene silencing in Ascobolus immersus and essential for long 
life span. Molecular and cellular biology 20: 61-69. 
Barry, J. D., (1979) Capping of variable antigen on Trypanosoma brucei, and its immunological 
and biological significance. Journal of cell science 37: 287-302. 
Barry, J. D., M. L. Ginger, P. Burton & R. McCulloch, (2003) Why are parasite contingency genes 
often associated with telomeres? International journal for parasitology 33: 29-45. 
Barry, J. D. & R. McCulloch, (2001) Antigenic variation in trypanosomes: enhanced phenotypic 
variation in a eukaryotic parasite. Adv Parasitol 49: 1-70. 
Bates, D. L., P. J. Butler, E. C. Pearson & J. O. Thomas, (1981) Stability of the higher-order 
structure of chicken-erythrocyte chromatin in solution. European journal of 
biochemistry / FEBS 119: 469-476. 
Batram, C., N. G. Jones, C. J. Janzen, S. M. Markert & M. Engstler, (2014) Expression site 
attenuation mechanistically links antigenic variation and development in Trypanosoma 
brucei. Elife 3: e02324. 
Becker, M., N. Aitcheson, E. Byles, B. Wickstead, E. Louis & G. Rudenko, (2004) Isolation of the 
repertoire of VSG expression site containing telomeres of Trypanosoma brucei 427 
using transformation-associated recombination in yeast. Genome research 14: 2319-
2329. 
Bednar, J., R. A. Horowitz, S. A. Grigoryev, L. M. Carruthers, J. C. Hansen, A. J. Koster & C. L. 
Woodcock, (1998) Nucleosomes, linker DNA, and linker histone form a unique 




Proceedings of the National Academy of Sciences of the United States of America 95: 
14173-14178. 
Belli, S. I., (2000) Chromatin remodelling during the life cycle of trypanosomatids. International 
journal for parasitology 30: 679-687. 
Bender, K., B. Betschart & H. Hecker, (1992) Histone-DNA interactions in the chromatin of 
procyclic Trypanosoma brucei brucei. Parasitology research 78: 495-500. 
Benjamini, Y. & Y. Hochberg, (1995) Controlling the False Discovery Rate - a Practical and 
Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-
Methodological 57: 289-300. 
Benmerzouga, I., J. Concepcion-Acevedo, H. S. Kim, A. V. Vandoros, G. A. Cross, M. M. Klingbeil 
& B. Li, (2013) Trypanosoma brucei Orc1 is essential for nuclear DNA replication and 
affects both VSG silencing and VSG switching. Molecular microbiology 87: 196-210. 
Benne, R., J. Van den Burg, J. P. Brakenhoff, P. Sloof, J. H. Van Boom & M. C. Tromp, (1986) 
Major transcript of the frameshifted coxII gene from trypanosome mitochondria 
contains four nucleotides that are not encoded in the DNA. Cell 46: 819-826. 
Berriman, M., E. Ghedin, C. Hertz-Fowler, G. Blandin, H. Renauld, D. C. Bartholomeu, N. J. 
Lennard, E. Caler, N. E. Hamlin, B. Haas, U. Bohme, L. Hannick, M. A. Aslett, J. Shallom, 
L. Marcello, L. Hou, B. Wickstead, U. C. Alsmark, C. Arrowsmith, R. J. Atkin, A. J. Barron, 
F. Bringaud, K. Brooks, M. Carrington, I. Cherevach, T. J. Chillingworth, C. Churcher, L. 
N. Clark, C. H. Corton, A. Cronin, R. M. Davies, J. Doggett, A. Djikeng, T. Feldblyum, M. 
C. Field, A. Fraser, I. Goodhead, Z. Hance, D. Harper, B. R. Harris, H. Hauser, J. 
Hostetler, A. Ivens, K. Jagels, D. Johnson, J. Johnson, K. Jones, A. X. Kerhornou, H. Koo, 
N. Larke, S. Landfear, C. Larkin, V. Leech, A. Line, A. Lord, A. Macleod, P. J. Mooney, S. 
Moule, D. M. Martin, G. W. Morgan, K. Mungall, H. Norbertczak, D. Ormond, G. Pai, C. 
S. Peacock, J. Peterson, M. A. Quail, E. Rabbinowitsch, M. A. Rajandream, C. Reitter, S. 
L. Salzberg, M. Sanders, S. Schobel, S. Sharp, M. Simmonds, A. J. Simpson, L. Tallon, C. 
M. Turner, A. Tait, A. R. Tivey, S. Van Aken, D. Walker, D. Wanless, S. Wang, B. White, 
O. White, S. Whitehead, J. Woodward, J. Wortman, M. D. Adams, T. M. Embley, K. Gull, 
E. Ullu, J. D. Barry, A. H. Fairlamb, F. Opperdoes, B. G. Barrell, J. E. Donelson, N. Hall, C. 
M. Fraser, et al., (2005) The genome of the African trypanosome Trypanosoma brucei. 
Science 309: 416-422. 
Bharath, M. M., N. R. Chandra & M. R. Rao, (2003) Molecular modeling of the chromatosome 
particle. Nucleic acids research 31: 4264-4274. 
Bindereif, A., (2012) RNA metabolism in trypanosomes. Springer, New York. 
Bitter, W., H. Gerrits, R. Kieft & P. Borst, (1998) The role of transferrin-receptor variation in the 
host range of Trypanosoma brucei. Nature 391: 499-502. 
Black, S. J., P. Guirnalda, D. Frenkel, C. Haynes & V. Bockstal, (2010) Induction and regulation of 
Trypanosoma brucei VSG-specific antibody responses. Parasitology 137: 2041-2049. 
Blasco, M. A., (2007) The epigenetic regulation of mammalian telomeres. Nature reviews. 
Genetics 8: 299-309. 
Blattner, J. & C. E. Clayton, (1995) The 3'-untranslated regions from the Trypanosoma brucei 
phosphoglycerate kinase-encoding genes mediate developmental regulation. Gene 
162: 153-156. 
Blum, J., C. Schmid & C. Burri, (2006) Clinical aspects of 2541 patients with second stage 
human African trypanosomiasis. Acta tropica 97: 55-64. 
Blum, M. L., J. A. Down, A. M. Gurnett, M. Carrington, M. J. Turner & D. C. Wiley, (1993) A 
structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature 
362: 603-609. 
Boothroyd, C. E., O. Dreesen, T. Leonova, K. I. Ly, L. M. Figueiredo, G. A. Cross & F. N. 
Papavasiliou, (2009) A yeast-endonuclease-generated DNA break induces antigenic 




Boothroyd, J. C. & G. A. Cross, (1982) Transcripts coding for variant surface glycoproteins of 
Trypanosoma brucei have a short, identical exon at their 5' end. Gene 20: 281-289. 
Branche, C., L. Kohl, G. Toutirais, J. Buisson, J. Cosson & P. Bastin, (2006) Conserved and 
specific functions of axoneme components in trypanosome motility. Journal of cell 
science 119: 3443-3455. 
Brandenburg, J., B. Schimanski, E. Nogoceke, T. N. Nguyen, J. C. Padovan, B. T. Chait, G. A. 
Cross & A. Gunzl, (2007) Multifunctional class I transcription in Trypanosoma brucei 
depends on a novel protein complex. The EMBO journal 26: 4856-4866. 
Brown, S. D., J. Huang & L. H. Van der Ploeg, (1992) The promoter for the procyclic acidic 
repetitive protein (PARP) genes of Trypanosoma brucei shares features with RNA 
polymerase I promoters. Molecular and cellular biology 12: 2644-2652. 
Brun, R., J. Blum, F. Chappuis & C. Burri, (2010) Human African trypanosomiasis. Lancet 375: 
148-159. 
Buguet, A., S. Bisser, T. Josenando, F. Chapotot & R. Cespuglio, (2005) Sleep structure: a new 
diagnostic tool for stage determination in sleeping sickness. Acta tropica 93: 107-117. 
Burri, M., W. Schlimme, B. Betschart & H. Hecker, (1994) Characterization of the histones of 
Trypanosoma brucei brucei bloodstream forms. Acta tropica 58: 291-305. 
Burri, M., W. Schlimme, B. Betschart, U. Kampfer, J. Schaller & H. Hecker, (1993) Biochemical 
and functional characterization of histone H1-like proteins in procyclic Trypanosoma 
brucei brucei. Parasitology research 79: 649-659. 
Burri, M., W. Schlimme, B. Betschart, H. Lindner, U. Kampfer, J. Schaller & H. Hecker, (1995) 
Partial amino acid sequence and functional aspects of histone H1 proteins in 
Trypanosoma brucei brucei. Biology of the cell / under the auspices of the European 
Cell Biology Organization 83: 23-31. 
Burton, P., D. J. McBride, J. M. Wilkes, J. D. Barry & R. McCulloch, (2007) Ku heterodimer-
independent end joining in Trypanosoma brucei cell extracts relies upon sequence 
microhomology. Eukaryotic cell 6: 1773-1781. 
Calderano, S. G., W. C. Drosopoulos, M. M. Quaresma, C. A. Marques, S. Kosiyatrakul, R. 
McCulloch, C. L. Schildkraut & M. C. Elias, (2015) Single molecule analysis of 
Trypanosoma brucei DNA replication dynamics. Nucleic acids research 43: 2655-2665. 
Carrington, M. & J. Boothroyd, (1996) Implications of conserved structural motifs in disparate 
trypanosome surface proteins. Molecular and biochemical parasitology 81: 119-126. 
Carrington, M., N. Miller, M. Blum, I. Roditi, D. Wiley & M. Turner, (1991) Variant specific 
glycoprotein of Trypanosoma brucei consists of two domains each having an 
independently conserved pattern of cysteine residues. Journal of molecular biology 
221: 823-835. 
Catez, F., H. Yang, K. J. Tracey, R. Reeves, T. Misteli & M. Bustin, (2004) Network of dynamic 
interactions between histone H1 and high-mobility-group proteins in chromatin. 
Molecular and cellular biology 24: 4321-4328. 
Cavalier-Smith, T., (2010) Kingdoms Protozoa and Chromista and the eozoan root of the 
eukaryotic tree. Biology letters 6: 342-345. 
Chaves, I., J. Zomerdijk, A. Dirks-Mulder, R. W. Dirks, A. K. Raap & P. Borst, (1998) Subnuclear 
localization of the active variant surface glycoprotein gene expression site in 
Trypanosoma brucei. Proceedings of the National Academy of Sciences of the United 
States of America 95: 12328-12333. 
Chen, K. K. & J. E. Donelson, (1980) Sequences of two kinetoplast DNA minicircles of 
Tryptanosoma brucei. Proceedings of the National Academy of Sciences of the United 
States of America 77: 2445-2449. 
Chen, Z. H., M. Zhu, J. Yang, H. Liang, J. He, S. He, P. Wang, X. Kang, M. A. McNutt, Y. Yin & W. 
H. Shen, (2014) PTEN Interacts with Histone H1 and Controls Chromatin Condensation. 




Cheung, V., G. Chua, N. N. Batada, C. R. Landry, S. W. Michnick, T. R. Hughes & F. Winston, 
(2008) Chromatin- and transcription-related factors repress transcription from within 
coding regions throughout the Saccharomyces cerevisiae genome. PLoS biology 6: 
e277. 
Clayton, C. E. & M. R. Mowatt, (1989) The procyclic acidic repetitive proteins of Trypanosoma 
brucei. Purification and post-translational modification. The Journal of biological 
chemistry 264: 15088-15093. 
Cleary, M. D., C. D. Meiering, E. Jan, R. Guymon & J. C. Boothroyd, (2005) Biosynthetic labeling 
of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of 
mRNA synthesis and decay. Nature biotechnology 23: 232-237. 
Cliffe, L. J., R. Kieft, T. Southern, S. R. Birkeland, M. Marshall, K. Sweeney & R. Sabatini, (2009) 
JBP1 and JBP2 are two distinct thymidine hydroxylases involved in J biosynthesis in 
genomic DNA of African trypanosomes. Nucleic acids research 37: 1452-1462. 
Conway, C., R. McCulloch, M. L. Ginger, N. P. Robinson, A. Browitt & J. D. Barry, (2002) Ku is 
important for telomere maintenance, but not for differential expression of telomeric 
VSG genes, in African trypanosomes. The Journal of biological chemistry 277: 21269-
21277. 
Core, L. J., J. J. Waterfall & J. T. Lis, (2008) Nascent RNA sequencing reveals widespread pausing 
and divergent initiation at human promoters. Science 322: 1845-1848. 
Corona, D. F., G. Siriaco, J. A. Armstrong, N. Snarskaya, S. A. McClymont, M. P. Scott & J. W. 
Tamkun, (2007) ISWI regulates higher-order chromatin structure and histone H1 
assembly in vivo. PLoS biology 5: e232. 
Croken, M. M., S. C. Nardelli & K. Kim, (2012) Chromatin modifications, epigenetics, and how 
protozoan parasites regulate their lives. Trends in parasitology 28: 202-213. 
Cross, G. A., (1975) Identification, purification and properties of clone-specific glycoprotein 
antigens constituting the surface coat of Trypanosoma brucei. Parasitology 71: 393-
417. 
Cross, G. A., (1984) Structure of the variant glycoproteins and surface coat of Trypanosoma 
brucei. Philosophical transactions of the Royal Society of London. Series B, Biological 
sciences 307: 3-12. 
Cross, G. A., H. S. Kim & B. Wickstead, (2014) Capturing the variant surface glycoprotein 
repertoire (the VSGnome) of Trypanosoma brucei Lister 427. Molecular and 
biochemical parasitology 195: 59-73. 
Dammann, R., R. Lucchini, T. Koller & J. M. Sogo, (1993) Chromatin structures and transcription 
of rDNA in yeast Saccharomyces cerevisiae. Nucleic acids research 21: 2331-2338. 
Das, A., Q. Zhang, J. B. Palenchar, B. Chatterjee, G. A. Cross & V. Bellofatto, (2005) 
Trypanosomal TBP functions with the multisubunit transcription factor tSNAP to direct 
spliced-leader RNA gene expression. Molecular and cellular biology 25: 7314-7322. 
de Koning, H. P., D. J. Bridges & R. J. Burchmore, (2005) Purine and pyrimidine transport in 
pathogenic protozoa: from biology to therapy. FEMS microbiology reviews 29: 987-
1020. 
Deans, C. & K. A. Maggert, (2015) What do you mean, "epigenetic"? Genetics 199: 887-896. 
DeGrasse, J. A., K. N. DuBois, D. Devos, T. N. Siegel, A. Sali, M. C. Field, M. P. Rout & B. T. Chait, 
(2009) Evidence for a shared nuclear pore complex architecture that is conserved from 
the last common eukaryotic ancestor. Molecular & cellular proteomics : MCP 8: 2119-
2130. 
Denninger, V., A. Fullbrook, M. Bessat, K. Ersfeld & G. Rudenko, (2010) The FACT subunit 
TbSpt16 is involved in cell cycle specific control of VSG expression sites in 
Trypanosoma brucei. Molecular microbiology 78: 459-474. 
Denninger, V. & G. Rudenko, (2014) FACT plays a major role in histone dynamics affecting VSG 




Devaux, S., S. Kelly, L. Lecordier, B. Wickstead, D. Perez-Morga, E. Pays, L. Vanhamme & K. Gull, 
(2007) Diversification of function by different isoforms of conventionally shared RNA 
polymerase subunits. Molecular biology of the cell 18: 1293-1301. 
Dolken, L., Z. Ruzsics, B. Radle, C. C. Friedel, R. Zimmer, J. Mages, R. Hoffmann, P. Dickinson, T. 
Forster, P. Ghazal & U. H. Koszinowski, (2008) High-resolution gene expression 
profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 
14: 1959-1972. 
Donelson, J. E., (2003) Antigenic variation and the African trypanosome genome. Acta tropica 
85: 391-404. 
Dooijes, D., I. Chaves, R. Kieft, A. Dirks-Mulder, W. Martin & P. Borst, (2000) Base J originally 
found in kinetoplastida is also a minor constituent of nuclear DNA of Euglena gracilis. 
Nucleic acids research 28: 3017-3021. 
Downs, J. A., E. Kosmidou, A. Morgan & S. P. Jackson, (2003) Suppression of homologous 
recombination by the Saccharomyces cerevisiae linker histone. Molecular cell 11: 
1685-1692. 
Doyle, J. J., H. Hirumi, K. Hirumi, E. N. Lupton & G. A. Cross, (1980) Antigenic variation in clones 
of animal-infective Trypanosoma brucei derived and maintained in vitro. Parasitology 
80: 359-369. 
DuBois, K. N., S. Alsford, J. M. Holden, J. Buisson, M. Swiderski, J. M. Bart, A. V. Ratushny, Y. 
Wan, P. Bastin, J. D. Barry, M. Navarro, D. Horn, J. D. Aitchison, M. P. Rout & M. C. 
Field, (2012) NUP-1 Is a large coiled-coil nucleoskeletal protein in trypanosomes with 
lamin-like functions. PLoS biology 10: e1001287. 
Dubois, M. E., K. P. Demick & J. M. Mansfield, (2005) Trypanosomes expressing a mosaic 
variant surface glycoprotein coat escape early detection by the immune system. 
Infection and immunity 73: 2690-2697. 
Duffy, E. E., M. Rutenberg-Schoenberg, C. D. Stark, R. R. Kitchen, M. B. Gerstein & M. D. Simon, 
(2015) Tracking Distinct RNA Populations Using Efficient and Reversible Covalent 
Chemistry. Molecular cell 59: 858-866. 
Dunbar, D. A., A. A. Chen, S. Wormsley & S. J. Baserga, (2000) The genes for small nucleolar 
RNAs in Trypanosoma brucei are organized in clusters and are transcribed as a 
polycistronic RNA. Nucleic acids research 28: 2855-2861. 
Ekanayake, D. & R. Sabatini, (2011) Epigenetic regulation of polymerase II transcription 
initiation in Trypanosoma cruzi: modulation of nucleosome abundance, histone 
modification, and polymerase occupancy by O-linked thymine DNA glucosylation. 
Eukaryotic cell 10: 1465-1472. 
Ekanayake, D. K., T. Minning, B. Weatherly, K. Gunasekera, D. Nilsson, R. Tarleton, T. 
Ochsenreiter & R. Sabatini, (2011) Epigenetic regulation of transcription and virulence 
in Trypanosoma cruzi by O-linked thymine glucosylation of DNA. Molecular and cellular 
biology 31: 1690-1700. 
El-Sayed, N. M., E. Ghedin, J. Song, A. MacLeod, F. Bringaud, C. Larkin, D. Wanless, J. Peterson, 
L. Hou, S. Taylor, A. Tweedie, N. Biteau, H. G. Khalak, X. Lin, T. Mason, L. Hannick, E. 
Caler, G. Blandin, D. Bartholomeu, A. J. Simpson, S. Kaul, H. Zhao, G. Pai, S. Van Aken, 
T. Utterback, B. Haas, H. L. Koo, L. Umayam, B. Suh, C. Gerrard, V. Leech, R. Qi, S. Zhou, 
D. Schwartz, T. Feldblyum, S. Salzberg, A. Tait, C. M. Turner, E. Ullu, O. White, S. 
Melville, M. D. Adams, C. M. Fraser & J. E. Donelson, (2003) The sequence and analysis 
of Trypanosoma brucei chromosome II. Nucleic acids research 31: 4856-4863. 
El Gazzar, M., B. K. Yoza, X. Chen, B. A. Garcia, N. L. Young & C. E. McCall, (2009) Chromatin-
specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes 
during endotoxin tolerance. Molecular and cellular biology 29: 1959-1971. 
Eme, L., S. C. Sharpe, M. W. Brown & A. J. Roger, (2014) On the age of eukaryotes: evaluating 




Engstler, M., T. Pfohl, S. Herminghaus, M. Boshart, G. Wiegertjes, N. Heddergott & P. Overath, 
(2007) Hydrodynamic flow-mediated protein sorting on the cell surface of 
trypanosomes. Cell 131: 505-515. 
Ersfeld, K., (2011) Nuclear architecture, genome and chromatin organisation in Trypanosoma 
brucei. Res Microbiol 162: 626-636. 
Ersfeld, K., K. Asbeck & K. Gull, (1998) Direct visualisation of individual gene organisation in 
Trypanosoma brucei by high-resolution in situ hybridisation. Chromosoma 107: 237-
240. 
Ersfeld, K., R. Docherty, S. Alsford & K. Gull, (1996) A fluorescence in situ hybridisation study of 
the regulation of histone mRNA levels during the cell cycle of Trypanosoma brucei. 
Molecular and biochemical parasitology 81: 201-209. 
Fadda, A., M. Ryten, D. Droll, F. Rojas, V. Farber, J. R. Haanstra, C. Merce, B. M. Bakker, K. 
Matthews & C. Clayton, (2014) Transcriptome-wide analysis of trypanosome mRNA 
decay reveals complex degradation kinetics and suggests a role for co-transcriptional 
degradation in determining mRNA levels. Molecular microbiology 94: 307-326. 
Fan, Y., T. Nikitina, E. M. Morin-Kensicki, J. Zhao, T. R. Magnuson, C. L. Woodcock & A. I. 
Skoultchi, (2003) H1 linker histones are essential for mouse development and affect 
nucleosome spacing in vivo. Molecular and cellular biology 23: 4559-4572. 
Fan, Y., T. Nikitina, J. Zhao, T. J. Fleury, R. Bhattacharyya, E. E. Bouhassira, A. Stein, C. L. 
Woodcock & A. I. Skoultchi, (2005) Histone H1 depletion in mammals alters global 
chromatin structure but causes specific changes in gene regulation. Cell 123: 1199-
1212. 
Fantoni, A., A. O. Dare & C. Tschudi, (1994) RNA polymerase III-mediated transcription of the 
trypanosome U2 small nuclear RNA gene is controlled by both intragenic and 
extragenic regulatory elements. Molecular and cellular biology 14: 2021-2028. 
FAO, (2014) Programme Against African Trypanosomosis (PAAT). In: 
http://www.fao.org/ag/AGAINFO/programmes/en/paat/disease.html. Food and 
Agriculture Organization of the United Nations, pp. 
Ferguson, M. A., S. W. Homans, R. A. Dwek & T. W. Rademacher, (1988) Glycosyl-
phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface 
glycoprotein to the membrane. Science 239: 753-759. 
Ferrante, A. & A. C. Allison, (1983) Alternative pathway activation of complement by African 
trypanosomes lacking a glycoprotein coat. Parasite immunology 5: 491-498. 
Field, M. C., D. Horn, S. Alsford, L. Koreny & M. P. Rout, (2012) Telomeres, tethers and 
trypanosomes. Nucleus 3: 478-486. 
Figueiredo, L. M. & G. A. Cross, (2010) Nucleosomes are depleted at the VSG expression site 
transcribed by RNA polymerase I in African trypanosomes. Eukaryotic cell 9: 148-154. 
Figueiredo, L. M., G. A. Cross & C. J. Janzen, (2009) Epigenetic regulation in African 
trypanosomes: a new kid on the block. Nature reviews. Microbiology 7: 504-513. 
Figueiredo, L. M., C. J. Janzen & G. A. Cross, (2008) A histone methyltransferase modulates 
antigenic variation in African trypanosomes. PLoS biology 6: e161. 
Friedel, C. C., L. Dolken, Z. Ruzsics, U. H. Koszinowski & R. Zimmer, (2009) Conserved principles 
of mammalian transcriptional regulation revealed by RNA half-life. Nucleic acids 
research 37: e115. 
Gadad, S. S., P. Senapati, S. H. Syed, R. E. Rajan, J. Shandilya, V. Swaminathan, S. Chatterjee, E. 
Colombo, S. Dimitrov, P. G. Pelicci, U. Ranga & T. K. Kundu, (2011) The multifunctional 
protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. Biochemistry 
50: 2780-2789. 
Garcia-Salcedo, J. A., P. Gijon, D. P. Nolan, P. Tebabi & E. Pays, (2003) A chromosomal SIR2 
homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase 





Gassen, A., D. Brechtefeld, N. Schandry, J. M. Arteaga-Salas, L. Israel, A. Imhof & C. J. Janzen, 
(2012) DOT1A-dependent H3K76 methylation is required for replication regulation in 
Trypanosoma brucei. Nucleic acids research 40: 10302-10311. 
Gay, L., K. V. Karfilis, M. R. Miller, C. Q. Doe & K. Stankunas, (2014) Applying thiouracil tagging 
to mouse transcriptome analysis. Nat Protoc 9: 410-420. 
Genest, P. A., B. ter Riet, C. Dumas, B. Papadopoulou, H. G. van Luenen & P. Borst, (2005) 
Formation of linear inverted repeat amplicons following targeting of an essential gene 
in Leishmania. Nucleic acids research 33: 1699-1709. 
Gerrits, H., R. Mussmann, W. Bitter, R. Kieft & P. Borst, (2002) The physiological significance of 
transferrin receptor variations in Trypanosoma brucei. Molecular and biochemical 
parasitology 119: 237-247. 
Ghorbal, M., M. Gorman, C. R. Macpherson, R. M. Martins, A. Scherf & J. J. Lopez-Rubio, (2014) 
Genome editing in the human malaria parasite Plasmodium falciparum using the 
CRISPR-Cas9 system. Nature biotechnology 32: 819-821. 
Gibson, W., (2007) Resolution of the species problem in African trypanosomes. International 
journal for parasitology 37: 829-838. 
Gilinger, G. & V. Bellofatto, (2001) Trypanosome spliced leader RNA genes contain the first 
identified RNA polymerase II gene promoter in these organisms. Nucleic acids research 
29: 1556-1564. 
Giloni, L., M. Takeshita, F. Johnson, C. Iden & A. P. Grollman, (1981) Bleomycin-induced strand-
scission of DNA. Mechanism of deoxyribose cleavage. The Journal of biological 
chemistry 256: 8608-8615. 
Ginger, M. L., P. A. Blundell, A. M. Lewis, A. Browitt, A. Gunzl & J. D. Barry, (2002) Ex vivo and in 
vitro identification of a consensus promoter for VSG genes expressed by metacyclic-
stage trypanosomes in the tsetse fly. Eukaryotic cell 1: 1000-1009. 
Giresi, P. G., J. Kim, R. M. McDaniell, V. R. Iyer & J. D. Lieb, (2007) FAIRE (Formaldehyde-
Assisted Isolation of Regulatory Elements) isolates active regulatory elements from 
human chromatin. Genome research 17: 877-885. 
Giroud, C., F. Ottones, V. Coustou, D. Dacheux, N. Biteau, B. Miezan, N. Van Reet, M. 
Carrington, F. Doua & T. Baltz, (2009) Murine Models for Trypanosoma brucei 
gambiense disease progression--from silent to chronic infections and early brain 
tropism. PLoS neglected tropical diseases 3: e509. 
Gjini, E., D. T. Haydon, J. D. Barry & C. A. Cobbold, (2010) Critical interplay between parasite 
differentiation, host immunity, and antigenic variation in trypanosome infections. The 
American naturalist 176: 424-439. 
Glover, L., S. Alsford, C. Beattie & D. Horn, (2007) Deletion of a trypanosome telomere leads to 
loss of silencing and progressive loss of terminal DNA in the absence of cell cycle 
arrest. Nucleic acids research 35: 872-880. 
Glover, L. & D. Horn, (2006) Repression of polymerase I-mediated gene expression at 
Trypanosoma brucei telomeres. EMBO reports 7: 93-99. 
Glover, L. & D. Horn, (2012) Trypanosomal histone gammaH2A and the DNA damage response. 
Molecular and biochemical parasitology 183: 78-83. 
Glover, L. & D. Horn, (2014) Locus-specific control of DNA resection and suppression of 
subtelomeric VSG recombination by HAT3 in the African trypanosome. Nucleic acids 
research 42: 12600-12613. 
Glover, L., J. Jun & D. Horn, (2011) Microhomology-mediated deletion and gene conversion in 
African trypanosomes. Nucleic acids research 39: 1372-1380. 
Glover, L., R. McCulloch & D. Horn, (2008) Sequence homology and microhomology dominate 
chromosomal double-strand break repair in African trypanosomes. Nucleic acids 
research 36: 2608-2618. 
Gommers-Ampt, J. H., F. Van Leeuwen, A. L. de Beer, J. F. Vliegenthart, M. Dizdaroglu, J. A. 




modified base present in the DNA of the parasitic protozoan T. brucei. Cell 75: 1129-
1136. 
Goringer, H. U., (2012) 'Gestalt,' composition and function of the Trypanosoma brucei 
editosome. Annu Rev Microbiol 66: 65-82. 
Gottschling, D. E., O. M. Aparicio, B. L. Billington & V. A. Zakian, (1990) Position effect at S. 
cerevisiae telomeres: reversible repression of Pol II transcription. Cell 63: 751-762. 
Graham, S. V. & J. D. Barry, (1995) Transcriptional regulation of metacyclic variant surface 
glycoprotein gene expression during the life cycle of Trypanosoma brucei. Molecular 
and cellular biology 15: 5945-5956. 
Gray, A. R., (1965) Antigenic variation in a strain of Trypanosoma brucei transmitted by 
Glossina morsitans and G. palpalis. J Gen Microbiol 41: 195-214. 
Grummt, I. & G. Langst, (2013) Epigenetic control of RNA polymerase I transcription in 
mammalian cells. Biochimica et biophysica acta 1829: 393-404. 
Grunfelder, C. G., M. Engstler, F. Weise, H. Schwarz, Y. D. Stierhof, M. Boshart & P. Overath, 
(2002) Accumulation of a GPI-anchored protein at the cell surface requires sorting at 
multiple intracellular levels. Traffic 3: 547-559. 
Gruter, E. & B. Betschart, (2001) Isolation, characterisation and organisation of histone H1 
genes in African trypanosomes. Parasitology research 87: 977-984. 
Guirnalda, P., N. B. Murphy, D. Nolan & S. J. Black, (2007) Anti-Trypanosoma brucei activity in 
Cape buffalo serum during the cryptic phase of parasitemia is mediated by antibodies. 
International journal for parasitology 37: 1391-1399. 
Gunzl, A., T. Bruderer, G. Laufer, B. Schimanski, L. C. Tu, H. M. Chung, P. T. Lee & M. G. Lee, 
(2003) RNA polymerase I transcribes procyclin genes and variant surface glycoprotein 
gene expression sites in Trypanosoma brucei. Eukaryotic cell 2: 542-551. 
Gunzl, A., J. K. Kirkham, T. N. Nguyen, N. Badjatia & S. H. Park, (2014) Mono-allelic VSG 
expression by RNA polymerase I in Trypanosoma brucei: Expression site control from 
both ends? Gene. 
Gunzl, A., E. Ullu, M. Dorner, S. P. Fragoso, K. F. Hoffmann, J. D. Milner, Y. Morita, E. K. Nguu, S. 
Vanacova, S. Wunsch, A. O. Dare, H. Kwon & C. Tschudi, (1997) Transcription of the 
Trypanosoma brucei spliced leader RNA gene is dependent only on the presence of 
upstream regulatory elements. Molecular and biochemical parasitology 85: 67-76. 
Gurard-Levin, Z. A., J. P. Quivy & G. Almouzni, (2014) Histone chaperones: assisting histone 
traffic and nucleosome dynamics. Annual review of biochemistry 83: 487-517. 
Haenni, S., C. K. Renggli, C. M. Fragoso, M. Oberle & I. Roditi, (2006) The procyclin-associated 
genes of Trypanosoma brucei are not essential for cyclical transmission by tsetse. 
Molecular and biochemical parasitology 150: 144-156. 
Haenni, S., E. Studer, G. S. Burkard & I. Roditi, (2009) Bidirectional silencing of RNA polymerase 
I transcription by a strand switch region in Trypanosoma brucei. Nucleic acids research 
37: 5007-5018. 
Hajduk, S. L. & K. Vickerman, (1981) Antigenic Variation in Cyclically Transmitted Trypanosoma-
Brucei - Variable Antigen Type Composition of the 1st Parasitemia in Mice Bitten by 
Trypanosome-Infected Glossina-Morsitans. Parasitology 83: 609-621. 
Hall, J. P., H. Wang & J. D. Barry, (2013) Mosaic VSGs and the scale of Trypanosoma brucei 
antigenic variation. PLoS pathogens 9: e1003502. 
Happel, N. & D. Doenecke, (2009) Histone H1 and its isoforms: contribution to chromatin 
structure and function. Gene 431: 1-12. 
Harshman, S. W., N. L. Young, M. R. Parthun & M. A. Freitas, (2013) H1 histones: current 
perspectives and challenges. Nucleic acids research 41: 9593-9609. 
Hashimoto, H., Y. Takami, E. Sonoda, T. Iwasaki, H. Iwano, M. Tachibana, S. Takeda, T. 
Nakayama, H. Kimura & Y. Shinkai, (2010) Histone H1 null vertebrate cells exhibit 




Hayashi, T., H. Hayashi & K. Iwai, (1987) Tetrahymena histone H1. Isolation and amino acid 
sequence lacking the central hydrophobic domain conserved in other H1 histones. 
Journal of biochemistry 102: 369-376. 
Hecker, H., B. Betschart, K. Bender, M. Burri & W. Schlimme, (1994) The chromatin of 
trypanosomes. International journal for parasitology 24: 809-819. 
Hecker, H. & E. S. Gander, (1985) The compaction pattern of the chromatin of trypanosomes. 
Biology of the cell / under the auspices of the European Cell Biology Organization 53: 
199-208. 
Hellauer, K., E. Sirard & B. Turcotte, (2001) Decreased expression of specific genes in yeast cells 
lacking histone H1. The Journal of biological chemistry 276: 13587-13592. 
Hendzel, M. J., M. A. Lever, E. Crawford & J. P. Th'ng, (2004) The C-terminal domain is the 
primary determinant of histone H1 binding to chromatin in vivo. The Journal of 
biological chemistry 279: 20028-20034. 
Hennig, B. P. & T. Fischer, (2013) The great repression: chromatin and cryptic transcription. 
Transcription 4: 97-101. 
Hertz-Fowler, C., L. M. Figueiredo, M. A. Quail, M. Becker, A. Jackson, N. Bason, K. Brooks, C. 
Churcher, S. Fahkro, I. Goodhead, P. Heath, M. Kartvelishvili, K. Mungall, D. Harris, H. 
Hauser, M. Sanders, D. Saunders, K. Seeger, S. Sharp, J. E. Taylor, D. Walker, B. White, 
R. Young, G. A. Cross, G. Rudenko, J. D. Barry, E. J. Louis & M. Berriman, (2008) 
Telomeric expression sites are highly conserved in Trypanosoma brucei. PloS one 3: 
e3527. 
Hirumi, H. & K. Hirumi, (1989) Continuous cultivation of Trypanosoma brucei blood stream 
forms in a medium containing a low concentration of serum protein without feeder 
cell layers. The Journal of parasitology 75: 985-989. 
Hitchcock, R. A., S. Thomas, D. A. Campbell & N. R. Sturm, (2007) The promoter and 
transcribed regions of the Leishmania tarentolae spliced leader RNA gene array are 
devoid of nucleosomes. BMC microbiology 7: 44. 
Horn, D. & G. A. Cross, (1995) A developmentally regulated position effect at a telomeric locus 
in Trypanosoma brucei. Cell 83: 555-561. 
Horn, D. & G. A. Cross, (1997) Position-dependent and promoter-specific regulation of gene 
expression in Trypanosoma brucei. The EMBO journal 16: 7422-7431. 
Hotz, H. R., S. Biebinger, J. Flaspohler & C. Clayton, (1998) PARP gene expression: control at 
many levels. Molecular and biochemical parasitology 91: 131-143. 
Hotz, H. R., C. Hartmann, K. Huober, M. Hug & C. Clayton, (1997) Mechanisms of 
developmental regulation in Trypanosoma brucei: a polypyrimidine tract in the 3'-
untranslated region of a surface protein mRNA affects RNA abundance and translation. 
Nucleic acids research 25: 3017-3026. 
Huang, J. & L. H. van der Ploeg, (1991) Maturation of polycistronic pre-mRNA in Trypanosoma 
brucei: analysis of trans splicing and poly(A) addition at nascent RNA transcripts from 
the hsp70 locus. Molecular and cellular biology 11: 3180-3190. 
Hughes, K., M. Wand, L. Foulston, R. Young, K. Harley, S. Terry, K. Ersfeld & G. Rudenko, (2007) 
A novel ISWI is involved in VSG expression site downregulation in African 
trypanosomes. The EMBO journal 26: 2400-2410. 
Imboden, M. A., P. W. Laird, M. Affolter & T. Seebeck, (1987) Transcription of the intergenic 
regions of the tubulin gene cluster of Trypanosoma brucei: evidence for a polycistronic 
transcription unit in a eukaryote. Nucleic acids research 15: 7357-7368. 
Ingram, A. K. & D. Horn, (2002) Histone deacetylases in Trypanosoma brucei: two are essential 
and another is required for normal cell cycle progression. Molecular microbiology 45: 
89-97. 
Izzo, A., K. Kamieniarz & R. Schneider, (2008) The histone H1 family: specific members, specific 




Jackson, D. G., M. J. Owen & H. P. Voorheis, (1985) A new method for the rapid purification of 
both the membrane-bound and released forms of the variant surface glycoprotein 
from Trypanosoma brucei. The Biochemical journal 230: 195-202. 
Jae, N., P. Wang, T. Gu, M. Huhn, Z. Palfi, H. Urlaub & A. Bindereif, (2010) Essential role of a 
trypanosome U4-specific Sm core protein in small nuclear ribonucleoprotein assembly 
and splicing. Eukaryotic cell 9: 379-386. 
Jamonneau, V., H. Ilboudo, J. Kabore, D. Kaba, M. Koffi, P. Solano, A. Garcia, D. Courtin, C. 
Laveissiere, K. Lingue, P. Buscher & B. Bucheton, (2012) Untreated human infections by 
Trypanosoma brucei gambiense are not 100% fatal. PLoS neglected tropical diseases 6: 
e1691. 
Janzen, C. J., J. P. Fernandez, H. Deng, R. Diaz, S. B. Hake & G. A. Cross, (2006a) Unusual histone 
modifications in Trypanosoma brucei. FEBS letters 580: 2306-2310. 
Janzen, C. J., S. B. Hake, J. E. Lowell & G. A. Cross, (2006b) Selective di- or trimethylation of 
histone H3 lysine 76 by two DOT1 homologs is important for cell cycle regulation in 
Trypanosoma brucei. Molecular cell 23: 497-507. 
Janzen, C. J., F. Lander, O. Dreesen & G. A. Cross, (2004) Telomere length regulation and 
transcriptional silencing in KU80-deficient Trypanosoma brucei. Nucleic acids research 
32: 6575-6584. 
Jehi, S. E., X. Li, R. Sandhu, F. Ye, I. Benmerzouga, M. Zhang, Y. Zhao & B. Li, (2014a) 
Suppression of subtelomeric VSG switching by Trypanosoma brucei TRF requires its 
TTAGGG repeat-binding activity. Nucleic acids research 42: 12899-12911. 
Jehi, S. E., F. Wu & B. Li, (2014b) Trypanosoma brucei TIF2 suppresses VSG switching by 
maintaining subtelomere integrity. Cell research. 
Jensen, B. C., G. Ramasamy, E. J. Vasconcelos, N. T. Ingolia, P. J. Myler & M. Parsons, (2014) 
Extensive stage-regulation of translation revealed by ribosome profiling of 
Trypanosoma brucei. BMC genomics 15: 911. 
Jensen, B. C., D. Sivam, C. T. Kifer, P. J. Myler & M. Parsons, (2009) Widespread variation in 
transcript abundance within and across developmental stages of Trypanosoma brucei. 
BMC genomics 10: 482. 
Jensen, R. E. & P. T. Englund, (2012) Network news: the replication of kinetoplast DNA. Annu 
Rev Microbiol 66: 473-491. 
Jensen, T. H., A. Jacquier & D. Libri, (2013) Dealing with pervasive transcription. Molecular cell 
52: 473-484. 
Johnson, J. G. & G. A. Cross, (1979) Selective cleavage of variant surface glycoproteins from 
Trypanosoma brucei. The Biochemical journal 178: 689-697. 
Kabani, S., K. Fenn, A. Ross, A. Ivens, T. K. Smith, P. Ghazal & K. Matthews, (2009) Genome-
wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic 
analysis of mRNA alterations during synchronous differentiation in Trypanosoma 
brucei. BMC genomics 10: 427. 
Kaplan, C. D., L. Laprade & F. Winston, (2003) Transcription elongation factors repress 
transcription initiation from cryptic sites. Science 301: 1096-1099. 
Kassem, A., E. Pays & L. Vanhamme, (2014) Transcription is initiated on silent variant surface 
glycoprotein expression sites despite monoallelic expression in Trypanosoma brucei. 
Proceedings of the National Academy of Sciences of the United States of America 111: 
8943-8948. 
Kawahara, T., T. N. Siegel, A. K. Ingram, S. Alsford, G. A. Cross & D. Horn, (2008) Two essential 
MYST-family proteins display distinct roles in histone H4K10 acetylation and telomeric 
silencing in trypanosomes. Molecular microbiology 69: 1054-1068. 
Kennedy, P. G., (2013) Clinical features, diagnosis, and treatment of human African 
trypanosomiasis (sleeping sickness). Lancet neurology 12: 186-194. 
Kenzelmann, M., S. Maertens, M. Hergenhahn, S. Kueffer, A. Hotz-Wagenblatt, L. Li, S. Wang, 




H. J. Grone & G. Schutz, (2007) Microarray analysis of newly synthesized RNA in cells 
and animals. Proceedings of the National Academy of Sciences of the United States of 
America 104: 6164-6169. 
Kim, H. S., S. H. Park, A. Gunzl & G. A. Cross, (2013) MCM-BP is required for repression of life-
cycle specific genes transcribed by RNA polymerase I in the mammalian infectious 
form of Trypanosoma brucei. PloS one 8: e57001. 
Knusel, S. & I. Roditi, (2013) Insights into the regulation of GPEET procyclin during 
differentiation from early to late procyclic forms of Trypanosoma brucei. Molecular 
and biochemical parasitology 191: 66-74. 
Koenig-Martin, E., M. Yamage & I. Roditi, (1992) A procyclin-associated gene in Trypanosoma 
brucei encodes a polypeptide related to ESAG 6 and 7 proteins. Molecular and 
biochemical parasitology 55: 135-145. 
Kolev, N. G., J. B. Franklin, S. Carmi, H. Shi, S. Michaeli & C. Tschudi, (2010) The transcriptome 
of the human pathogen Trypanosoma brucei at single-nucleotide resolution. PLoS 
pathogens 6: e1001090. 
Kolev, N. G., K. Ramey-Butler, G. A. Cross, E. Ullu & C. Tschudi, (2012) Developmental 
progression to infectivity in Trypanosoma brucei triggered by an RNA-binding protein. 
Science 338: 1352-1353. 
Kolev, N. G., E. Ullu & C. Tschudi, (2014) The emerging role of RNA-binding proteins in the life 
cycle of Trypanosoma brucei. Cellular microbiology 16: 482-489. 
Kooter, J. M. & P. Borst, (1984) Alpha-amanitin-insensitive transcription of variant surface 
glycoprotein genes provides further evidence for discontinuous transcription in 
trypanosomes. Nucleic acids research 12: 9457-9472. 
Kramer, S., (2012) Developmental regulation of gene expression in the absence of 
transcriptional control: the case of kinetoplastids. Molecular and biochemical 
parasitology 181: 61-72. 
Lam, Y. W. & L. Trinkle-Mulcahy, (2015) New insights into nucleolar structure and function. 
F1000prime reports 7: 48. 
Lamont, G. S., R. S. Tucker & G. A. Cross, (1986) Analysis of antigen switching rates in 
Trypanosoma brucei. Parasitology 92 ( Pt 2): 355-367. 
Landeira, D., J. M. Bart, D. Van Tyne & M. Navarro, (2009) Cohesin regulates VSG monoallelic 
expression in trypanosomes. The Journal of cell biology 186: 243-254. 
Landeira, D. & M. Navarro, (2007) Nuclear repositioning of the VSG promoter during 
developmental silencing in Trypanosoma brucei. The Journal of cell biology 176: 133-
139. 
Langmead, B., C. Trapnell, M. Pop & S. L. Salzberg, (2009) Ultrafast and memory-efficient 
alignment of short DNA sequences to the human genome. Genome biology 10: R25. 
Laufer, G. & A. Gunzl, (2001) In-vitro competition analysis of procyclin gene and variant surface 
glycoprotein gene expression site transcription in Trypanosoma brucei. Molecular and 
biochemical parasitology 113: 55-65. 
Laybourn, P. J. & J. T. Kadonaga, (1991) Role of nucleosomal cores and histone H1 in regulation 
of transcription by RNA polymerase II. Science 254: 238-245. 
LeBowitz, J. H., H. Q. Smith, L. Rusche & S. M. Beverley, (1993) Coupling of poly(A) site 
selection and trans-splicing in Leishmania. Genes & development 7: 996-1007. 
Lecordier, L., D. Walgraffe, S. Devaux, P. Poelvoorde, E. Pays & L. Vanhamme, (2005) 
Trypanosoma brucei RNA interference in the mammalian host. Molecular and 
biochemical parasitology 140: 127-131. 
Lee, J. S., E. Smith & A. Shilatifard, (2010) The language of histone crosstalk. Cell 142: 682-685. 
Lever, M. A., J. P. Th'ng, X. Sun & M. J. Hendzel, (2000) Rapid exchange of histone H1.1 on 
chromatin in living human cells. Nature 408: 873-876. 
Li, B., (2015) DNA double-strand breaks and telomeres play important roles in trypanosoma 




Li, B., A. Espinal & G. A. Cross, (2005) Trypanosome telomeres are protected by a homologue 
of mammalian TRF2. Molecular and cellular biology 25: 5011-5021. 
Li, C., J. E. Mueller, M. Elfline & M. Bryk, (2008) Linker histone H1 represses recombination at 
the ribosomal DNA locus in the budding yeast Saccharomyces cerevisiae. Molecular 
microbiology 67: 906-919. 
Lin, R., R. G. Cook & C. D. Allis, (1991) Proteolytic removal of core histone amino termini and 
dephosphorylation of histone H1 correlate with the formation of condensed chromatin 
and transcriptional silencing during Tetrahymena macronuclear development. Genes & 
development 5: 1601-1610. 
Liniger, M., K. Bodenmuller, E. Pays, S. Gallati & I. Roditi, (2001) Overlapping sense and 
antisense transcription units in Trypanosoma brucei. Molecular microbiology 40: 869-
878. 
Lopez-Farfan, D., J. M. Bart, D. I. Rojas-Barros & M. Navarro, (2014) SUMOylation by the E3 
ligase TbSIZ1/PIAS1 positively regulates VSG expression in Trypanosoma brucei. PLoS 
pathogens 10: e1004545. 
Lopez, R., B. Sarg, H. Lindner, S. Bartolome, I. Ponte, P. Suau & A. Roque, (2015) Linker histone 
partial phosphorylation: effects on secondary structure and chromatin condensation. 
Nucleic acids research 43: 4463-4476. 
Lowell, J. E. & G. A. Cross, (2004) A variant histone H3 is enriched at telomeres in Trypanosoma 
brucei. Journal of cell science 117: 5937-5947. 
Lowell, J. E., F. Kaiser, C. J. Janzen & G. A. Cross, (2005) Histone H2AZ dimerizes with a novel 
variant H2B and is enriched at repetitive DNA in Trypanosoma brucei. Journal of cell 
science 118: 5721-5730. 
Lu, X., S. N. Wontakal, A. V. Emelyanov, P. Morcillo, A. Y. Konev, D. V. Fyodorov & A. I. 
Skoultchi, (2009) Linker histone H1 is essential for Drosophila development, the 
establishment of pericentric heterochromatin, and a normal polytene chromosome 
structure. Genes & development 23: 452-465. 
Luger, K., M. L. Dechassa & D. J. Tremethick, (2012) New insights into nucleosome and 
chromatin structure: an ordered state or a disordered affair? Nature reviews. 
Molecular cell biology 13: 436-447. 
Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent & T. J. Richmond, (1997) Crystal structure 
of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260. 
Luger, K. & T. J. Richmond, (1998) The histone tails of the nucleosome. Current opinion in 
genetics & development 8: 140-146. 
Luijsterburg, M. S., M. F. White, R. van Driel & R. T. Dame, (2008) The major architects of 
chromatin: architectural proteins in bacteria, archaea and eukaryotes. Crit Rev 
Biochem Mol Biol 43: 393-418. 
Lukes, J., T. Skalicky, J. Tyc, J. Votypka & V. Yurchenko, (2014) Evolution of parasitism in 
kinetoplastid flagellates. Molecular and biochemical parasitology 195: 115-122. 
Lundin, C., M. North, K. Erixon, K. Walters, D. Jenssen, A. S. Goldman & T. Helleday, (2005) 
Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable 
in vivo DNA double-strand breaks. Nucleic acids research 33: 3799-3811. 
Lythgoe, K. A., L. J. Morrison, A. F. Read & J. D. Barry, (2007) Parasite-intrinsic factors can 
explain ordered progression of trypanosome antigenic variation. Proceedings of the 
National Academy of Sciences of the United States of America 104: 8095-8100. 
Ma, W., J. W. Westmoreland, D. A. Gordenin & M. A. Resnick, (2011) Alkylation base damage is 
converted into repairable double-strand breaks and complex intermediates in G2 cells 
lacking AP endonuclease. PLoS genetics 7: e1002059. 
MacGregor, P., N. J. Savill, D. Hall & K. R. Matthews, (2011) Transmission stages dominate 





Maeshima, K., S. Hihara & M. Eltsov, (2010) Chromatin structure: does the 30-nm fibre exist in 
vivo? Current opinion in cell biology 22: 291-297. 
Mair, G., H. Shi, H. Li, A. Djikeng, H. O. Aviles, J. R. Bishop, F. H. Falcone, C. Gavrilescu, J. L. 
Montgomery, M. I. Santori, L. S. Stern, Z. Wang, E. Ullu & C. Tschudi, (2000) A new 
twist in trypanosome RNA metabolism: cis-splicing of pre-mRNA. RNA 6: 163-169. 
Mandava, V., J. P. Fernandez, H. Deng, C. J. Janzen, S. B. Hake & G. A. Cross, (2007) Histone 
modifications in Trypanosoma brucei. Molecular and biochemical parasitology 156: 41-
50. 
Manful, T., A. Fadda & C. Clayton, (2011) The role of the 5'-3' exoribonuclease XRNA in 
transcriptome-wide mRNA degradation. RNA 17: 2039-2047. 
Mansfield, J. M. & D. M. Paulnock, (2005) Regulation of innate and acquired immunity in 
African trypanosomiasis. Parasite immunology 27: 361-371. 
Marcello, L. & J. D. Barry, (2007) Analysis of the VSG gene silent archive in Trypanosoma brucei 
reveals that mosaic gene expression is prominent in antigenic variation and is favored 
by archive substructure. Genome research 17: 1344-1352. 
Martinez-Calvillo, S., J. C. Vizuet-de-Rueda, L. E. Florencio-Martinez, R. G. Manning-Cela & E. E. 
Figueroa-Angulo, (2010) Gene expression in trypanosomatid parasites. Journal of 
biomedicine & biotechnology 2010: 525241. 
Martinez-Calvillo, S., S. Yan, D. Nguyen, M. Fox, K. Stuart & P. J. Myler, (2003) Transcription of 
Leishmania major Friedlin chromosome 1 initiates in both directions within a single 
region. Molecular cell 11: 1291-1299. 
Marzluff, W. F., (2005) Metazoan replication-dependent histone mRNAs: a distinct set of RNA 
polymerase II transcripts. Current opinion in cell biology 17: 274-280. 
Masina, S., H. Zangger, D. Rivier & N. Fasel, (2007) Histone H1 regulates chromatin 
condensation in Leishmania parasites. Experimental parasitology 116: 83-87. 
Matthews, K. R., R. McCulloch & L. J. Morrison, (2015) The within-host dynamics of African 
trypanosome infections. Philosophical transactions of the Royal Society of London. 
Series B, Biological sciences 370. 
Mazurier, F., A. Fontanellas, S. Salesse, L. Taine, S. Landriau, F. Moreau-Gaudry, J. Reiffers, B. 
Peault, J. P. Di Santo & H. de Verneuil, (1999) A novel immunodeficient mouse model--
RAG2 x common cytokine receptor gamma chain double mutants--requiring 
exogenous cytokine administration for human hematopoietic stem cell engraftment. 
Journal of interferon & cytokine research : the official journal of the International 
Society for Interferon and Cytokine Research 19: 533-541. 
McAndrew, M., S. Graham, C. Hartmann & C. Clayton, (1998) Testing promoter activity in the 
trypanosome genome: isolation of a metacyclic-type VSG promoter, and unexpected 
insights into RNA polymerase II transcription. Experimental parasitology 90: 65-76. 
McCulloch, R. & J. D. Barry, (1999) A role for RAD51 and homologous recombination in 
Trypanosoma brucei antigenic variation. Genes & development 13: 2875-2888. 
McCulloch, R. & M. C. Field, (2015) Quantitative sequencing confirms VSG diversity as central 
to immune evasion by Trypanosoma brucei. Trends in parasitology. 
McCulloch, R. & D. Horn, (2009) What has DNA sequencing revealed about the VSG expression 
sites of African trypanosomes? Trends in parasitology 25: 359-363. 
McCulloch, R., L. J. Morrison & J. P. Hall, (2015) DNA Recombination Strategies During 
Antigenic Variation in the African Trypanosome. Microbiology spectrum 3. 
McCulloch, R., G. Rudenko & P. Borst, (1997) Gene conversions mediating antigenic variation in 
Trypanosoma brucei can occur in variant surface glycoprotein expression sites lacking 
70-base-pair repeat sequences. Molecular and cellular biology 17: 833-843. 
Mechali, M., K. Yoshida, P. Coulombe & P. Pasero, (2013) Genetic and epigenetic determinants 
of DNA replication origins, position and activation. Current opinion in genetics & 




Melville, S. E., V. Leech, M. Navarro & G. A. Cross, (2000) The molecular karyotype of the 
megabase chromosomes of Trypanosoma brucei stock 427. Molecular and biochemical 
parasitology 111: 261-273. 
Michaeli, S., D. Podell, N. Agabian & E. Ullu, (1992) The 7SL RNA homologue of Trypanosoma 
brucei is closely related to mammalian 7SL RNA. Molecular and biochemical 
parasitology 51: 55-64. 
Michels, P. A., A. Y. Liu, A. Bernards, P. Sloof, M. M. Van der Bijl, A. H. Schinkel, H. H. Menke, P. 
Borst, G. H. Veeneman, M. C. Tromp & J. H. Van Boom, (1983) Activation of the genes 
for variant surface glycoproteins 117 and 118 in Trypanosoma brucei. Journal of 
molecular biology 166: 537-556. 
Militello, K. T., P. Wang, S. K. Jayakar, R. L. Pietrasik, C. D. Dupont, K. Dodd, A. M. King & P. R. 
Valenti, (2008) African trypanosomes contain 5-methylcytosine in nuclear DNA. 
Eukaryotic cell 7: 2012-2016. 
Miller, C., B. Schwalb, K. Maier, D. Schulz, S. Dumcke, B. Zacher, A. Mayer, J. Sydow, L. 
Marcinowski, L. Dolken, D. E. Martin, A. Tresch & P. Cramer, (2011) Dynamic 
transcriptome analysis measures rates of mRNA synthesis and decay in yeast. Mol Syst 
Biol 7: 458. 
Miller, E. N., L. M. Allan & M. J. Turner, (1984) Mapping of antigenic determinants within 
peptides of a variant surface glycoprotein of Trypanosoma brucei. Molecular and 
biochemical parasitology 13: 309-322. 
Miller, E. N. & M. J. Turner, (1981) Analysis of antigenic types appearing in first relapse 
populations of clones of Trypanosoma brucei. Parasitology 82: 63-80. 
Miller, M. R., K. J. Robinson, M. D. Cleary & C. Q. Doe, (2009) TU-tagging: cell type-specific RNA 
isolation from intact complex tissues. Nat Methods 6: 439-441. 
Misteli, T., (2005) Concepts in nuclear architecture. Bioessays 27: 477-487. 
Misteli, T., (2014) The long reach of telomeres. Genes & development 28: 2445-2446. 
Misteli, T., A. Gunjan, R. Hock, M. Bustin & D. T. Brown, (2000) Dynamic binding of histone H1 
to chromatin in living cells. Nature 408: 877-881. 
Mogk, S., A. Meiwes, S. Shtopel, U. Schraermeyer, M. Lazarus, B. Kubata, H. Wolburg & M. 
Duszenko, (2014) Cyclical appearance of African trypanosomes in the cerebrospinal 
fluid: new insights in how trypanosomes enter the CNS. PloS one 9: e91372. 
Morey, J. S. & F. M. Van Dolah, (2013) Global analysis of mRNA half-lives and de novo 
transcription in a dinoflagellate, Karenia brevis. PloS one 8: e66347. 
Morrison, L. J., P. Majiwa, A. F. Read & J. D. Barry, (2005) Probabilistic order in antigenic 
variation of Trypanosoma brucei. International journal for parasitology 35: 961-972. 
Morrison, W. I., S. J. Black, J. Paris, C. A. Hinson & P. W. Wells, (1982) Protective immunity and 
specificity of antibody responses elicited in cattle by irradiated Trypanosoma brucei. 
Parasite immunology 4: 395-407. 
Mowatt, M. R. & C. E. Clayton, (1987) Developmental regulation of a novel repetitive protein of 
Trypanosoma brucei. Molecular and cellular biology 7: 2838-2844. 
Mugnier, M. R., G. A. Cross & F. N. Papavasiliou, (2015) The in vivo dynamics of antigenic 
variation in Trypanosoma brucei. Science 347: 1470-1473. 
Muhich, M. L. & J. C. Boothroyd, (1988) Polycistronic transcripts in trypanosomes and their 
accumulation during heat shock: evidence for a precursor role in mRNA synthesis. 
Molecular and cellular biology 8: 3837-3846. 
Munoz-Jordan, J. L., K. P. Davies & G. A. Cross, (1996) Stable expression of mosaic coats of 
variant surface glycoproteins in Trypanosoma brucei. Science 272: 1795-1797. 
Murga, M., I. Jaco, Y. Fan, R. Soria, B. Martinez-Pastor, M. Cuadrado, S. M. Yang, M. A. Blasco, 
A. I. Skoultchi & O. Fernandez-Capetillo, (2007) Global chromatin compaction limits the 




Najafabadi, H. S., Z. Lu, C. MacPherson, V. Mehta, V. Adoue, T. Pastinen & R. Salavati, (2013) 
Global identification of conserved post-transcriptional regulatory programs in 
trypanosomatids. Nucleic acids research 41: 8591-8600. 
Nakaar, V., A. O. Dare, D. Hong, E. Ullu & C. Tschudi, (1994) Upstream tRNA genes are essential 
for expression of small nuclear and cytoplasmic RNA genes in trypanosomes. 
Molecular and cellular biology 14: 6736-6742. 
Nalabothula, N., G. McVicker, J. Maiorano, R. Martin, J. K. Pritchard & Y. N. Fondufe-
Mittendorf, (2014) The chromatin architectural proteins HMGD1 and H1 bind 
reciprocally and have opposite effects on chromatin structure and gene regulation. 
BMC genomics 15: 92. 
Narayanan, M. S., M. Kushwaha, K. Ersfeld, A. Fullbrook, T. M. Stanne & G. Rudenko, (2011) 
NLP is a novel transcription regulator involved in VSG expression site control in 
Trypanosoma brucei. Nucleic acids research 39: 2018-2031. 
Narayanan, M. S. & G. Rudenko, (2013) TDP1 is an HMG chromatin protein facilitating RNA 
polymerase I transcription in African trypanosomes. Nucleic acids research 41: 2981-
2992. 
Narlikar, G. J., R. Sundaramoorthy & T. Owen-Hughes, (2013) Mechanisms and functions of 
ATP-dependent chromatin-remodeling enzymes. Cell 154: 490-503. 
Natesan, S. K., L. Peacock, K. Matthews, W. Gibson & M. C. Field, (2007) Activation of 
endocytosis as an adaptation to the mammalian host by trypanosomes. Eukaryotic cell 
6: 2029-2037. 
Navarro, M. & K. Gull, (2001) A pol I transcriptional body associated with VSG mono-allelic 
expression in Trypanosoma brucei. Nature 414: 759-763. 
Navarro, M., X. Penate & D. Landeira, (2007) Nuclear architecture underlying gene expression 
in Trypanosoma brucei. Trends Microbiol 15: 263-270. 
Ngo, H., C. Tschudi, K. Gull & E. Ullu, (1998) Double-stranded RNA induces mRNA degradation 
in Trypanosoma brucei. Proceedings of the National Academy of Sciences of the United 
States of America 95: 14687-14692. 
Nguyen, T. N., L. S. Muller, S. H. Park, T. N. Siegel & A. Gunzl, (2014) Promoter occupancy of the 
basal class I transcription factor A differs strongly between active and silent VSG 
expression sites in Trypanosoma brucei. Nucleic acids research 42: 3164-3176. 
Nguyen, T. N., B. N. Nguyen, J. H. Lee, A. K. Panigrahi & A. Gunzl, (2012) Characterization of a 
novel class I transcription factor A (CITFA) subunit that is indispensable for 
transcription by the multifunctional RNA polymerase I of Trypanosoma brucei. 
Eukaryotic cell 11: 1573-1581. 
Nguyen, T. N., B. Schimanski & A. Gunzl, (2007) Active RNA polymerase I of Trypanosoma 
brucei harbors a novel subunit essential for transcription. Molecular and cellular 
biology 27: 6254-6263. 
Nguyen, T. N., B. Schimanski, A. Zahn, B. Klumpp & A. Gunzl, (2006) Purification of an eight 
subunit RNA polymerase I complex in Trypanosoma brucei. Molecular and biochemical 
parasitology 149: 27-37. 
Nightingale, K., S. Dimitrov, R. Reeves & A. P. Wolffe, (1996) Evidence for a shared structural 
role for HMG1 and linker histones B4 and H1 in organizing chromatin. The EMBO 
journal 15: 548-561. 
Nikolova, T., M. Ensminger, M. Lobrich & B. Kaina, (2010) Homologous recombination protects 
mammalian cells from replication-associated DNA double-strand breaks arising in 
response to methyl methanesulfonate. DNA Repair (Amst) 9: 1050-1063. 
Nilsson, D., K. Gunasekera, J. Mani, M. Osteras, L. Farinelli, L. Baerlocher, I. Roditi & T. 
Ochsenreiter, (2010) Spliced leader trapping reveals widespread alternative splicing 





Nishino, Y., M. Eltsov, Y. Joti, K. Ito, H. Takata, Y. Takahashi, S. Hihara, A. S. Frangakis, N. 
Imamoto, T. Ishikawa & K. Maeshima, (2012) Human mitotic chromosomes consist 
predominantly of irregularly folded nucleosome fibres without a 30-nm chromatin 
structure. The EMBO journal 31: 1644-1653. 
Noble, W. S., (2009) How does multiple testing correction work? Nature biotechnology 27: 
1135-1137. 
Noll, M. & R. D. Kornberg, (1977) Action of micrococcal nuclease on chromatin and the location 
of histone H1. Journal of molecular biology 109: 393-404. 
Ogawa, Y., S. Aizawa, H. Shirakawa & M. Yoshida, (1995) Stimulation of transcription 
accompanying relaxation of chromatin structure in cells overexpressing high mobility 
group 1 protein. The Journal of biological chemistry 270: 9272-9280. 
Ogbadoyi, E., K. Ersfeld, D. Robinson, T. Sherwin & K. Gull, (2000) Architecture of the 
Trypanosoma brucei nucleus during interphase and mitosis. Chromosoma 108: 501-
513. 
Oguchi, Y., E. Kummer, F. Seyffer, M. Berynskyy, B. Anstett, R. Zahn, R. C. Wade, A. Mogk & B. 
Bukau, (2012) A tightly regulated molecular toggle controls AAA+ disaggregase. Nature 
structural & molecular biology 19: 1338-1346. 
Ong, H. B., N. Sienkiewicz, S. Wyllie, S. Patterson & A. H. Fairlamb, (2013) Trypanosoma brucei 
(UMP synthase null mutants) are avirulent in mice, but recover virulence upon 
prolonged culture in vitro while retaining pyrimidine auxotrophy. Molecular 
microbiology 90: 443-455. 
Opperdoes, F. R. & P. Borst, (1977) Localization of nine glycolytic enzymes in a microbody-like 
organelle in Trypanosoma brucei: the glycosome. FEBS letters 80: 360-364. 
Padeken, J. & P. Heun, (2014) Nucleolus and nuclear periphery: velcro for heterochromatin. 
Current opinion in cell biology 28: 54-60. 
Pan, W., O. Ogunremi, G. Wei, M. Shi & H. Tabel, (2006) CR3 (CD11b/CD18) is the major 
macrophage receptor for IgM antibody-mediated phagocytosis of African 
trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha 
and nitric oxide. Microbes Infect 8: 1209-1218. 
Pandya, U. M., R. Sandhu & B. Li, (2013) Silencing subtelomeric VSGs by Trypanosoma brucei 
RAP1 at the insect stage involves chromatin structure changes. Nucleic acids research 
41: 7673-7682. 
Park, S. H., T. N. Nguyen & A. Gunzl, (2012) Development of an efficient in vitro transcription 
system for bloodstream form Trypanosoma brucei reveals life cycle-independent 
functionality of class I transcription factor A. Molecular and biochemical parasitology 
181: 29-36. 
Park, S. H., T. N. Nguyen, J. K. Kirkham, J. H. Lee & A. Gunzl, (2011) Transcription by the 
multifunctional RNA polymerase I in Trypanosoma brucei functions independently of 
RPB7. Molecular and biochemical parasitology 180: 35-42. 
Patterton, H. G., C. C. Landel, D. Landsman, C. L. Peterson & R. T. Simpson, (1998) The 
biochemical and phenotypic characterization of Hho1p, the putative linker histone H1 
of Saccharomyces cerevisiae. The Journal of biological chemistry 273: 7268-7276. 
Pays, E., H. Coquelet, P. Tebabi, A. Pays, D. Jefferies, M. Steinert, E. Koenig, R. O. Williams & I. 
Roditi, (1990) Trypanosoma brucei: constitutive activity of the VSG and procyclin gene 
promoters. The EMBO journal 9: 3145-3151. 
Pays, E., J. Hanocq-Quertier, F. Hanocq, S. Van Assel, D. Nolan & S. Rolin, (1993) Abrupt RNA 
changes precede the first cell division during the differentiation of Trypanosoma brucei 
bloodstream forms into procyclic forms in vitro. Molecular and biochemical 
parasitology 61: 107-114. 
Peacock, L., V. Ferris, R. Sharma, J. Sunter, M. Bailey, M. Carrington & W. Gibson, (2011) 




Proceedings of the National Academy of Sciences of the United States of America 108: 
3671-3676. 
Pedram, M. & J. E. Donelson, (1999) The anatomy and transcription of a monocistronic 
expression site for a metacyclic variant surface glycoprotein gene in Trypanosoma 
brucei. The Journal of biological chemistry 274: 16876-16883. 
Perez-Morga, D., A. Amiguet-Vercher, D. Vermijlen & E. Pays, (2001) Organization of telomeres 
during the cell and life cycles of Trypanosoma brucei. The Journal of eukaryotic 
microbiology 48: 221-226. 
Perez-Ortin, J. E., P. Alepuz, S. Chavez & M. Choder, (2013) Eukaryotic mRNA decay: 
methodologies, pathways, and links to other stages of gene expression. Journal of 
molecular biology 425: 3750-3775. 
Pfaffl, M. W., (2001) A new mathematical model for relative quantification in real-time RT-PCR. 
Nucleic acids research 29: e45. 
Pham, V. P., C. C. Qi & K. M. Gottesdiener, (1996) A detailed mutational analysis of the VSG 
gene expression site promoter. Molecular and biochemical parasitology 75: 241-254. 
Pombo, A. & N. Dillon, (2015) Three-dimensional genome architecture: players and 
mechanisms. Nature reviews. Molecular cell biology 16: 245-257. 
Povelones, M. L., E. Gluenz, M. Dembek, K. Gull & G. Rudenko, (2012) Histone H1 Plays a Role 
in Heterochromatin Formation and VSG Expression Site Silencing in Trypanosoma 
brucei. PLoS pathogens 8: e1003010. 
Preuss, S. & C. S. Pikaard, (2007) rRNA gene silencing and nucleolar dominance: insights into a 
chromosome-scale epigenetic on/off switch. Biochimica et biophysica acta 1769: 383-
392. 
Proudfoot, C. & R. McCulloch, (2005) Distinct roles for two RAD51-related genes in 
Trypanosoma brucei antigenic variation. Nucleic acids research 33: 6906-6919. 
Proudfoot, C. & R. McCulloch, (2006) Trypanosoma brucei DMC1 does not act in DNA 
recombination, repair or antigenic variation in bloodstream stage cells. Molecular and 
biochemical parasitology 145: 245-253. 
Queiroz, R., C. Benz, K. Fellenberg, J. D. Hoheisel & C. Clayton, (2009) Transcriptome analysis of 
differentiating trypanosomes reveals the existence of multiple post-transcriptional 
regulons. BMC genomics 10: 495. 
Rabani, M., J. Z. Levin, L. Fan, X. Adiconis, R. Raychowdhury, M. Garber, A. Gnirke, C. Nusbaum, 
N. Hacohen, N. Friedman, I. Amit & A. Regev, (2011) Metabolic labeling of RNA 
uncovers principles of RNA production and degradation dynamics in mammalian cells. 
Nature biotechnology 29: 436-442. 
Radle, B., A. J. Rutkowski, Z. Ruzsics, C. C. Friedel, U. H. Koszinowski & L. Dolken, (2013) 
Metabolic labeling of newly transcribed RNA for high resolution gene expression 
profiling of RNA synthesis, processing and decay in cell culture. Journal of visualized 
experiments : JoVE. 
Ramachandran, A., M. Omar, P. Cheslock & G. R. Schnitzler, (2003) Linker histone H1 
modulates nucleosome remodeling by human SWI/SNF. The Journal of biological 
chemistry 278: 48590-48601. 
Ramakrishnan, V., (1997) Histone structure and the organization of the nucleosome. Annual 
review of biophysics and biomolecular structure 26: 83-112. 
Ramakrishnan, V., J. T. Finch, V. Graziano, P. L. Lee & R. M. Sweet, (1993) Crystal structure of 
globular domain of histone H5 and its implications for nucleosome binding. Nature 
362: 219-223. 
Ramey-Butler, K., E. Ullu, N. G. Kolev & C. Tschudi, (2015) Synchronous expression of individual 
metacyclic variant surface glycoprotein genes in Trypanosoma brucei. Molecular and 




Raz, B., M. Iten, Y. Grether-Buhler, R. Kaminsky & R. Brun, (1997) The Alamar Blue assay to 
determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. 
gambiense) in vitro. Acta tropica 68: 139-147. 
Respuela, P., M. Ferella, A. Rada-Iglesias & L. Aslund, (2008) Histone acetylation and 
methylation at sites initiating divergent polycistronic transcription in Trypanosoma 
cruzi. The Journal of biological chemistry 283: 15884-15892. 
Reuner, B., E. Vassella, B. Yutzy & M. Boshart, (1997) Cell density triggers slender to stumpy 
differentiation of Trypanosoma brucei bloodstream forms in culture. Molecular and 
biochemical parasitology 90: 269-280. 
Reynolds, D., L. Cliffe, K. U. Forstner, C. C. Hon, T. N. Siegel & R. Sabatini, (2014) Regulation of 
transcription termination by glucosylated hydroxymethyluracil, base J, in Leishmania 
major and Trypanosoma brucei. Nucleic acids research 42: 9717-9729. 
Robinson, N. P., N. Burman, S. E. Melville & J. D. Barry, (1999) Predominance of duplicative VSG 
gene conversion in antigenic variation in African trypanosomes. Molecular and cellular 
biology 19: 5839-5846. 
Robinson, P. J. & D. Rhodes, (2006) Structure of the '30 nm' chromatin fibre: a key role for the 
linker histone. Current opinion in structural biology 16: 336-343. 
Roditi, I., A. Furger, S. Ruepp, N. Schurch & P. Butikofer, (1998) Unravelling the procyclin coat 
of Trypanosoma brucei. Molecular and biochemical parasitology 91: 117-130. 
Roditi, I., H. Schwarz, T. W. Pearson, R. P. Beecroft, M. K. Liu, J. P. Richardson, H. J. Buhring, J. 
Pleiss, R. Bulow, R. O. Williams & et al., (1989) Procyclin gene expression and loss of 
the variant surface glycoprotein during differentiation of Trypanosoma brucei. The 
Journal of cell biology 108: 737-746. 
Ross, R. & D. Thomson, (1910) A Case of Sleeping Sickness showing Regular Periodical Increase 
of the Parasites Disclosed. British medical journal 1: 1544-1545. 
Roth, S. Y. & C. D. Allis, (1992) Chromatin condensation: does histone H1 dephosphorylation 
play a role? Trends in biochemical sciences 17: 93-98. 
Rout, M. P. & M. C. Field, (2001) Isolation and characterization of subnuclear compartments 
from Trypanosoma brucei. Identification of a major repetitive nuclear lamina 
component. The Journal of biological chemistry 276: 38261-38271. 
Rudenko, G., (2010) Epigenetics and transcriptional control in African trypanosomes. Essays 
Biochem 48: 201-219. 
Rudenko, G., (2011) African trypanosomes: the genome and adaptations for immune evasion. 
Essays Biochem 51: 47-62. 
Rudenko, G., D. Bishop, K. Gottesdiener & L. H. Van der Ploeg, (1989) Alpha-amanitin resistant 
transcription of protein coding genes in insect and bloodstream form Trypanosoma 
brucei. The EMBO journal 8: 4259-4263. 
Rudenko, G., H. M. Chung, V. P. Pham & L. H. Van der Ploeg, (1991) RNA polymerase I can 
mediate expression of CAT and neo protein-coding genes in Trypanosoma brucei. The 
EMBO journal 10: 3387-3397. 
Rudenko, G., S. Le Blancq, J. Smith, M. G. Lee, A. Rattray & L. H. Van der Ploeg, (1990) Procyclic 
acidic repetitive protein (PARP) genes located in an unusually small alpha-amanitin-
resistant transcription unit: PARP promoter activity assayed by transient DNA 
transfection of Trypanosoma brucei. Molecular and cellular biology 10: 3492-3504. 
Ruepp, S., A. Furger, U. Kurath, C. K. Renggli, A. Hemphill, R. Brun & I. Roditi, (1997) Survival of 
Trypanosoma brucei in the tsetse fly is enhanced by the expression of specific forms of 
procyclin. The Journal of cell biology 137: 1369-1379. 
Sabo, A., T. R. Kress, M. Pelizzola, S. de Pretis, M. M. Gorski, A. Tesi, M. J. Morelli, P. Bora, M. 
Doni, A. Verrecchia, C. Tonelli, G. Faga, V. Bianchi, A. Ronchi, D. Low, H. Muller, E. 
Guccione, S. Campaner & B. Amati, (2014) Selective transcriptional regulation by Myc 




Salmon, D., F. Paturiaux-Hanocq, P. Poelvoorde, L. Vanhamme & E. Pays, (2005) Trypanosoma 
brucei: growth differences in different mammalian sera are not due to the species-
specificity of transferrin. Experimental parasitology 109: 188-194. 
Sancho, M., E. Diani, M. Beato & A. Jordan, (2008) Depletion of human histone H1 variants 
uncovers specific roles in gene expression and cell growth. PLoS genetics 4: e1000227. 
Scherf, A., J. J. Lopez-Rubio & L. Riviere, (2008) Antigenic variation in Plasmodium falciparum. 
Annu Rev Microbiol 62: 445-470. 
Schimanski, B., T. N. Nguyen & A. Gunzl, (2005) Characterization of a multisubunit transcription 
factor complex essential for spliced-leader RNA gene transcription in Trypanosoma 
brucei. Molecular and cellular biology 25: 7303-7313. 
Schlimme, W., M. Burri, K. Bender, B. Betschart & H. Hecker, (1993) Trypanosoma brucei 
brucei: differences in the nuclear chromatin of bloodstream forms and procyclic 
culture forms. Parasitology 107 ( Pt 3): 237-247. 
Schurch, N., A. Furger, U. Kurath & I. Roditi, (1997) Contributions of the procyclin 3' 
untranslated region and coding region to the regulation of expression in bloodstream 
forms of Trypanosoma brucei. Molecular and biochemical parasitology 89: 109-121. 
Schwede, A., N. Jones, M. Engstler & M. Carrington, (2011) The VSG C-terminal domain is 
inaccessible to antibodies on live trypanosomes. Molecular and biochemical 
parasitology 175: 201-204. 
Seyffer, F., E. Kummer, Y. Oguchi, J. Winkler, M. Kumar, R. Zahn, V. Sourjik, B. Bukau & A. 
Mogk, (2012) Hsp70 proteins bind Hsp100 regulatory M domains to activate AAA+ 
disaggregase at aggregate surfaces. Nature structural & molecular biology 19: 1347-
1355. 
Sharma, R., E. Gluenz, L. Peacock, W. Gibson, K. Gull & M. Carrington, (2009) The heart of 
darkness: growth and form of Trypanosoma brucei in the tsetse fly. Trends in 
parasitology 25: 517-524. 
Sheader, K., S. Vaughan, J. Minchin, K. Hughes, K. Gull & G. Rudenko, (2005) Variant surface 
glycoprotein RNA interference triggers a precytokinesis cell cycle arrest in African 
trypanosomes. Proceedings of the National Academy of Sciences of the United States 
of America 102: 8716-8721. 
Shen, X. & M. A. Gorovsky, (1996) Linker histone H1 regulates specific gene expression but not 
global transcription in vivo. Cell 86: 475-483. 
Shen, X., L. Yu, J. W. Weir & M. A. Gorovsky, (1995) Linker histones are not essential and affect 
chromatin condensation in vivo. Cell 82: 47-56. 
Shimamura, A., M. Sapp, A. Rodriguez-Campos & A. Worcel, (1989) Histone H1 represses 
transcription from minichromosomes assembled in vitro. Molecular and cellular 
biology 9: 5573-5584. 
Shultz, L. D., F. Ishikawa & D. L. Greiner, (2007) Humanized mice in translational biomedical 
research. Nature reviews. Immunology 7: 118-130. 
Sidaway-Lee, K., M. J. Costa, D. A. Rand, B. Finkenstadt & S. Penfield, (2014) Direct 
measurement of transcription rates reveals multiple mechanisms for configuration of 
the Arabidopsis ambient temperature response. Genome biology 15: R45. 
Siegel, T. N., D. R. Hekstra, L. E. Kemp, L. M. Figueiredo, J. E. Lowell, D. Fenyo, X. Wang, S. 
Dewell & G. A. Cross, (2009) Four histone variants mark the boundaries of polycistronic 
transcription units in Trypanosoma brucei. Genes & development 23: 1063-1076. 
Siegel, T. N., D. R. Hekstra, X. Wang, S. Dewell & G. A. Cross, (2010) Genome-wide analysis of 
mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of 
splicing and polyadenylation sites. Nucleic acids research 38: 4946-4957. 
Siegel, T. N., T. Kawahara, J. A. Degrasse, C. J. Janzen, D. Horn & G. A. Cross, (2008) Acetylation 
of histone H4K4 is cell cycle regulated and mediated by HAT3 in Trypanosoma brucei. 




Simpson, R. T., (1978) Structure of the chromatosome, a chromatin particle containing 160 
base pairs of DNA and all the histones. Biochemistry 17: 5524-5531. 
Siriaco, G., R. Deuring, M. Chioda, P. B. Becker & J. W. Tamkun, (2009) Drosophila ISWI 
regulates the association of histone H1 with interphase chromosomes in vivo. Genetics 
182: 661-669. 
Sloof, P., A. de Haan, W. Eier, M. van Iersel, E. Boel, H. van Steeg & R. Benne, (1992) The 
nucleotide sequence of the variable region in Trypanosoma brucei completes the 
sequence analysis of the maxicircle component of mitochondrial kinetoplast DNA. 
Molecular and biochemical parasitology 56: 289-299. 
Smirlis, D., S. N. Bisti, E. Xingi, G. Konidou, M. Thiakaki & K. P. Soteriadou, (2006) Leishmania 
histone H1 overexpression delays parasite cell-cycle progression, parasite 
differentiation and reduces Leishmania infectivity in vivo. Molecular microbiology 60: 
1457-1473. 
Smith, T. K., N. Vasileva, E. Gluenz, S. Terry, N. Portman, S. Kramer, M. Carrington, S. Michaeli, 
K. Gull & G. Rudenko, (2009) Blocking variant surface glycoprotein synthesis in 
Trypanosoma brucei triggers a general arrest in translation initiation. PloS one 4: 
e7532. 
Stanne, T., M. S. Narayanan, S. Ridewood, A. Ling, K. Witmer, M. Kushwaha, S. Wiesler, B. 
Wickstead, J. Wood & G. Rudenko, (2015) Identification of the ISWI chromatin 
remodeling complex of the early branching eukaryote Trypanosoma brucei. The 
Journal of biological chemistry. 
Stanne, T. M., M. Kushwaha, M. Wand, J. E. Taylor & G. Rudenko, (2011) TbISWI regulates 
multiple polymerase I (Pol I)-transcribed loci and is present at Pol II transcription 
boundaries in Trypanosoma brucei. Eukaryotic cell 10: 964-976. 
Stanne, T. M. & G. Rudenko, (2010) Active VSG expression sites in Trypanosoma brucei are 
depleted of nucleosomes. Eukaryotic cell 9: 136-147. 
Strahl, B. D. & C. D. Allis, (2000) The language of covalent histone modifications. Nature 403: 
41-45. 
Stros, M., (2010) HMGB proteins: interactions with DNA and chromatin. Biochimica et 
biophysica acta 1799: 101-113. 
Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. 
Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander & J. P. Mesirov, (2005) Gene set 
enrichment analysis: a knowledge-based approach for interpreting genome-wide 
expression profiles. Proceedings of the National Academy of Sciences of the United 
States of America 102: 15545-15550. 
Talbert, P. B., K. Ahmad, G. Almouzni, J. Ausio, F. Berger, P. L. Bhalla, W. M. Bonner, W. Z. 
Cande, B. P. Chadwick, S. W. Chan, G. A. Cross, L. Cui, S. I. Dimitrov, D. Doenecke, J. M. 
Eirin-Lopez, M. A. Gorovsky, S. B. Hake, B. A. Hamkalo, S. Holec, S. E. Jacobsen, K. 
Kamieniarz, S. Khochbin, A. G. Ladurner, D. Landsman, J. A. Latham, B. Loppin, H. S. 
Malik, W. F. Marzluff, J. R. Pehrson, J. Postberg, R. Schneider, M. B. Singh, M. M. Smith, 
E. Thompson, M. E. Torres-Padilla, D. J. Tremethick, B. M. Turner, J. H. Waterborg, H. 
Wollmann, R. Yelagandula, B. Zhu & S. Henikoff, (2012) A unified phylogeny-based 
nomenclature for histone variants. Epigenetics & chromatin 5: 7. 
Tani, H. & N. Akimitsu, (2012) Genome-wide technology for determining RNA stability in 
mammalian cells: historical perspective and recent advantages based on modified 
nucleotide labeling. RNA Biol 9: 1233-1238. 
Tham, W. H. & V. A. Zakian, (2002) Transcriptional silencing at Saccharomyces telomeres: 
implications for other organisms. Oncogene 21: 512-521. 
Thatcher, T. H. & M. A. Gorovsky, (1994) Phylogenetic analysis of the core histones H2A, H2B, 




Thoma, F., T. Koller & A. Klug, (1979) Involvement of histone H1 in the organization of the 
nucleosome and of the salt-dependent superstructures of chromatin. The Journal of 
cell biology 83: 403-427. 
Thomas, J. O. & K. Stott, (2012) H1 and HMGB1: modulators of chromatin structure. 
Biochemical Society transactions 40: 341-346. 
Thomas, S., A. Green, N. R. Sturm, D. A. Campbell & P. J. Myler, (2009) Histone acetylations 
mark origins of polycistronic transcription in Leishmania major. BMC genomics 10: 152. 
Tiengwe, C., L. Marcello, H. Farr, N. Dickens, S. Kelly, M. Swiderski, D. Vaughan, K. Gull, J. D. 
Barry, S. D. Bell & R. McCulloch, (2012) Genome-wide analysis reveals extensive 
functional interaction between DNA replication initiation and transcription in the 
genome of Trypanosoma brucei. Cell Rep 2: 185-197. 
Travers, A. A., (2003) Priming the nucleosome: a role for HMGB proteins? EMBO reports 4: 
131-136. 
Trojer, P. & D. Reinberg, (2007) Facultative heterochromatin: is there a distinctive molecular 
signature? Molecular cell 28: 1-13. 
Turner, C. M., (1997) The rate of antigenic variation in fly-transmitted and syringe-passaged 
infections of Trypanosoma brucei. FEMS microbiology letters 153: 227-231. 
Turner, C. M. & J. D. Barry, (1989) High frequency of antigenic variation in Trypanosoma brucei 
rhodesiense infections. Parasitology 99 Pt 1: 67-75. 
Ullu, E., K. R. Matthews & C. Tschudi, (1993) Temporal order of RNA-processing reactions in 
trypanosomes: rapid trans splicing precedes polyadenylation of newly synthesized 
tubulin transcripts. Molecular and cellular biology 13: 720-725. 
Ullu, E. & C. Tschudi, (1991) Trans splicing in trypanosomes requires methylation of the 5' end 
of the spliced leader RNA. Proceedings of the National Academy of Sciences of the 
United States of America 88: 10074-10078. 
Urwyler, S., E. Studer, C. K. Renggli & I. Roditi, (2007) A family of stage-specific alanine-rich 
proteins on the surface of epimastigote forms of Trypanosoma brucei. Molecular 
microbiology 63: 218-228. 
Urwyler, S., E. Vassella, J. Van Den Abbeele, C. K. Renggli, P. Blundell, J. D. Barry & I. Roditi, 
(2005) Expression of procyclin mRNAs during cyclical transmission of Trypanosoma 
brucei. PLoS pathogens 1: e22. 
Ushinsky, S. C., H. Bussey, A. A. Ahmed, Y. Wang, J. Friesen, B. A. Williams & R. K. Storms, 
(1997) Histone H1 in Saccharomyces cerevisiae. Yeast 13: 151-161. 
van Leeuwen, F., M. C. Taylor, A. Mondragon, H. Moreau, W. Gibson, R. Kieft & P. Borst, (1998) 
beta-D-glucosyl-hydroxymethyluracil is a conserved DNA modification in kinetoplastid 
protozoans and is abundant in their telomeres. Proceedings of the National Academy 
of Sciences of the United States of America 95: 2366-2371. 
van Luenen, H. G., C. Farris, S. Jan, P. A. Genest, P. Tripathi, A. Velds, R. M. Kerkhoven, M. 
Nieuwland, A. Haydock, G. Ramasamy, S. Vainio, T. Heidebrecht, A. Perrakis, L. Pagie, 
B. van Steensel, P. J. Myler & P. Borst, (2012) Glucosylated hydroxymethyluracil, DNA 
base J, prevents transcriptional readthrough in Leishmania. Cell 150: 909-921. 
Vanhamme, L., M. Berberof, D. Le Ray & E. Pays, (1995a) Stimuli of differentiation regulate 
RNA elongation in the transcription units for the major stage-specific antigens of 
Trypanosoma brucei. Nucleic acids research 23: 1862-1869. 
Vanhamme, L., A. Pays, P. Tebabi, S. Alexandre & E. Pays, (1995b) Specific binding of proteins 
to the noncoding strand of a crucial element of the variant surface glycoprotein, 
procyclin, and ribosomal promoters of trypanosoma brucei. Molecular and cellular 
biology 15: 5598-5606. 
Vanhamme, L., P. Poelvoorde, A. Pays, P. Tebabi, H. Van Xong & E. Pays, (2000) Differential 
RNA elongation controls the variant surface glycoprotein gene expression sites of 




Vasquez, J. J., C. C. Hon, J. T. Vanselow, A. Schlosser & T. N. Siegel, (2014) Comparative 
ribosome profiling reveals extensive translational complexity in different Trypanosoma 
brucei life cycle stages. Nucleic acids research 42: 3623-3637. 
Vassella, E., A. Acosta-Serrano, E. Studer, S. H. Lee, P. T. Englund & I. Roditi, (2001) Multiple 
procyclin isoforms are expressed differentially during the development of insect forms 
of Trypanosoma brucei. Journal of molecular biology 312: 597-607. 
Vassella, E., J. V. Den Abbeele, P. Butikofer, C. K. Renggli, A. Furger, R. Brun & I. Roditi, (2000) A 
major surface glycoprotein of trypanosoma brucei is expressed transiently during 
development and can be regulated post-transcriptionally by glycerol or hypoxia. Genes 
& development 14: 615-626. 
Vassella, E., M. Probst, A. Schneider, E. Studer, C. K. Renggli & I. Roditi, (2004) Expression of a 
major surface protein of Trypanosoma brucei insect forms is controlled by the activity 
of mitochondrial enzymes. Molecular biology of the cell 15: 3986-3993. 
Vassella, E., B. Reuner, B. Yutzy & M. Boshart, (1997) Differentiation of African trypanosomes is 
controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP 
pathway. Journal of cell science 110 ( Pt 21): 2661-2671. 
Veitch, N. J., P. C. Johnson, U. Trivedi, S. Terry, D. Wildridge & A. MacLeod, (2010) Digital gene 
expression analysis of two life cycle stages of the human-infective parasite, 
Trypanosoma brucei gambiense reveals differentially expressed clusters of co-
regulated genes. BMC genomics 11: 124. 
Venkatesh, S. & J. L. Workman, (2015) Histone exchange, chromatin structure and the 
regulation of transcription. Nature reviews. Molecular cell biology 16: 178-189. 
Vicent, G. P., A. S. Nacht, J. Font-Mateu, G. Castellano, L. Gaveglia, C. Ballare & M. Beato, 
(2011) Four enzymes cooperate to displace histone H1 during the first minute of 
hormonal gene activation. Genes & development 25: 845-862. 
Vickerman, K., (1985) Developmental cycles and biology of pathogenic trypanosomes. British 
medical bulletin 41: 105-114. 
Vickerman, K. & T. M. Preston, (1970) Spindle microtubules in the dividing nuclei of 
trypanosomes. Journal of cell science 6: 365-383. 
Vujatovic, O., K. Zaragoza, A. Vaquero, O. Reina, J. Bernues & F. Azorin, (2012) Drosophila 
melanogaster linker histone dH1 is required for transposon silencing and to preserve 
genome integrity. Nucleic acids research 40: 5402-5414. 
Walrad, P. B., P. Capewell, K. Fenn & K. R. Matthews, (2012) The post-transcriptional trans-
acting regulator, TbZFP3, co-ordinates transmission-stage enriched mRNAs in 
Trypanosoma brucei. Nucleic acids research 40: 2869-2883. 
Wang, Q. P., T. Kawahara & D. Horn, (2010) Histone deacetylases play distinct roles in 
telomeric VSG expression site silencing in African trypanosomes. Molecular 
microbiology 77: 1237-1245. 
Wenrich, B. R. & T. A. Trumbo, (2012) Interaction of nucleic acids with Coomassie Blue G-250 in 
the Bradford assay. Analytical biochemistry 428: 93-95. 
WHO, (2013) Control and surveillance of human African trypanosomiasis: report of a WHO 
expert committee. In: WHO Tecnical Report Series. Geneva, Switzerland: World Health 
Organization, pp. 
WHO, (2015) Investing to overcome the global impact of neglected tropical diseases: third 
WHO report on neglected tropical diseases 
In. Geneva, Switzerland, pp. 
Wickstead, B., K. Ersfeld & K. Gull, (2004) The small chromosomes of Trypanosoma brucei 
involved in antigenic variation are constructed around repetitive palindromes. Genome 
research 14: 1014-1024. 
Williams, R. O., J. R. Young & P. A. Majiwa, (1982) Genomic environment of T. brucei VSG 




Windhager, L., T. Bonfert, K. Burger, Z. Ruzsics, S. Krebs, S. Kaufmann, G. Malterer, A. 
L'Hernault, M. Schilhabel, S. Schreiber, P. Rosenstiel, R. Zimmer, D. Eick, C. C. Friedel & 
L. Dolken, (2012) Ultrashort and progressive 4sU-tagging reveals key characteristics of 
RNA processing at nucleotide resolution. Genome research 22: 2031-2042. 
Wirtz, E., S. Leal, C. Ochatt & G. A. Cross, (1999) A tightly regulated inducible expression 
system for conditional gene knock-outs and dominant-negative genetics in 
Trypanosoma brucei. Molecular and biochemical parasitology 99: 89-101. 
Wolffe, A. P., S. Khochbin & S. Dimitrov, (1997) What do linker histones do in chromatin? 
Bioessays 19: 249-255. 
Woodcock, C. L., A. I. Skoultchi & Y. Fan, (2006) Role of linker histone in chromatin structure 
and function: H1 stoichiometry and nucleosome repeat length. Chromosome research : 
an international journal on the molecular, supramolecular and evolutionary aspects of 
chromosome biology 14: 17-25. 
Woodward, R. & K. Gull, (1990) Timing of nuclear and kinetoplast DNA replication and early 
morphological events in the cell cycle of Trypanosoma brucei. Journal of cell science 95 
( Pt 1): 49-57. 
Wright, J. R., T. N. Siegel & G. A. Cross, (2010) Histone H3 trimethylated at lysine 4 is enriched 
at probable transcription start sites in Trypanosoma brucei. Molecular and biochemical 
parasitology 172: 141-144. 
Wurst, M., B. Seliger, B. A. Jha, C. Klein, R. Queiroz & C. Clayton, (2012) Expression of the RNA 
recognition motif protein RBP10 promotes a bloodstream-form transcript pattern in 
Trypanosoma brucei. Molecular microbiology 83: 1048-1063. 
Yang, X., L. M. Figueiredo, A. Espinal, E. Okubo & B. Li, (2009) RAP1 is essential for silencing 
telomeric variant surface glycoprotein genes in Trypanosoma brucei. Cell 137: 99-109. 
Yun, M., J. Wu, J. L. Workman & B. Li, (2011) Readers of histone modifications. Cell research 21: 
564-578. 
Zhang, J. R., J. M. Hardham, A. G. Barbour & S. J. Norris, (1997) Antigenic variation in Lyme 
disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 
89: 275-285. 
Zhang, Y., M. Cooke, S. Panjwani, K. Cao, B. Krauth, P. Y. Ho, M. Medrzycki, D. T. Berhe, C. Pan, 
T. C. McDevitt & Y. Fan, (2012) Histone h1 depletion impairs embryonic stem cell 
differentiation. PLoS genetics 8: e1002691. 
Zheng, Y., S. John, J. J. Pesavento, J. R. Schultz-Norton, R. L. Schiltz, S. Baek, A. M. Nardulli, G. L. 
Hager, N. L. Kelleher & C. A. Mizzen, (2010) Histone H1 phosphorylation is associated 
with transcription by RNA polymerases I and II. The Journal of cell biology 189: 407-
415. 
Zomerdijk, J. C., R. Kieft & P. Borst, (1991) Efficient production of functional mRNA mediated 
by RNA polymerase I in Trypanosoma brucei. Nature 353: 772-775. 
Zomerdijk, J. C., M. Ouellette, A. L. ten Asbroek, R. Kieft, A. M. Bommer, C. E. Clayton & P. 
Borst, (1990) The promoter for a variant surface glycoprotein gene expression site in 
Trypanosoma brucei. The EMBO journal 9: 2791-2801. 
 
 
  
 
160 
 
7 ANNEXES 
 
7.1 PUBLICATIONS 
